https://bostonlifesciencestimes.com/2022/09/cadence-completes-acquisition-of-openeye-scientific/ 2022-09-01T14:53:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Cadence-Design-Systems.jpg https://bostonlifesciencestimes.com/2022/09/natures-toolbox-names-yesim-roth-as-chief-financial-officer/ 2022-09-01T14:54:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Yesim-Roth.jpg https://bostonlifesciencestimes.com/2022/09/biocytogen-lists-on-the-main-board-of-hkex-aiming-to-become-the-headstream-of-new-drugs/ 2022-09-01T15:01:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Biocytogen.jpg https://bostonlifesciencestimes.com/2022/09/algotherapeutix-announces-initiation-of-global-phase-2-clinical-trial-of-atx01-for-the-relief-of-pain-in-chemotherapy-induced-peripheral-neuropathy-in-adults/ 2022-09-01T15:05:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/AlgoTherapeutix.jpg https://bostonlifesciencestimes.com/2022/09/immusoft-announces-fda-clearance-of-ind-application-for-isp-001-for-mps-i-the-first-engineered-b-cell-therapy-to-enter-into-clinical-trials/ 2022-09-01T15:08:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Robert-Sikorski-MD-PhD.jpg https://bostonlifesciencestimes.com/2022/09/siemens-healthineers-brings-millions-of-rapid-covid-19-tests-to-market-with-rrds-supply-chain-and-warehousing-solutions/ 2022-09-01T15:14:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Siemens-Healthineers.jpg https://bostonlifesciencestimes.com/2022/09/garmin-releases-the-venu-sq-2-smart-watch-series/ 2022-09-01T15:18:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Venu-Sq-2.jpg https://bostonlifesciencestimes.com/2022/09/childrens-hospital-los-angeles-completes-2022-community-health-needs-assessment-to-help-understand-and-strengthen-its-neighborhood/ 2022-09-01T15:21:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Childrens-Hospital-Los-Angeles.jpg https://bostonlifesciencestimes.com/2022/09/lendmark-financial-commits-to-raising-10m-in-10-years-for-childhood-cancer-research/ 2022-09-01T15:24:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Lendmark.jpg https://bostonlifesciencestimes.com/2022/09/shrujal-baxi-md-mph-joins-iterative-scopes-as-chief-medical-officer/ 2022-09-01T15:26:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Shrujal-Baxi-MD-MPH.jpg https://bostonlifesciencestimes.com/2022/09/novo-nordisk-to-acquire-forma-therapeutics-and-expand-presence-in-sickle-cell-disease-and-rare-blood-disorders/ 2022-09-01T15:29:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Novo-Nordisk.jpg https://bostonlifesciencestimes.com/2022/09/esfm-launches-team-to-expand-self-performed-sustainability-and-energy-solutions/ 2022-09-01T15:59:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/ESFM.jpg https://bostonlifesciencestimes.com/2022/09/stryker-launches-new-gamma4-hip-fracture-nailing-system/ 2022-09-01T17:06:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Strykers-Gamma-System.jpg https://bostonlifesciencestimes.com/2022/09/know-labs-provides-update-on-irb-approved-internal-trial-of-non-invasive-glucose-monitoring-technology/ 2022-09-02T16:22:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Know-Labs.jpeg https://bostonlifesciencestimes.com/2022/09/walgreens-now-offering-appointments-for-updated-covid-19-pfizer-and-moderna-boosters/ 2022-09-02T16:24:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Walgreens.jpg https://bostonlifesciencestimes.com/2022/09/alira-health-expands-north-american-capabilities-with-the-acquisition-of-artisan-healthcare-consulting/ 2022-09-06T13:08:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Alira-Health.jpeg https://bostonlifesciencestimes.com/2022/09/enpro-announces-agreement-to-sell-ggb-to-timken-for-305-million/ 2022-09-06T13:11:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Enpro-scaled-e1638203095458.webp https://bostonlifesciencestimes.com/2022/09/magnus-medical-receives-fda-clearance-for-the-saint-neuromodulation-system-for-non-invasive-individualized-and-precise-treatment-of-severe-depression/ 2022-09-06T13:13:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Magnus-Medical.jpg https://bostonlifesciencestimes.com/2022/09/trinity-life-sciences-announces-the-appointment-of-maia-germain-as-chief-people-officer/ 2022-09-06T13:15:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Maia-Germain.jpg https://bostonlifesciencestimes.com/2022/09/synthace-appoints-dr-donald-deieso-as-new-board-chair/ 2022-09-06T13:16:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Donald-Deieso.jpg https://bostonlifesciencestimes.com/2022/09/imfinzi-durvalumab-plus-chemotherapy-approved-in-the-us-as-the-first-immunotherapy-regimen-for-patients-with-advanced-biliary-tract-cancer/ 2022-09-06T13:19:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/IMFINZI.jpg https://bostonlifesciencestimes.com/2022/09/dr-fabian-geldmacher-is-director-strategy-business-development-of-lysando-ag/ 2022-09-06T13:20:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Fabian-Geldmacher.jpg https://bostonlifesciencestimes.com/2022/09/ventus-therapeutics-opens-new-facility-in-waltham-ma-as-first-phase-of-global-expansion/ 2022-09-06T13:23:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Marcelo-Bigal-M.D.-Ph.D-e1662470592796.jpg https://bostonlifesciencestimes.com/2022/09/pelvic-fragility-fracture-patient-at-the-university-of-missouri-in-columbia-is-the-100th-person-treated-with-curvafix-im-implant-for-pelvic-fracture-fixation/ 2022-09-06T13:26:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/The-CurvaFix%C2%AE-IM-Implant.jpg https://bostonlifesciencestimes.com/2022/09/new-12-month-results-from-the-vatrac-trial-confirm-durable-efficacy-of-aerin-medicals-vivaer-in-patients-with-nasal-valve-collapse/ 2022-09-06T13:27:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/VATRAC.jpg https://bostonlifesciencestimes.com/2022/09/arsenal-biosciences-closes-220-million-series-b-financing-to-advance-programmable-cell-therapy-programs-into-clinical-development/ 2022-09-06T13:29:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Ken-Drazan-M.D..webp https://bostonlifesciencestimes.com/2022/09/cytoagents-announces-appointment-of-new-chief-medical-officer/ 2022-09-07T14:15:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Arthur-P.-Bertolino-MD-PhD-MBA.jpg https://bostonlifesciencestimes.com/2022/09/alloy-therapeutics-hires-people-executive-trier-bryant-as-president-of-venture-studio-82vs/ 2022-09-07T14:16:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Trier-Bryant.jpg https://bostonlifesciencestimes.com/2022/09/medable-selected-by-gsk-to-power-decentralized-and-hybrid-clinical-trials-across-global-product-portfolio/ 2022-09-07T14:18:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/medable.jpg https://bostonlifesciencestimes.com/2022/09/octapharma-usa-to-present-clinical-overview-of-dermatomyositis-during-the-myositis-associations-annual-conference/ 2022-09-07T14:20:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Octapharma.jpg https://bostonlifesciencestimes.com/2022/09/vandemark-chemical-announces-investment-from-sk-capital-in-partnership-with-comvest-partners/ 2022-09-07T14:23:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Jeff-Davis.jpg https://bostonlifesciencestimes.com/2022/09/sonoma-biotherapeutics-appoints-jessica-stitt-as-chief-financial-officer/ 2022-09-07T14:25:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Jessica-Stitt.jpg https://bostonlifesciencestimes.com/2022/09/voxneuro-announces-collaboration-with-boston-university-and-launch-of-clinical-studies-focusing-on-concussion-and-alzheimers-disease/ 2022-09-07T14:26:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Andrew-Budson-MD-Boston-University-Dr.-Kyle-Ruiter-PhD-VoxNeuro-Dr.-Katherine-Turk-MD-Boston-University.jpg https://bostonlifesciencestimes.com/2022/09/carroucell-raises-e1-5-million-to-introduce-breakthrough-microcarriers-and-customizable-processes-to-cell-and-gene-therapy-market/ 2022-09-07T14:29:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Screenshot-2022-09-07-at-10-28-16-Carroucell-%E2%80%93-Tailoring-microcarriers.png https://bostonlifesciencestimes.com/2022/09/guided-therapeutics-closes-3-3-million-bridge-financing/ 2022-09-07T14:31:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Guided-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/09/premia-spines-tops-spinal-joint-replacement-shows-potential-to-relieve-back-pain-and-maintain-mobility-without-adjacent-level-degeneration/ 2022-09-07T14:33:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/The-TOPS-System.jpg https://bostonlifesciencestimes.com/2022/09/otolith-labs-announces-20-million-series-a-financing-by-morningside-ventures/ 2022-09-07T14:38:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Sam-Owen-e1662561503185.jpg https://bostonlifesciencestimes.com/2022/09/bostongene-announces-strategic-alliance-with-the-massachusetts-general-hospital-cancer-center/ 2022-09-07T14:40:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/BostonGene.jpg https://bostonlifesciencestimes.com/2022/09/earlens-shares-fda-historical-ruling-on-otc-hearing-aids/ 2022-09-07T14:42:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Earlens.jpg https://bostonlifesciencestimes.com/2022/09/penumbra-announces-european-launch-of-red-reperfusion-catheters-for-stroke-care/ 2022-09-07T14:47:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Penumbras-RED.jpg https://bostonlifesciencestimes.com/2022/09/ambient-photonics-closes-17-5m-in-equipment-financing-to-support-opening-of-u-s-based-manufacturing-facility/ 2022-09-07T14:50:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Ambient-Photonics.jpg https://bostonlifesciencestimes.com/2022/09/capstan-therapeutics-launches-with-165-million-to-deliver-on-the-clinical-promise-of-precise-in-vivo-cell-engineering/ 2022-09-14T14:03:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/capstan-logo-black-cymk.jpg https://bostonlifesciencestimes.com/2022/09/integrated-dna-technologies-expands-customization-options-for-alt-r-custom-crispr-grna-libraries-for-drug-discovery/ 2022-09-14T14:11:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Alt-R%E2%84%A2-Custom-CRISPR-gRNA-Libraries.jpg https://bostonlifesciencestimes.com/2022/09/diamedica-therapeutics-appoints-julie-daves-as-svp-clinical-development-operations/ 2022-09-14T14:14:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/DiaMedica-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/09/olympus-launches-visera-elite-iii-surgical-visualization-platform/ 2022-09-14T14:17:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Surgical-visualization-platform-VISERA-ELITE-III.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/VISERA-ELITE-III-video-systems-center-OLYMPUS-OTV-S700.jpg https://bostonlifesciencestimes.com/2022/09/smithers-announces-new-environmental-risk-sciences-president/ 2022-09-14T14:21:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Stewart-B.-Jacobson.jpg https://bostonlifesciencestimes.com/2022/09/adding-multimedia-ideon-technologies-raises-us16m-series-a-to-accelerate-supernova-charged-subsurface-imaging-solution-for-critical-mineral-discovery/ 2022-09-14T14:25:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Ideon-Technologies-Cofounders.jpg https://bostonlifesciencestimes.com/2022/09/aptar-appoints-matthew-l-trerotola-to-its-board-of-directors/ 2022-09-14T14:29:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Matthew-L.-Trerotola.jpg https://bostonlifesciencestimes.com/2022/09/atomwise-appoints-gavin-hirst-ph-d-as-chief-scientific-officer/ 2022-09-14T14:33:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Atomwise-e1663166023421.jpg https://bostonlifesciencestimes.com/2022/09/dunad-therapeutics-announces-appointment-of-chief-rd-officer/ 2022-09-14T14:37:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dunad-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/09/new-scientific-research-confirms-high-accuracy-of-perfect-corp-ai-skin-technology-for-evaluating-skin-concerns-in-dermatology-settings/ 2022-09-14T14:45:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Perfect-Corp.-AI-Skin-Technology.jpg https://bostonlifesciencestimes.com/2022/09/cardiac-implants-announces-successful-therapeutic-adjustment-procedure-using-tri-ring-percutaneous-annuloplasty-device/ 2022-09-14T14:56:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Cardiac-Implants-LLC.jpg https://bostonlifesciencestimes.com/2022/09/heru-expands-wearable-platform-with-launch-of-dark-adaptation-establishing-market-leading-amd-portfolio/ 2022-09-14T14:57:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Heru.jpg https://bostonlifesciencestimes.com/2022/09/tct-2022-impella-enables-complete-revascularization-improved-quality-of-life-and-native-heart-recovery/ 2022-09-14T15:00:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Impella-5.5.jpg https://bostonlifesciencestimes.com/2022/09/acadia-healthcare-appoints-dr-nasser-khan-to-lead-its-ctc-business/ 2022-09-14T15:01:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Nasser-Khan.jpg https://bostonlifesciencestimes.com/2022/09/new-peer-reviewed-study-leverages-neuroptics-automated-pupillometry-to-measure-pupil-reactivity-differences-an-earlier-indicator-of-neurological-injury/ 2022-09-14T15:03:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/The-NeurOptics-NPi-Pupillometer.jpg https://bostonlifesciencestimes.com/2022/09/sollis-health-announces-new-chief-executive-officer/ 2022-09-14T15:05:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Brad-Olson.jpg https://bostonlifesciencestimes.com/2022/09/fabric-genomics-expands-leadership-team-in-precision-medicine/ 2022-09-14T15:08:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Sean-Hofherr-PhD-FACMG.jpg https://bostonlifesciencestimes.com/2022/09/probius-emerges-to-transform-data-acquisition-for-ai-in-healthcare-adding-john-baldoni-chief-scientific-officer-and-juan-c-cuevas-svp-marketing-and-business-development/ 2022-09-14T15:11:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/John-Baldoni.jpg https://bostonlifesciencestimes.com/2022/09/pfizer-initiates-phase-3-study-of-mrna-based-influenza-vaccine/ 2022-09-14T15:15:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pfizer.jpg https://bostonlifesciencestimes.com/2022/09/inversago-pharma-receives-ind-clearance-for-phase-2-trial-of-inv-202-in-diabetic-kidney-disease/ 2022-09-15T14:15:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Francois-Ravenelle.jpg https://bostonlifesciencestimes.com/2022/09/momentous-announces-6-5m-series-a/ 2022-09-15T14:19:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Momentous.jpg https://bostonlifesciencestimes.com/2022/09/vbi-vaccines-secures-100-million-debt-facility-from-k2-healthventures/ 2022-09-15T14:22:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Jeff-Baxter.webp https://bostonlifesciencestimes.com/2022/09/haya-therapeutics-appoints-brian-c-thomas-ph-d-as-chairperson-of-the-board-of-directors/ 2022-09-15T14:23:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Brian-C.-Thomas-Ph.D..jpg https://bostonlifesciencestimes.com/2022/09/diality-names-pamela-wapnick-as-chief-financial-officer/ 2022-09-15T14:26:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Pamela-Wapnick.png https://bostonlifesciencestimes.com/2022/09/alnylam-and-regeneron-report-promising-data-from-ongoing-phase-1-study-of-aln-hsd-in-nash-patients-and-healthy-volunteers/ 2022-09-15T14:29:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Alnylam-Ranks.jpg https://bostonlifesciencestimes.com/2022/09/heartbeam-granted-patent-for-12-lead-electrocardiogram-ecg-patch-monitor-intended-for-detection-of-heart-attacks-and-complex-cardiac-arrhythmias/ 2022-09-15T14:39:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/HeartBeam.webp https://bostonlifesciencestimes.com/2022/09/thermo-fisher-scientifics-ppd-clinical-research-business-selected-to-support-national-cancer-institutes-cancer-trials-support-unit/ 2022-09-15T14:41:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/09/endometriosis-researchers-one-step-closer-to-diagnosing-condition-with-menstrual-blood/ 2022-09-15T14:43:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Drs.-Peter-Gregersen-and-Christine-Metz.jpg https://bostonlifesciencestimes.com/2022/09/lifespin-launches-commercial-access-to-its-metabolic-profiler-software-and-database-for-pharma-and-biobank-services/ 2022-09-15T14:45:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Lifespin-GmbH.jpg https://bostonlifesciencestimes.com/2022/09/albertsons-companies-partners-with-winncompanies-to-bring-essential-services-directly-to-seniors-and-families-living-in-affordable-housing-communities/ 2022-09-15T14:49:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Albertsons-Companies.jpg https://bostonlifesciencestimes.com/2022/09/seoul-semiconductor-applies-violeds-disinfection-technology-to-luxury-sedan-genesis-g90/ 2022-09-15T14:52:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Violeds-UV-C-LED.jpg https://bostonlifesciencestimes.com/2022/09/hyperice-brings-the-heat-with-introduction-of-all-new-venom-go-and-venom-2/ 2022-09-15T15:02:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Robin-Arzon.jpg https://bostonlifesciencestimes.com/2022/09/lionrock-announces-stop-the-stigma-theme-for-2022-national-online-recovery-day-as-overdose-rates-surge/ 2022-09-15T15:07:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Lionrock.jpg https://bostonlifesciencestimes.com/2022/09/syngenta-seedcare-and-bioceres-crop-solutions-collaborate-to-bring-innovative-biological-seed-treatments-to-market/ 2022-09-16T15:01:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Syngenta-Seedcare.jpg https://bostonlifesciencestimes.com/2022/09/fda-approves-recover-iv-randomized-controlled-trial-with-exception-from-informed-consent-efic/ 2022-09-16T15:04:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/RECOVER-IV.jpg https://bostonlifesciencestimes.com/2022/09/nordson-corporation-appoints-milton-morris-to-board-of-directors/ 2022-09-16T15:07:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Nordson.png https://bostonlifesciencestimes.com/2022/09/naveris-inc-raises-51-million-to-advance-commercialization-of-navdx/ 2022-09-19T14:20:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Piyush-B.-Gupta-Ph.D..jpg https://bostonlifesciencestimes.com/2022/09/renovorx-appoints-angela-gill-nelms-as-chief-operating-officer/ 2022-09-19T14:29:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Angela-Gill.jpg https://bostonlifesciencestimes.com/2022/09/gamida-cell-appoints-abigail-l-jenkins-as-president-and-chief-executive-officer-bringing-broad-leadership-experience-in-commercializing-innovative-therapies/ 2022-09-19T14:32:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Abigail-L.-Jenkins.jpg https://bostonlifesciencestimes.com/2022/09/elevation-spine-inc-closes-11-million-series-b-financing/ 2022-09-19T14:35:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Elevation-Spine.png https://bostonlifesciencestimes.com/2022/09/biocorp-announces-the-ce-marking-of-solosmart-an-accessory-medical-device-for-sanofi-solostar-pens-at-the-occasion-of-easd/ 2022-09-19T14:36:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/BIOCORP.jpg https://bostonlifesciencestimes.com/2022/09/by-latinos-for-latinos-healthcare-startup-zocalo-health-closes-5-million-in-funding-to-launch-primary-care-services/ 2022-09-19T14:53:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Zocalo.jpg https://bostonlifesciencestimes.com/2022/09/masimo-appoints-new-leader-for-consumer-division/ 2022-09-19T15:09:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Blair-Tripodi.jpg https://bostonlifesciencestimes.com/2022/09/henry-schein-continues-its-mission-of-advancing-diversity-inclusion-in-dentistry/ 2022-09-19T15:14:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Henry-Schein.jpg https://bostonlifesciencestimes.com/2022/09/cosette-pharmaceuticals-announces-the-approval-and-launch-of-first-generic-versions-of-tazorac-tazarotene-gel-0-05-and-0-1-with-180-days-competitive-generic-therapy-cgt-exclusivity/ 2022-09-20T15:01:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Apurva-Saraf.jpg https://bostonlifesciencestimes.com/2022/09/scholar-rock-appoints-jay-backstrom-m-d-m-p-h-to-be-its-next-chief-executive-officer/ 2022-09-20T15:02:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Jay-Backstrom-M.D.-M.P.H..jpg https://bostonlifesciencestimes.com/2022/09/neuway-pharma-appoints-dr-oliver-ernst-as-chief-executive-officer-and-dr-thomas-christoph-as-chief-development-officer/ 2022-09-20T15:04:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Oliver-Ernst.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Thomas-Christoph.jpg https://bostonlifesciencestimes.com/2022/09/charles-river-associates-cra-expands-its-life-sciences-practice/ 2022-09-20T15:07:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-12-at-10-21-21-Paul-Maleh-Our-People-Charles-River-Associates.png https://bostonlifesciencestimes.com/2022/09/bxp-expands-life-sciences-portfolio-in-kendall-square-in-cambridge-ma/ 2022-09-20T15:12:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Bryan-J.-Koop.jpg https://bostonlifesciencestimes.com/2022/09/maxwell-biosciences-expands-leadership-team-with-the-appointment-of-three-senior-executives/ 2022-09-20T15:15:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Tony-Verco-MD-MBA.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Beth-Burnside-PhD.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Donald-Treacy-Jr.-PhD.jpg https://bostonlifesciencestimes.com/2022/09/veranex-expands-european-medtech-capabilities-with-acquisition-of-medidee/ 2022-09-20T15:21:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/David-W.-Dockhorn-M.S.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/09/butterfly-network-distributes-500-butterfly-iq-devices-to-healthcare-workers-in-kenya-to-transform-maternal-and-fetal-health/ 2022-09-20T15:46:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Butterfly-iQ-devices.jpg https://bostonlifesciencestimes.com/2022/09/revbio-receives-nih-grant-to-explore-the-treatment-of-vertebral-compression-fractures-with-its-regenerative-bone-adhesive-technology/ 2022-09-20T15:47:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/TETRANITE.jpg https://bostonlifesciencestimes.com/2022/09/see-a-more-complete-picture-of-your-health-with-index-bpm-an-fda-cleared-smart-blood-pressure-monitor-from-garmin/ 2022-09-20T15:49:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Garmin.jpg https://bostonlifesciencestimes.com/2022/09/johnson-johnson-opens-state-of-the-art-science-and-technology-campus-in-san-francisco-bay-area/ 2022-09-20T15:51:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Johnson-Johnson.jpg https://bostonlifesciencestimes.com/2022/09/therapeutic-solutions-international-secures-financing-to-complete-current-phase-iii-stem-cell-clinical-trial/ 2022-09-20T15:54:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Therapeutic-Solutions-International.jpg https://bostonlifesciencestimes.com/2022/09/dr-lawrence-garcia-joins-the-vascular-care-group-newton-wellesley/ 2022-09-20T15:55:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Lawrence-Garcia.jpg https://bostonlifesciencestimes.com/2022/09/northstar-medical-radioisotopes-and-iba-sign-agreement-for-two-additional-rhodotron-electron-beam-accelerators-for-commercial-production-of-radioisotopes/ 2022-09-20T15:57:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/IBA-Rhodotron%C2%AETT300-HE.jpg https://bostonlifesciencestimes.com/2022/09/thermo-fisher-scientific-partners-with-pennsylvania-biotechnology-center-to-support-life-sciences-growth-in-philadelphia/ 2022-09-21T14:16:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/09/cro-alliance-pharmas-executive-team-grows-by-four-supporting-bioanalytical-and-cmc-testing-expansions/ 2022-09-21T14:18:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Alliance-Pharma.jpg https://bostonlifesciencestimes.com/2022/09/nucleai-and-propath-uk-announce-partnership-for-end-to-end-ai-powered-spatial-analysis-of-a-30-plex-immunofluorescence-immuno-oncology-panel/ 2022-09-21T14:21:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/10-plex-immunofluorescence-stain.jpg https://bostonlifesciencestimes.com/2022/09/university-of-maryland-school-of-pharmacy-taps-komodo-health-platform-to-power-real-world-evidence-research/ 2022-09-21T14:25:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Screenshot_2021-01-11-Komodo-Health-Values-and-Mission.png https://bostonlifesciencestimes.com/2022/09/livermultiscan-shown-to-be-a-cost-effective-alternative-to-liver-biopsies-for-monitoring-patients-with-autoimmune-hepatitis/ 2022-09-21T14:34:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Perspectum.jpg https://bostonlifesciencestimes.com/2022/09/us-medical-innovations-raises-10-2-m-in-private-placement/ 2022-09-21T14:36:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/US-Medical-Innovations.jpg https://bostonlifesciencestimes.com/2022/09/bostongene-showcases-lifesaving-cancer-diagnostic-and-treatment-recommendation-test-at-the-81st-annual-meeting-of-the-japanese-cancer-association/ 2022-09-21T14:40:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/BostonGene.jpg https://bostonlifesciencestimes.com/2022/09/curative-upends-traditional-employer-based-healthcare-coverage-by-launching-a-no-copay-no-deductible-health-insurance-plan/ 2022-09-21T14:47:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Curative-Commons.jpg https://bostonlifesciencestimes.com/2022/09/hni-healthcare-a-leader-in-value-based-care-is-awarded-three-patents-for-innovations-that-transform-how-hospitalists-manage-inpatient-episodes/ 2022-09-21T14:56:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/VitalsMD.jpg https://bostonlifesciencestimes.com/2022/09/digilens-hires-ar-industry-pioneer-to-lead-next-phase-of-market-growth/ 2022-09-21T15:00:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Brian-Hamilton.jpg https://bostonlifesciencestimes.com/2022/09/poppy-health-releases-results-from-pilot-with-primary-health-on-indoor-air-safety-monitoring-for-schools/ 2022-09-21T15:07:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Poppy-Health.jpg https://bostonlifesciencestimes.com/2022/09/more-than-1-5-billion-women-worldwide-lack-essential-health-screenings/ 2022-09-21T15:09:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Hologic-Global-Womens-Health-Index.jpg https://bostonlifesciencestimes.com/2022/09/new-alliance-launched-to-tackle-global-seed-shortage-and-scale-reforestation/ 2022-09-21T15:12:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/seed-banks.jpg https://bostonlifesciencestimes.com/2022/09/aptar-expands-pharmaceutical-services-announces-exclusive-collaboration-between-aptar-pharma-and-fluidda/ 2022-09-22T15:56:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Aptar.jpg https://bostonlifesciencestimes.com/2022/09/tae-life-sciences-sponsored-study-details-results-of-proton-boron-fusion-therapy-biological-effectiveness/ 2022-09-22T16:05:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Bruce-Bauer-PhD.jpg https://bostonlifesciencestimes.com/2022/09/peter-bailey-joins-sentrics-as-chief-executive-officer/ 2022-09-22T16:09:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Peter-Bailey-e1663862962832.png https://bostonlifesciencestimes.com/2022/09/koch-modular-process-systems-to-discuss-optimal-mixing-in-agitated-extraction-columns-at-isec-2022/ 2022-09-22T16:12:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Don-Glatz.jpg https://bostonlifesciencestimes.com/2022/09/lazurite-to-work-with-lg-electronics-usa-as-a-reseller-of-lg-surgical-monitors/ 2022-09-22T16:17:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Lazurite.jpg https://bostonlifesciencestimes.com/2022/09/rockley-photonics-unveils-next-generation-higher-density-laser-spectrophotometer-chip-for-wearable-health-monitoring/ 2022-09-22T16:19:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/mTP-laser-array.jpg https://bostonlifesciencestimes.com/2022/09/penumbra-and-asahi-intecc-partner-with-goal-of-introducing-indigo-system-including-lightning-intelligent-aspiration-to-japan/ 2022-09-22T16:21:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/enumbras-Indigo%E2%84%A2-Aspiration-System.jpg https://bostonlifesciencestimes.com/2022/09/northwell-health-surpasses-1-billion-goal-in-its-first-system-wide-fundraising-campaign/ 2022-09-22T16:25:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Michael-Dowling.jpg https://bostonlifesciencestimes.com/2022/09/idex-corporation-appoints-katrina-l-helmkamp-as-non-executive-chair-william-m-cook-to-retire/ 2022-09-22T16:41:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Katrina-L.-Helmkamp.jpg https://bostonlifesciencestimes.com/2022/09/astera-labs-unveils-new-vancouver-location-to-further-expand-its-leadership-in-purpose-built-connectivity-solutions-for-ai-ml-infrastructure/ 2022-09-22T16:44:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Astera-Labs.jpg https://bostonlifesciencestimes.com/2022/09/carbon-ridge-secures-6-million-investment-from-leading-climate-investors-and-maritime-industry-leaders/ 2022-09-22T16:45:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Carbon-Ridge.jpg https://bostonlifesciencestimes.com/2022/09/leuko-raises-5-million-series-a-to-validate-and-bring-to-market-its-noninvasive-white-blood-cell-monitoring-technology-for-cancer-patients/ 2022-09-23T13:31:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dr.-Carlos-Castro-Gonzalez.jpg https://bostonlifesciencestimes.com/2022/09/spectrum-pharmaceuticals-announces-debt-financing-agreement-with-slr-capital-partners-with-30-million-funded-at-closing/ 2022-09-23T13:33:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Tom-Riga.jpg https://bostonlifesciencestimes.com/2022/09/janux-therapeutics-appoints-brenda-van-vreeswyk-as-head-of-human-resources/ 2022-09-23T13:35:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Janux-Therapeutics.png https://bostonlifesciencestimes.com/2022/09/volta-extends-its-charging-for-all-initiative-with-a-campaign-that-inspires-all-drivers-to-go-electric/ 2022-09-23T13:41:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Volta-Extends.jpg https://bostonlifesciencestimes.com/2022/09/tampax-makes-a-donation-to-the-endometriosis-foundation-of-america/ 2022-09-23T13:49:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Amy-Schumer.jpg https://bostonlifesciencestimes.com/2022/09/kaiser-permanente-mid-atlantic-health-plans-achieve-top-quality-ratings-in-the-nation/ 2022-09-23T13:51:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Richard-McCarthy-MD.jpg https://bostonlifesciencestimes.com/2022/09/nucleus-biologics-unveils-expanded-facility-in-san-diego-new-cleanrooms-to-support-cell-culture-media-manufacturing/ 2022-09-26T14:05:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Nucleus-Biologics.jpg https://bostonlifesciencestimes.com/2022/09/integrated-dna-technologies-launches-new-primetime-qpcr-one-step-master-mix-with-exclusive-mutant-enzyme/ 2022-09-26T14:12:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/IDT.jpg https://bostonlifesciencestimes.com/2022/09/amerihealth-caritas-appoints-david-finkel-executive-vice-president-specialty-products-and-services-and-strategic-business-operations/ 2022-09-26T14:17:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/David-Finkel.jpg https://bostonlifesciencestimes.com/2022/09/pfizer-and-biontech-submit-application-to-u-s-fda-for-emergency-use-authorization-of-omicron-ba-4-ba-5-adapted-bivalent-vaccine-booster-in-children-5-through-11-years-of-age/ 2022-09-26T14:18:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Pfizer.jpg https://bostonlifesciencestimes.com/2022/09/childrens-hospital-los-angeles-identifies-molecular-markers-to-increase-precision-in-treatment-of-retinoblastoma/ 2022-09-26T14:21:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Jesse-Berry-MD.jpg https://bostonlifesciencestimes.com/2022/09/massbios-biotech-accelerator-massbiodrive-announces-fall-2022-cohort-of-startups/ 2022-09-26T14:23:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Kendalle-Burlin-OConnell.jpg https://bostonlifesciencestimes.com/2022/09/more-than-200-exhibitors-on-hand-for-exciting-biomedevice-boston-show/ 2022-09-26T14:28:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Adrienne-Zepeda.png https://bostonlifesciencestimes.com/2022/09/synchronized-solutions-appoints-melissa-byington-as-chief-executive-officer/ 2022-09-26T14:31:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Synchronized-Solutions-e1664202696408.png https://bostonlifesciencestimes.com/2022/09/carejourney-appoints-ram-ramachandran-to-its-executive-team-as-president-products-and-services/ 2022-09-26T14:41:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Ram-Ramachandran.jpg https://bostonlifesciencestimes.com/2022/09/frazier-healthcare-partners-promotes-andy-caine-to-coo-partner-for-center-of-excellence-adds-two-center-of-excellence-team-members/ 2022-09-27T14:04:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Andy-Caine.jpg https://bostonlifesciencestimes.com/2022/09/arsenal-biosciences-announces-joint-discovery-collaboration-with-genentech-to-identify-features-of-successful-t-cell-therapies-for-oncology/ 2022-09-27T14:06:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Ken-Drazan-MD.webp https://bostonlifesciencestimes.com/2022/09/colossal-biosciences-spins-out-form-bio-to-revolutionize-computational-life-sciences/ 2022-09-27T14:18:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Colossal-Biosciences.jpg https://bostonlifesciencestimes.com/2022/09/komodo-health-appoints-lauren-stahl-as-head-of-sales/ 2022-09-27T14:22:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Lauren-Stahl.jpg https://bostonlifesciencestimes.com/2022/09/dem-biopharma-establishes-leadership-team-with-appointment-of-nenad-grmusa-as-ceo-and-christophe-queva-ph-d-as-cso/ 2022-09-27T14:26:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Nenad-Grmusa.jpg https://bostonlifesciencestimes.com/2022/09/gilles-gallant-bpharm-phd-fopq-receives-the-george-r-pettit-individual-input-to-the-field-award-for-2022/ 2022-09-27T14:29:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Gilles-Gallant.jpg https://bostonlifesciencestimes.com/2022/09/dalan-animal-health-closes-3-55-million-financing-round-for-launch-of-the-worlds-first-honeybee-vaccine/ 2022-09-27T14:33:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Dalan-Animal-Health.png https://bostonlifesciencestimes.com/2022/09/mesh-suture-inc-receives-fda-510k-clearance-for-duramesh/ 2022-09-27T14:40:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/MSi.jpg https://bostonlifesciencestimes.com/2022/09/siemens-first-to-receive-ul-listing-for-120-volt-single-pole-solid-state-circuit-breaker/ 2022-09-27T14:42:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Siemens.jpg https://bostonlifesciencestimes.com/2022/09/woebot-health-names-brad-gescheider-as-chief-commercial-officer/ 2022-09-27T14:44:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Brad-Gescheider.jpg https://bostonlifesciencestimes.com/2022/09/guideway-care-chief-medical-officer-edward-e-partridge-md-honored-at-2022-beyond-blue-benefit-to-end-prostate-cancer/ 2022-09-27T14:47:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Edward-E.-Partridge-MD.jpg https://bostonlifesciencestimes.com/2022/09/blue-earth-diagnostics-announces-fda-acceptance-of-new-drug-application-for-18f-rhpsma-7-3-a-radiohybrid-prostate-specific-membrane-antigen-targeted-pet-imaging-agent-for-prostate-cancer/ 2022-09-27T14:48:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/18F-rhPSMA-7.3-PET.jpg https://bostonlifesciencestimes.com/2022/09/wasabi-technologies-closes-250-million-in-new-funding-to-usher-in-the-future-of-cloud-storage/ 2022-09-27T14:53:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Wasabi-Technologies.png https://bostonlifesciencestimes.com/2022/09/avidbots-raises-70m-in-series-c-funding/ 2022-09-27T15:03:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Avidbots.jpg https://bostonlifesciencestimes.com/2022/09/qnovia-inc-raises-17-million-in-series-a-funding-to-advance-its-inhalable-therapeutics-pipeline/ 2022-09-28T13:57:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Qnovia.jpg https://bostonlifesciencestimes.com/2022/09/is-it-covid-19-or-flu-a-dual-antigen-test-developed-by-irish-company-mybio-now-available-to-the-public/ 2022-09-28T14:00:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Screenshot-2022-09-28-at-10-00-07-Linda-300.jpg-AVIF-Image-300-%C3%97-300-pixels.png https://bostonlifesciencestimes.com/2022/09/cinrx-pharma-announces-first-study-participant-dosed-in-cinfinas-phase-i-multiple-ascending-dose-mad-study-of-cin-109-for-the-treatment-of-obesity/ 2022-09-28T14:04:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Screenshot-2022-09-28-at-10-03-33-About-CINRX-Pharma.png https://bostonlifesciencestimes.com/2022/09/rob-parr-rejoins-wilson-sonsini-in-boston-as-the-firm-continues-to-expand-its-technology-transactions-department/ 2022-09-28T14:12:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Rob-Parr.jpg https://bostonlifesciencestimes.com/2022/09/code-biotherapeutics-names-david-anderson-phd-as-chief-scientific-officer/ 2022-09-28T14:17:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Code-Biotherapeutics.webp https://bostonlifesciencestimes.com/2022/09/thermo-fisher-scientific-launches-a-more-sustainable-solution-for-large-scale-cell-culture-harvesting/ 2022-09-28T14:30:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Thermo-Fisher-Scientific.jpg https://bostonlifesciencestimes.com/2022/09/gandeeva-therapeutics-appoints-matthew-lucas-ph-d-as-chief-scientific-officer-and-david-poon-ph-d-as-chief-business-officer/ 2022-09-28T14:32:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Matthew-Lucas-Ph.D..jpg https://bostonlifesciencestimes.com/2022/09/sudo-biosciences-raises-37m-series-a-financing-to-advance-precision-tyk2-therapeutics/ 2022-09-28T14:34:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Scott-Byrd.jpg https://bostonlifesciencestimes.com/2022/09/spectrum-chemical-appoints-russell-kneipp-as-president-and-ceo-names-randy-burg-co-chairman/ 2022-09-28T14:37:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Russell-Kneipp.jpg https://bostonlifesciencestimes.com/2022/09/gov-hochul-tours-renovated-feinstein-institutes-bioelectronic-medicine-lab-announces-first-10-million-award/ 2022-09-28T14:39:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Kathy-Hochul.jpg https://bostonlifesciencestimes.com/2022/09/heartbeam-granted-patent-for-signal-transformation-from-vector-electrocardiogram-vecg-to-12-lead-electrocardiogram-ecg/ 2022-09-28T15:04:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/HeartBeam.webp https://bostonlifesciencestimes.com/2022/09/scientists-create-non-psychedelic-compound-with-same-anti-depressant-effect/ 2022-09-28T15:07:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Byran-L.-Roth-MD-PhD.jpg https://bostonlifesciencestimes.com/2022/09/northwell-health-spearheads-national-gun-safety-movement-to-address-guns-as-leading-cause-of-death-in-kids/ 2022-09-28T15:09:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Northwell-Health.jpg https://bostonlifesciencestimes.com/2022/09/henry-ford-health-and-acadia-healthcare-break-ground-on-new-behavioral-health-hospital/ 2022-09-28T15:12:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Henry-Ford-Health-and-Acadia-Healthcare.jpg https://bostonlifesciencestimes.com/2022/09/restore-hyper-wellness-appoints-kathryn-stalmack-as-general-counsel/ 2022-09-28T15:14:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Kathryn-Stalmack.jpg https://bostonlifesciencestimes.com/2022/10/wavemaker-three-sixty-health-expands-footprint-with-opening-of-outpost-in-the-bay-area/ 2022-10-03T13:33:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Kunal-Varshneya-M.D.jpg https://bostonlifesciencestimes.com/2022/10/h-i-g-capital-acquires-morningside-healthcare-and-morningside-pharmaceuticals/ 2022-10-03T13:34:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/H.I.G.-Capital.jpg https://bostonlifesciencestimes.com/2022/10/alloy-therapeutics-raises-42-million-series-d-financing-to-accelerate-discovery-technology-development-across-biologic-modalities/ 2022-10-03T13:36:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Alloy-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/10/erika-cheung-opens-biomedevice-boston-with-keynote-on-ethical-practices-for-medtech-industry-from-theranos-experience/ 2022-10-03T13:41:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Erika-Cheung.jpg https://bostonlifesciencestimes.com/2022/10/wearable-medical-devices-company-acurable-raises-e11m-in-series-a-funding-round/ 2022-10-03T13:42:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Acurable.jpg https://bostonlifesciencestimes.com/2022/10/alexion-astrazeneca-rare-disease-to-acquire-logicbio-therapeutics-to-accelerate-growth-in-genomic-medicine/ 2022-10-03T13:47:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/AstraZeneca-India.jpg https://bostonlifesciencestimes.com/2022/10/enviva-celebrates-its-recently-opened-wood-biomass-facility-in-george-county-mississippi-with-ceremonial-ribbon-cutting/ 2022-10-03T14:13:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Enviva.jpg https://bostonlifesciencestimes.com/2022/10/arctoris-welcomes-on-board-globally-recognized-experts-in-machine-learning-chemical-computation-and-alzheimers-disease/ 2022-10-04T13:56:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Arctoris.jpg https://bostonlifesciencestimes.com/2022/10/inder-sidhu-joins-innovaccers-leadership-team/ 2022-10-04T13:58:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Inder-Sidhu.jpg https://bostonlifesciencestimes.com/2022/10/bostongene-announces-publication-in-cell-reports-revealing-spatial-heterogeneity-in-the-tumor-microenvironment-of-multiregional-clear-cell-renal-cell-carcinoma-biopsies/ 2022-10-04T14:01:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/BostonGene.jpg https://bostonlifesciencestimes.com/2022/10/thermo-fisher-scientific-adds-new-ultra-low-temperature-chest-freezer-to-green-portfolio-offering-eco-friendly-compliant-and-secure-cold-storage/ 2022-10-04T14:03:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Thermo-Scientific-TDE-Series-80%C2%B0C-Chest-Freezers.jpg https://bostonlifesciencestimes.com/2022/10/quantum-si-appoints-jeff-hawkins-as-chief-executive-officer/ 2022-10-04T14:04:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jeff-Hawkins.jpg https://bostonlifesciencestimes.com/2022/10/cellarity-announces-close-of-121-million-series-c-financing/ 2022-10-04T14:07:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Fabrice-Chouraqui-PharmD.png https://bostonlifesciencestimes.com/2022/10/myrtelle-completes-dosing-of-8-patients-with-canavan-disease-in-its-phase-1-2-clinical-trial-of-the-investigational-gene-therapy-raav-olig001-aspa/ 2022-10-04T14:13:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Myrtelle.png https://bostonlifesciencestimes.com/2022/10/sibylla-biotech-raises-e23-million-series-a-to-advance-protein-degradation-by-folding-interference-pipeline-and-expand-technology-platform/ 2022-10-04T14:15:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Lidia-Pieri-PhD.jpg https://bostonlifesciencestimes.com/2022/10/exactech-names-new-chief-financial-officer/ 2022-10-04T14:17:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Tony-Collins.jpg https://bostonlifesciencestimes.com/2022/10/stryker-launches-monterey-al-interbody-system-with-new-pre-clinical-data/ 2022-10-04T14:19:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Strykers-Monterey-AL-Interbody-System.jpg https://bostonlifesciencestimes.com/2022/10/multi-radiance-medical-therapeutic-laser-receives-fda-clearance-for-the-treatment-of-pain-associated-with-fibromyalgia/ 2022-10-04T14:20:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Multi-Radiance-Medical.jpg https://bostonlifesciencestimes.com/2022/10/seoul-viosys-applies-violeds-disinfection-technology-to-kts-ai-disinfection-robots/ 2022-10-04T14:27:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Seoul-Viosys-Violeds-Technology-Applied-to-KTs-AI-Disinfection-Robots.jpg https://bostonlifesciencestimes.com/2022/10/spire-orthopedic-partners-announces-chief-financial-officer/ 2022-10-04T14:30:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Patrick-Seiler.jpg https://bostonlifesciencestimes.com/2022/10/cross-country-healthcare-closes-acquisitions-of-mint-medical-physician-staffing-lp-and-lotus-medical-staffing-llc/ 2022-10-04T14:32:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Cross-Country-Healthcare.jpg https://bostonlifesciencestimes.com/2022/10/adaptive-phage-therapeutics-awarded-additional-5-million-from-u-s-defense-health-agency-to-support-diabetic-foot-osteomyelitis-clinical-trial/ 2022-10-04T14:38:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Adaptive-Phage-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/10/personal-health-assistant-renee-launches-to-make-healthcare-as-easy-and-supportive-as-a-devoted-loved-one/ 2022-10-04T14:39:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Renee.jpg https://bostonlifesciencestimes.com/2022/10/thermo-fisher-scientific-announces-new-cryo-tem-with-expansive-automation-features-to-help-accelerate-drug-discovery-research/ 2022-10-05T13:25:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Glacios-2-Cryo-TEM.jpg https://bostonlifesciencestimes.com/2022/10/massive-bio-and-perthera-ai-partner-to-empower-cancer-patients-with-personalized-therapies-and-accurate-trial-recommendations/ 2022-10-05T13:28:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Selin-Kurnaz.jpg https://bostonlifesciencestimes.com/2022/10/myonex-completes-acquisition-of-hubertus-clinical-trial-and-packaging-business/ 2022-10-05T13:30:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Myonex.png https://bostonlifesciencestimes.com/2022/10/high-frequency-electrical-stimulation-helps-reduce-inflammation-pain-in-new-feinstein-institutes-study/ 2022-10-05T13:32:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Feinstein-Institutes.jpg https://bostonlifesciencestimes.com/2022/10/areteia-therapeutics-announces-the-appointments-of-dr-eric-bradford-as-chief-medical-officer-and-robin-walker-as-chief-legal-officer-and-corporate-secretary/ 2022-10-05T13:34:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Areteia-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/10/spinex-demonstrates-groundbreaking-technology-to-treat-children-with-cerebral-palsy/ 2022-10-05T13:49:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/SCiP.jpg https://bostonlifesciencestimes.com/2022/10/apnimed-expands-senior-leadership-team-by-appointing-john-cronin-m-d-senior-vice-president-clinical-development/ 2022-10-05T13:50:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/John-Cronin-M.D.jpg https://bostonlifesciencestimes.com/2022/10/bayer-completes-sale-of-its-environmental-science-professional-business-to-cinven/ 2022-10-05T13:54:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Bayer.jpg https://bostonlifesciencestimes.com/2022/10/credo-introduces-screaming-eagle-112g-retimer-dsp-with-industry-leading-1-6-terabit-capacity/ 2022-10-05T13:58:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Credo.jpg https://bostonlifesciencestimes.com/2022/10/pfizer-completes-acquisition-of-global-blood-therapeutics/ 2022-10-05T14:07:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pfizer.jpg https://bostonlifesciencestimes.com/2022/10/si-ware-partners-with-ab-vista-to-offer-the-neospectra-platform-to-the-animal-feed-industry/ 2022-10-06T14:43:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/NeoSpectra.jpg https://bostonlifesciencestimes.com/2022/10/bayer-names-william-dodero-new-u-s-general-counsel-beginning-january-2023/ 2022-10-06T14:46:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/William-Dodero.jpg https://bostonlifesciencestimes.com/2022/10/q%c2%b2-solutions-launches-innovative-self-collection-safety-lab-panel-in-collaboration-with-tasso/ 2022-10-06T14:48:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Brian-ODwyer.webp https://bostonlifesciencestimes.com/2022/10/lifemine-therapeutics-expands-management-team-with-appointments-of-martin-stahl-ph-d-as-chief-scientific-officer-and-louis-plamondon-ph-d-as-executive-vice-president-and-head-of-cmc/ 2022-10-06T14:53:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-06-at-10-51-01-Home-LifeMine.png https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-06-at-10-52-56-Home-LifeMine.png https://bostonlifesciencestimes.com/2022/10/revelation-biosciences-inc-and-vanderbilt-university-enter-exclusive-worldwide-license-agreement/ 2022-10-06T14:55:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Revelation-Biosciences-Inc.png https://bostonlifesciencestimes.com/2022/10/peptilogics-announces-first-patient-dosed-in-phase-1b-study-of-plg0206-for-periprosthetic-joint-infection/ 2022-10-06T14:57:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/David-Huang-M.D.-Ph.D.png https://bostonlifesciencestimes.com/2022/10/energy-capital-ventures-closes-61-million-fund-i-to-accelerate-the-natural-gas-industrys-esg-transformation/ 2022-10-06T14:59:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Vic-Pascucci.jpg https://bostonlifesciencestimes.com/2022/10/upstream-bio-announces-clinical-advisory-and-leadership-appointments/ 2022-10-06T15:02:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Upstream-Bio.jpg https://bostonlifesciencestimes.com/2022/10/rectify-pharmaceuticals-appoints-robert-hughes-as-executive-vice-president-drug-discovery-and-preclinical-development-and-xiaobing-li-as-chief-development-officer/ 2022-10-06T15:03:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Rectify-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/10/colossal-accelerates-research-and-development-of-life-saving-vaccine-to-prevent-elephant-extinction/ 2022-10-06T15:10:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Colossal-Biosciences.jpg https://bostonlifesciencestimes.com/2022/10/lazurite-to-exhibit-its-arthrofree-wireless-camera-system-at-the-american-college-of-surgeons-clinical-congress-2022/ 2022-10-06T15:12:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Lazurite.jpg https://bostonlifesciencestimes.com/2022/10/desktop-health-receives-fda-clearance-for-smileguard-resin-for-durable-and-comfortable-orthodontic-and-dental-appliances/ 2022-10-06T15:16:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/SmileGuard.jpg https://bostonlifesciencestimes.com/2022/10/icon-selected-by-barda-to-conduct-anthrax-vaccine-clinical-trial/ 2022-10-06T15:18:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dr.-Steve-Cutler.png https://bostonlifesciencestimes.com/2022/10/life-spine-announces-fda-510k-clearance-for-the-ghost-3d-printed-titanium-spacer-system/ 2022-10-06T15:21:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Life-Spine.jpg https://bostonlifesciencestimes.com/2022/10/nym-launches-radiology-coding-solution-for-revenue-cycle-management/ 2022-10-06T15:25:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-06-at-11-24-35-Company.png https://bostonlifesciencestimes.com/2022/10/soundport-the-new-domicile-of-ferring-pharmaceuticals-a-s-is-inaugurated/ 2022-10-06T15:28:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Ferring-Soundport-Building.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Ferring-Soundport-Building-1.jpg https://bostonlifesciencestimes.com/2022/10/eurosets-presents-colibri-the-lightest-and-most-compact-ecls-system-in-the-market-which-may-be-transported-even-in-a-backpack/ 2022-10-06T15:33:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Ettore-Sansavini.jpg https://bostonlifesciencestimes.com/2022/10/medical-properties-trust-announces-agreement-to-sell-connecticut-hospitals/ 2022-10-06T15:39:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Medical-Properties.jpg https://bostonlifesciencestimes.com/2022/10/topcon-introduces-nw500-non-mydriatic-retinal-camera/ 2022-10-06T15:44:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/NW500.jpg https://bostonlifesciencestimes.com/2022/10/self-collection-kits-provide-convenient-care-for-sexually-transmitted-infections-for-residents-in-all-alabama-counties/ 2022-10-06T15:47:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Alabama.jpg https://bostonlifesciencestimes.com/2022/10/phoenix-pharmalabs-awarded-8-7-million-grant-from-nida-to-study-compound-for-treatment-of-cocaine-use-disorder/ 2022-10-06T15:49:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Phoenix-PharmaLabs.png https://bostonlifesciencestimes.com/2022/10/adocia-announces-exceptional-weight-loss-for-obese-people-with-type-1-diabetes-using-m1pram-in-a-post-hoc-analysis/ 2022-10-06T15:57:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-06-at-11-30-50-Presentation-%E2%80%93-Management-%E2%80%93-ADOCIA-a-biotechnology-company-dedicated-to-protein-delivery.png https://bostonlifesciencestimes.com/2022/10/getvisibility-ramps-up-global-expansion-as-it-opens-new-san-francisco-office/ 2022-10-07T14:05:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jacinta-Tobin.jpg https://bostonlifesciencestimes.com/2022/10/waters-marks-25-years-in-ireland-with-e6-million-clinical-diagnostics-rd-center-expansion-in-wexford/ 2022-10-07T14:06:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Waters-Corp.jpg https://bostonlifesciencestimes.com/2022/10/6-month-data-from-the-surmodics-swing-first-in-human-study-to-be-presented-at-amp-europe/ 2022-10-07T14:09:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Surmodics.png https://bostonlifesciencestimes.com/2022/10/twinstrand-biosciences-announces-leadership-transition/ 2022-10-07T14:14:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Chad-Brown-e1665152039666.jpg https://bostonlifesciencestimes.com/2022/10/for-second-time-humana-kentucky-medicare-advantage-hmo-plan-achieves-prestigious-5-star-rating/ 2022-10-07T14:30:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Humana-Healthy-Horizons.jpg https://bostonlifesciencestimes.com/2022/10/teva-reaches-agreement-with-arkansas-to-settle-the-states-price-fixing-claims/ 2022-10-07T14:38:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Teva-Pharmaceuticals.png https://bostonlifesciencestimes.com/2022/10/invivo-therapeutics-announces-9-million-registered-direct-and-private-placement-offerings-priced-at-the-market-under-nasdaq-rules/ 2022-10-07T14:39:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/InVivo.jpg https://bostonlifesciencestimes.com/2022/10/trialbee-further-expands-leadership-team-with-new-vp-of-global-sales-jo-holton/ 2022-10-11T13:57:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jo-Holton.jpg https://bostonlifesciencestimes.com/2022/10/the-tissue-reference-group-at-the-fda-recognizes-biolab-sciences-membrane-wrap-hydro-as-an-hct-p/ 2022-10-11T14:01:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/BioLab-Sciences.jpg https://bostonlifesciencestimes.com/2022/10/u-s-fda-accepts-for-priority-review-the-supplemental-biologics-license-application-for-gileads-trodelvy-for-pre-treated-hr-her2-metastatic-breast-cancer/ 2022-10-11T14:02:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Trodelvy.webp https://bostonlifesciencestimes.com/2022/10/waters-automates-solid-phase-extraction-of-biological-food-and-environmental-samples-with-andrew-pipetting-robot/ 2022-10-11T14:03:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/The-Extraction-Connected-Device.jpg https://bostonlifesciencestimes.com/2022/10/perficient-announces-acquisition-of-ameex-technologies/ 2022-10-11T14:05:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Perficient.jpg https://bostonlifesciencestimes.com/2022/10/applied-dna-announces-receipt-of-largest-single-purchase-order-for-lineardna-to-date/ 2022-10-11T14:06:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Applied-DNA.jpg https://bostonlifesciencestimes.com/2022/10/1910-genetics-appoints-patrick-genestin-as-chief-business-officer/ 2022-10-11T14:09:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Patrick-Genestin.jpg https://bostonlifesciencestimes.com/2022/10/metagenomi-announces-opening-of-manufacturing-facility-for-its-next-generation-crispr-gene-editing-systems-and-therapies/ 2022-10-11T14:10:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Metagenomi.jpg https://bostonlifesciencestimes.com/2022/10/board-certified-orthopedic-and-spine-surgeon-dr-jaswinder-grover-joins-harvard-medtechs-medical-advisory-board/ 2022-10-11T14:14:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Harvard-MedTech.jpg https://bostonlifesciencestimes.com/2022/10/veranex-acquires-devicia-and-clarvin-expanding-regulatory-quality-and-clinical-expertise-for-ivd-and-medical-devices/ 2022-10-11T14:16:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Veranex.jpg https://bostonlifesciencestimes.com/2022/10/revival-healthcare-capital-is-pleased-to-announce-todd-m-pope-has-joined-revival-as-a-partner/ 2022-10-11T15:42:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Todd-M.-Pope.jpg https://bostonlifesciencestimes.com/2022/10/6-month-data-from-the-surmodics-swing-btk-first-in-human-trial-presented-at-amp-europe/ 2022-10-11T15:44:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Surmodics.webp https://bostonlifesciencestimes.com/2022/10/neuropace-announces-first-patient-implanted-in-nautilus-pivotal-study-for-the-treatment-of-idiopathic-generalized-epilepsy-ige/ 2022-10-11T15:46:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/NeuroPace.jpg https://bostonlifesciencestimes.com/2022/10/ntt-and-the-university-of-tokyo-produce-the-worlds-first-communication-signal-generated-from-an-environmentally-friendly-circuit-and-battery/ 2022-10-11T15:48:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/NTT.jpg https://bostonlifesciencestimes.com/2022/10/orthofix-and-seaspine-to-combine-in-merger-of-equals-to-create-leading-global-spine-and-orthopedics-company/ 2022-10-11T15:49:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Orthofix.webp https://bostonlifesciencestimes.com/2022/10/neumora-therapeutics-announces-112-million-series-b-financing/ 2022-10-11T15:54:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Paul-L.-Berns.jpg https://bostonlifesciencestimes.com/2022/10/caremore-health-offering-free-medication-reviews-on-national-check-your-meds-day/ 2022-10-11T15:57:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/CareMore-Health.jpg https://bostonlifesciencestimes.com/2022/10/knightscope-announces-acquisition-of-case-emergency-systems/ 2022-10-11T16:15:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Knightscope.jpg https://bostonlifesciencestimes.com/2022/10/walgreens-boots-alliance-accelerates-full-acquisition-of-carecentrix/ 2022-10-11T16:17:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/John-Driscoll.jpg https://bostonlifesciencestimes.com/2022/10/pfizer-and-biontech-receive-u-s-fda-emergency-use-authorization-for-omicron-ba-4-ba-5-adapted-bivalent-covid-19-vaccine-booster-in-children-5-through-11-years-of-age/ 2022-10-12T14:40:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pfizer.jpg https://bostonlifesciencestimes.com/2022/10/thermo-fisher-scientific-unveils-new-clinical-research-laboratory-in-virginia/ 2022-10-12T14:41:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2022/10/ancora-heart-appoints-david-j-tucker-as-chief-financial-officer/ 2022-10-12T14:49:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/David-J.-Tucker.jpg https://bostonlifesciencestimes.com/2022/10/multi-omics-startup-pleno-inc-announces-40-million-in-series-a-funding-led-by-deerfield-management-with-participation-by-foresite-capital/ 2022-10-12T14:57:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-12-at-10-55-47-Pieter-van-Rooyen-Headshot.jpg-WEBP-Image-849-%C3%97-849-pixels-e1665586600853.png https://bostonlifesciencestimes.com/2022/10/torus-biosystems-announces-appointment-of-nancy-hill-to-board-of-directors/ 2022-10-12T15:01:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Nancy-Hill.jpg https://bostonlifesciencestimes.com/2022/10/osivax-appoints-vincent-bille-as-chief-manufacturing-officer-and-announces-manufacturing-progress-for-ovx836/ 2022-10-12T15:08:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Vincent-Bille.png https://bostonlifesciencestimes.com/2022/10/neurologica-receives-ce-marking-for-all-elite-mobile-computed-tomography-systems/ 2022-10-12T15:13:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Elite-Mobile-Computed-Tomography-systems.jpg https://bostonlifesciencestimes.com/2022/10/orthofix-and-mtf-biologics-recognized-with-2022-spine-technology-award-for-virtuos-lyograft-a-first-of-its-kind-shelf-stable-and-complete-autograft-substitute-for-spine-and-orthopedic-proce/ 2022-10-12T15:17:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Virtuos-Lyograft.jpg https://bostonlifesciencestimes.com/2022/10/linear-health-sciences-recognized-for-leading-the-way-to-safer-iv-treatment-for-children/ 2022-10-12T15:20:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Linear-Health.jpg https://bostonlifesciencestimes.com/2022/10/freudenberg-medical-expands-handle-design-center-of-excellence/ 2022-10-12T15:22:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Freudenberg-Medical-Handle-Center-of-Excellence.jpg https://bostonlifesciencestimes.com/2022/10/world-renowned-gastroenterologist-to-livestream-milestone-weight-loss-procedure/ 2022-10-12T15:24:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dr.-Christopher-McGowan.jpg https://bostonlifesciencestimes.com/2022/10/organ-recovery-systems-lifeport-kidney-transporter-awarded-exclusive-contract-for-kidney-transplant-preservation-services-in-belgium/ 2022-10-12T15:25:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/LifePort-Kidney-Transporter.jpg https://bostonlifesciencestimes.com/2022/10/tevogen-bio-expresses-gratitude-for-2023-nobel-peace-prize-nomination-of-the-company-and-its-founding-ceo-ryan-saadi-in-recognition-of-its-novel-business-model-to-alleviate-health-inequality/ 2022-10-12T15:34:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Curtis-Patton-PhD.jpg https://bostonlifesciencestimes.com/2022/10/maternova-appoints-luna-mehrain-md-msc-as-chief-medical-officer/ 2022-10-12T15:38:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Maternova.png https://bostonlifesciencestimes.com/2022/10/tractor-supply-company-receives-ftc-clearance-to-close-orscheln-farm-and-home-acquisition/ 2022-10-12T15:46:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Tractor-Supply-Company.jpg https://bostonlifesciencestimes.com/2022/10/datalink-expands-executive-team-names-general-counsel-and-chief-human-resources-officer/ 2022-10-12T15:51:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jenifer-Brown.jpg https://bostonlifesciencestimes.com/2022/10/suffolk-hires-jay-fayette-as-president-of-florida-east-coast-to-continue-driving-growth-and-expansion-in-southeast-region/ 2022-10-12T15:54:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jay-Fayette.jpg https://bostonlifesciencestimes.com/2022/10/goodrx-announces-provider-mode-an-innovative-experience-built-specifically-for-healthcare-providers/ 2022-10-13T14:25:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/GoodRx.jpg https://bostonlifesciencestimes.com/2022/10/transcelerate-biopharma-appoints-janice-chang-as-new-ceo/ 2022-10-13T14:26:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Janice-Chang.jpg https://bostonlifesciencestimes.com/2022/10/lifemine-therapeutics-appoints-jennifer-a-jarrett-to-board-of-directors/ 2022-10-13T14:51:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-13-at-10-44-43-Home-LifeMine.png https://bostonlifesciencestimes.com/2022/10/new-medidata-technology-helps-sponsors-and-cros-improve-diversity-and-inclusion-in-clinical-trials/ 2022-10-13T14:57:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dassault-Systemes.jpg https://bostonlifesciencestimes.com/2022/10/obatala-sciences-closes-3-million-series-a-funding-round-co-led-by-etre-venture-capital-and-ochsner-health/ 2022-10-13T14:59:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Trivia-Frazier-PhD-MBA.jpg https://bostonlifesciencestimes.com/2022/10/axcella-therapeutics-announces-34-2-million-registered-direct-offering-of-common-stock-priced-at-the-market-appoints-two-new-board-members/ 2022-10-13T15:01:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Axcella-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/10/m-holland-company-collaborates-with-lyondellbasell-to-distribute-purell-medical-grade-resins/ 2022-10-13T15:07:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/M.-Holland.jpg https://bostonlifesciencestimes.com/2022/10/orthofix-announces-first-patient-implants-with-legacy-demineralized-bone-matrix-for-spine-pelvic-and-extremities-procedures/ 2022-10-13T15:14:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Legacy-Demineralized-Bone-Matrix.jpg https://bostonlifesciencestimes.com/2022/10/study-finds-video-dot-could-increase-access-to-methadone-treatment-and-reduce-risk/ 2022-10-13T15:17:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/mage-of-person-participating-in-Video-Directly-Observed-Therapy.jpg https://bostonlifesciencestimes.com/2022/10/yale-university-study-demonstrates-significant-survival-benefit-in-high-risk-pci-with-impella-support/ 2022-10-13T15:22:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Figure-1.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Figure-2.jpg https://bostonlifesciencestimes.com/2022/10/clayton-dubilier-rice-and-tpg-complete-acquisition-of-covetrus/ 2022-10-13T15:23:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Benjamin-Wolin.jpg https://bostonlifesciencestimes.com/2022/10/genomic-testing-cooperative-and-its-co-op-members-first-to-use-artificial-intelligence-to-distinguish-between-45-hematologic-and-solid-neoplasms-using-targeted-transcriptome/ 2022-10-13T15:31:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Genomic-Testing-Cooperative.png https://bostonlifesciencestimes.com/2022/10/accenture-federal-services-wins-189-million-centers-for-disease-control-and-prevention-cdc-contract/ 2022-10-13T15:33:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jill-Olmstead.jpg https://bostonlifesciencestimes.com/2022/10/ambu-the-world-leader-in-single-use-endoscopy-hosts-grand-opening-of-new-manufacturing-plant-in-mexico/ 2022-10-13T15:39:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Ambu.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Ambu%C2%AE-aScopeTM-5-Broncho.jpg https://bostonlifesciencestimes.com/2022/10/walgreens-now-offering-updated-covid-19-booster-appointments-for-children-ages-5/ 2022-10-13T15:44:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Walgreens.jpg https://bostonlifesciencestimes.com/2022/10/4moving-biotech-announces-first-patient-enrolled-in-phase-i-clinical-trial-on-osteoarthritis/ 2022-10-14T15:07:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/4Moving-Biotech.jpg https://bostonlifesciencestimes.com/2022/10/canbridge-umass-chan-medical-school-gene-therapy-research-in-oral-presentation-at-the-european-society-of-gene-and-cell-therapy-esgct-29th-annual-congress/ 2022-10-14T15:08:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/CANbridge-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/10/labcorp-appoints-google-cloud-executive-kirsten-kliphouse-to-its-board-of-directors/ 2022-10-14T15:11:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Kirsten-Kliphouse.jpg https://bostonlifesciencestimes.com/2022/10/feinstein-institutes-fifth-bioelectronic-medicine-summit-spotlights-innovation-future-of-science/ 2022-10-14T15:14:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dr.-Kevin-J.-Tracey.jpg https://bostonlifesciencestimes.com/2022/10/chmp-recommends-conditional-marketing-authorization-for-spesolimab-as-first-in-class-treatment-option-for-generalized-pustular-psoriasis-flares/ 2022-10-14T15:16:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/CHMP.jpg https://bostonlifesciencestimes.com/2022/10/mirum-pharmaceuticals-announces-positive-chmp-opinion-for-livmarli-maralixibat-oral-solution-for-cholestatic-pruritus/ 2022-10-14T15:19:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Mirum-Pharmaceuticals.png https://bostonlifesciencestimes.com/2022/10/hannon-armstrong-appoints-lizabeth-ardisana-to-board-of-directors/ 2022-10-14T15:22:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Lizabeth-Ardisana.jpg https://bostonlifesciencestimes.com/2022/10/wes-bush-joins-incubation-firm-red-cell-partners/ 2022-10-14T15:23:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Wes-Bush.jpg https://bostonlifesciencestimes.com/2022/10/verge-genomics-appoints-john-applegate-as-chief-financial-officer/ 2022-10-17T13:24:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Applegate_Headshot.jpg https://bostonlifesciencestimes.com/2022/10/thermo-fisher-scientific-launches-closed-and-automated-cell-isolation-and-bead-removal-solution-to-help-evolve-cell-therapy-manufacturing/ 2022-10-17T13:28:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/DynaCellect.jpg https://bostonlifesciencestimes.com/2022/10/inversago-pharma-raises-95-million-cad-in-series-c-financing/ 2022-10-17T13:29:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Dr.-Francois-Ravenelle.jpg https://bostonlifesciencestimes.com/2022/10/ankyra-therapeutics-appoints-joseph-j-elassal-m-d-mba-a-veteran-immuno-oncology-expert-as-chief-medical-officer/ 2022-10-17T13:33:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Joseph-J.-Elassal-M.D.-MBA.jpg https://bostonlifesciencestimes.com/2022/10/surmodics-announces-new-credit-facilities-providing-up-to-125-million-in-financing/ 2022-10-17T13:36:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/srmdx_logo_diamond_cmyk-590cropped.jpg https://bostonlifesciencestimes.com/2022/10/tivic-health-to-acquire-assets-of-reliefband/ 2022-10-17T13:40:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jennifer-Ernst.png https://bostonlifesciencestimes.com/2022/10/xentria-announces-25-million-equity-financing-round-to-advance-pipeline-and-execute-on-growth-strategy/ 2022-10-18T13:48:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Tom-Shea.jpg https://bostonlifesciencestimes.com/2022/10/cinrx-pharma-announces-gavin-samuels-m-d-m-b-a-as-chief-business-officer/ 2022-10-18T13:51:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Gavin-Samuels-M.D..jpg https://bostonlifesciencestimes.com/2022/10/axoft-launches-brain-implant-technology-to-treat-long-term-neurological-disorders-and-is-granted-fda-breakthrough-device-designation/ 2022-10-18T13:54:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/The-Axoft-founding-team.jpg https://bostonlifesciencestimes.com/2022/10/avrobio-granted-ilap-designation-from-u-k-mhra-for-first-in-class-gene-therapy-for-gaucher-disease/ 2022-10-18T13:56:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/AVROBIO.jpg https://bostonlifesciencestimes.com/2022/10/resource-label-group-expands-pharmaceutical-offering-with-acquisition-of-medlit-solutions/ 2022-10-18T13:58:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Resource-Label-Group.jpg https://bostonlifesciencestimes.com/2022/10/international-nonprofit-longevity-science-foundation-expands-to-the-united-states-with-new-ceo/ 2022-10-18T14:01:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Lisa-E.-Ireland.jpg https://bostonlifesciencestimes.com/2022/10/empyrean-neuroscience-launches-with-22m-series-a-and-genetic-engineering-platform-to-advance-pipeline-of-neuroactive-compounds-targeting-cns-disorders/ 2022-10-18T14:04:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dr.-Azam.jpg https://bostonlifesciencestimes.com/2022/10/lysando-ag-and-amicogen-inc-sign-general-development-agreement/ 2022-10-18T14:07:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Lysando.jpg https://bostonlifesciencestimes.com/2022/10/innovative-health-diagnostics-and-mate-fertility-transform-at-home-healthcare-access-by-bringing-fertility-testing-to-the-doorstep/ 2022-10-18T14:10:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Innovative-Health-Diagnostics.png https://bostonlifesciencestimes.com/2022/10/variantyx-secures-additional-20m-from-kreos-capital-following-41-5m-investment-round/ 2022-10-18T14:12:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Variantyx.jpg https://bostonlifesciencestimes.com/2022/10/teva-announces-results-from-3-year-study-assessing-the-safety-and-tolerability-of-austedo-tablets-for-the-treatment-of-chorea-associated-with-huntingtons-disease/ 2022-10-18T14:15:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/AUSTEDO.png https://bostonlifesciencestimes.com/2022/10/signify-health-expands-in-home-diagnostic-and-preventive-services-offering-introduces-spirometry-test-for-detecting-copd/ 2022-10-18T14:16:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Signify-Health.jpg https://bostonlifesciencestimes.com/2022/10/57-of-uk-doctors-see-patients-turning-to-private-care/ 2022-10-18T14:18:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Doctors.jpg https://bostonlifesciencestimes.com/2022/10/probius-expands-board-of-directors-further-enhancing-expertise-in-pharma-and-ai/ 2022-10-19T13:52:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/John-J.-MacWilliams-and-Janis-Naeve.jpg https://bostonlifesciencestimes.com/2022/10/patrick-gardner-joins-innovaccer-as-general-manager-of-revenue-ai/ 2022-10-19T13:55:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Patrick-Gardner.jpg https://bostonlifesciencestimes.com/2022/10/orionis-biosciences-secures-55-million-financing-to-support-advancement-into-clinic/ 2022-10-19T13:57:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Orionis-Biosciences.jpg https://bostonlifesciencestimes.com/2022/10/premia-spines-tops-facet-replacement-demonstrates-significant-improvement-in-all-patient-reported-outcome-measures-in-fda-trial/ 2022-10-19T14:08:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Premia-Spines-TOPS-System.jpg https://bostonlifesciencestimes.com/2022/10/anheart-therapeutics-expands-us-team-with-appointments-in-clinical-research-and-medical-affairs/ 2022-10-19T14:12:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Michael-J.-Humphries-Ph.D..jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Heinrich-Farin-M.D..jpg https://bostonlifesciencestimes.com/2022/10/pic-therapeutics-completes-35-million-series-a-financing-to-develop-treatments-for-drug-resistant-breast-cancer/ 2022-10-19T14:18:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Katherine-Bowdish.webp https://bostonlifesciencestimes.com/2022/10/milliken-company-commits-to-net-zero-future/ 2022-10-19T14:20:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Halsey-M.-Cook-Jr..jpg https://bostonlifesciencestimes.com/2022/10/kite-and-refuge-biotechnologies-announce-exclusive-license-agreement-for-investigational-gene-expression-platform-for-blood-cancers/ 2022-10-20T14:06:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Kite-a-Gilead-Compan.png https://bostonlifesciencestimes.com/2022/10/citiustech-announces-investment-and-strategic-partnership-from-bain-capital-private-equity/ 2022-10-20T14:19:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Bhaskar-Sambasivan.webp https://bostonlifesciencestimes.com/2022/10/subjectwell-raises-35-million-to-expand-patient-access-to-new-treatment-options/ 2022-10-20T14:20:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Ivor-Clarke.jpg https://bostonlifesciencestimes.com/2022/10/lazurite-to-be-showcased-at-the-medtech-industrys-leading-event-as-one-of-the-industrys-hottest-companies/ 2022-10-20T14:24:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Leah-Brownlee.jpg https://bostonlifesciencestimes.com/2022/10/elevate-ide-study-highlights-the-safety-and-effectiveness-of-the-alto-abdominal-stent-graft-system-in-one-year-results-data-to-be-presented-at-2022-veithsymposium/ 2022-10-20T14:28:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/ALTO-Abdominal-Stent-Graft-System.jpg https://bostonlifesciencestimes.com/2022/10/michael-blum-joins-seqone-genomics-to-head-the-companys-research-and-development/ 2022-10-20T14:30:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Michael-Blum-PhD.jpg https://bostonlifesciencestimes.com/2022/10/veranex-announces-tom-daulton-as-ceo-and-appointment-of-david-dockhorn-to-new-coo-role/ 2022-10-21T14:04:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Veranex-1.jpg https://bostonlifesciencestimes.com/2022/10/mevion-introduces-new-mevion-s250-fit-proton-therapy-system/ 2022-10-21T14:06:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/The-MEVION-S250-FIT-Proton-Therapy-System.jpg https://bostonlifesciencestimes.com/2022/10/saama-names-respected-clinical-technology-leader-lisa-moneymaker-as-cto-and-chief-product-officer/ 2022-10-24T13:32:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Lisa-Moneymaker.jpg https://bostonlifesciencestimes.com/2022/10/sagimet-biosciences-announces-appointment-of-david-happel-to-chief-executive-officer-dr-george-kemble-to-transition-to-executive-chairman-role/ 2022-10-24T13:34:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/David-Happel.jpg https://bostonlifesciencestimes.com/2022/10/maryland-tech-council-names-former-state-commerce-and-labor-secretary-kelly-schulz-new-ceo/ 2022-10-24T13:40:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Kelly-Schulz.jpg https://bostonlifesciencestimes.com/2022/10/thermo-fisher-scientific-demonstrates-commitment-to-transplant-patients-and-collaboration-at-ashi-2022/ 2022-10-24T13:41:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Thermo-Fisher-Scientific.jpg https://bostonlifesciencestimes.com/2022/10/novaliq-announces-fda-acceptance-of-the-new-drug-application-for-cyclasol-for-the-treatment-of-dry-eye-disease/ 2022-10-24T13:44:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Christian-Roesky-Ph.D.webp https://bostonlifesciencestimes.com/2022/10/gilead-presents-real-world-evidence-reinforcing-the-use-of-biktarvy-for-the-treatment-of-people-living-with-hiv-with-a-range-of-comorbidities/ 2022-10-24T13:46:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2022/10/longhorn-vaccines-and-diagnostics-reports-composite-peptide-vaccines-generate-immune-responses-to-both-influenza-and-coronavirus/ 2022-10-24T13:51:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Longhorn-Vaccines.jpg https://bostonlifesciencestimes.com/2022/10/dentalmonitoring-now-offers-smart-stl-powered-by-ai-driven-technology/ 2022-10-24T13:58:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/DentalMonitoring.jpg https://bostonlifesciencestimes.com/2022/10/walgreens-flu-index-shows-flu-activity-trending-10-times-higher-year-over-year/ 2022-10-24T14:00:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Walgreens-Flu-Index.jpg https://bostonlifesciencestimes.com/2022/10/whizai-closes-new-round-with-investment-from-shanda-group-and-amerisourcebergen-bringing-total-capital-raised-to-21-million/ 2022-10-25T13:44:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Rohit-Vashisht.jpeg https://bostonlifesciencestimes.com/2022/10/koneksa-announces-clinical-pipeline-of-validated-digital-biomarkers-to-accelerate-life-sciences-research/ 2022-10-25T13:48:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Koneksa-Clinical-Pipeline-.jpg https://bostonlifesciencestimes.com/2022/10/alto-neuroscience-announces-35-million-series-b-financing/ 2022-10-25T13:50:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Amit-Etkin-M.D.-Ph.D.jpg https://bostonlifesciencestimes.com/2022/10/revelation-biosciences-inc-announces-positive-results-in-preclinical-model-of-acute-and-chronic-kidney-disease/ 2022-10-25T13:54:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Revelation-Biosciences-Inc-1.png https://bostonlifesciencestimes.com/2022/10/be-the-match-biotherapies-expands-presence-in-the-san-francisco-bay-area-for-allogeneic-therapy-development-and-commercialization/ 2022-10-25T13:57:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Chris-McClain.webp https://bostonlifesciencestimes.com/2022/10/triumvira-immunologics-appoints-life-sciences-industry-leader-robert-williamson-as-president-and-chief-business-officer/ 2022-10-25T13:58:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Robert-Williamson-.jpg https://bostonlifesciencestimes.com/2022/10/normunity-announces-65-million-series-a-financing-to-expand-the-frontier-of-precision-immuno-oncology-with-immune-normalizer-therapies/ 2022-10-25T14:01:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Normunity.jpg https://bostonlifesciencestimes.com/2022/10/omnimed-launches-smartor/ 2022-10-25T14:03:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-25-at-10-01-45-OMNIMED%C2%AE-Launches-SmartOR%C2%AE.png https://bostonlifesciencestimes.com/2022/10/medtechvets-appoints-patrice-sutherland-enterprise-executive-director-at-integra-lifescience-as-new-board-chairperson/ 2022-10-25T14:05:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Patrice-Sutherland-.jpg https://bostonlifesciencestimes.com/2022/10/former-u-s-surgeon-general-joins-kentucky-diabetes-health-company-thrive365/ 2022-10-25T14:09:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dr.-Jerome-Adams.jpg https://bostonlifesciencestimes.com/2022/10/mevion-selected-to-provide-proton-therapy-technology-to-the-froedtert-the-medical-college-of-wisconsin-health-network/ 2022-10-25T14:14:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Froedtert-the-Medical-College-of-Wisconsin-Clinical-Cancer-Center-at-Froedtert-Hospital-campus-in-Milwaukee-Wis.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/MEVION-S250i-Proton-Therapy-System-.jpg https://bostonlifesciencestimes.com/2022/10/viz-ai-names-jieun-choe-chief-marketing-officer/ 2022-10-25T14:23:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jieun-Choe.jpg https://bostonlifesciencestimes.com/2022/10/ewegg-and-farmer-boys-join-forces-for-breakfast-all-flippin-day-encouraging-gamers-livestreamers-and-pc-builders-to-eat-breakfast-during-the-day/ 2022-10-25T14:25:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jeremy-Threat-and-Tori-Vasquez.jpg https://bostonlifesciencestimes.com/2022/10/histowiz-appoints-linh-hoang-as-ceo-and-board-member/ 2022-10-26T15:07:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Linh-Hoang.png https://bostonlifesciencestimes.com/2022/10/expansion-therapeutics-appoints-raymond-kelleher-m-d-ph-d-to-its-board-of-directors/ 2022-10-26T15:08:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Raymond-Kelleher-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/10/element-science-appoints-trish-howell-as-chief-operating-officer/ 2022-10-26T15:14:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Trish-Howell-.webp https://bostonlifesciencestimes.com/2022/10/thermo-fisher-scientific-reports-third-quarter-2022-results/ 2022-10-26T15:18:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/10/immunis-chairman-dr-hans-keirstead-visits-his-holiness-the-dalai-lama/ 2022-10-26T15:20:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dr.-Hans-Keirstead.jpg https://bostonlifesciencestimes.com/2022/10/evidation-launches-flusmart-a-direct-to-person-digital-flu-monitoring-program-to-better-understand-flu-in-everyday-life/ 2022-10-26T15:26:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Evidation.jpg https://bostonlifesciencestimes.com/2022/10/desktop-metal-names-jason-cole-chief-financial-officer/ 2022-10-26T15:30:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jason-Cole-.jpg https://bostonlifesciencestimes.com/2022/10/abiomed-creates-patient-assistance-program-to-address-disparities-in-healthcare/ 2022-10-26T15:31:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Abiomed.jpg https://bostonlifesciencestimes.com/2022/10/twist-bioscience-promotes-patrick-finn-ph-d-to-president-and-chief-operating-officer/ 2022-10-26T15:32:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Patrick-Finn-Ph.D..jpg https://bostonlifesciencestimes.com/2022/10/hca-healthcare-announces-operational-reorganization/ 2022-10-26T15:39:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jon-Foster.jpg https://bostonlifesciencestimes.com/2022/10/childrens-healthcare-of-atlanta-announces-550-million-initiative-to-tackle-childhood-mental-health-crisis/ 2022-10-26T15:41:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Donna-W.-Hyland.jpg https://bostonlifesciencestimes.com/2022/10/qhp-capital-acquires-autocruitment/ 2022-10-27T13:55:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/QHP-Capital-.png https://bostonlifesciencestimes.com/2022/10/milla-pharmaceuticals-inc-and-the-alter-pharma-group-announce-first-paragraph-iv-filing-and-acceptance-by-fda/ 2022-10-27T13:59:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Milla-Pharmaceuticals-Inc.jpg https://bostonlifesciencestimes.com/2022/10/ariceum-therapeutics-and-ambiopharm-enter-strategic-manufacturing-and-supply-partnership/ 2022-10-27T14:04:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-27-at-10-03-45-Senior-Team-%E2%80%93-Ariceum-Therapeutics.png https://bostonlifesciencestimes.com/2022/10/vizgen-announces-international-expansion-into-asia-pacific-and-emea/ 2022-10-27T14:14:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dale-Levitzke.png https://bostonlifesciencestimes.com/2022/10/powerplant-partners-announces-george-birman-as-principal-and-logan-schwartz-as-vp/ 2022-10-27T14:21:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Logan-Schwartz-e1666880460872.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/George-Birman--e1666880372124.jpg https://bostonlifesciencestimes.com/2022/10/robert-m-davis-to-succeed-kenneth-c-frazier-as-chairman-of-merck/ 2022-10-27T14:23:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Robert-M.-Davis-.webp https://bostonlifesciencestimes.com/2022/10/allurion-receives-approval-to-launch-in-brazil/ 2022-10-27T14:34:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/The-Allurion-Balloon.jpg https://bostonlifesciencestimes.com/2022/10/financial-industry-veteran-mary-hentges-joins-akilis-board-of-directors/ 2022-10-27T14:36:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Mary-Hentges.jpg https://bostonlifesciencestimes.com/2022/10/medisca-to-open-new-plattsburgh-ny-facility-exceeding-rigorous-quality-and-employee-safety-standards/ 2022-10-27T14:39:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/unnamed-file.jpg https://bostonlifesciencestimes.com/2022/10/aspen-surgical-acquires-symmetry-surgical/ 2022-10-27T14:46:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Aspen.jpg https://bostonlifesciencestimes.com/2022/10/takeda-becomes-first-enterprise-to-achieve-diamond-tier-status-as-a-best-in-resilience-certified-organization/ 2022-10-27T14:50:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Takeda.jpg https://bostonlifesciencestimes.com/2022/10/curia-celebrates-ground-breaking-ceremony-in-albuquerque/ 2022-10-28T13:58:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Curia-Celebrates-Ground-breaking.jpg https://bostonlifesciencestimes.com/2022/10/lazurite-named-small-tech-company-of-the-year-in-best-of-tech-awards/ 2022-10-28T14:02:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Lazurite.jpg https://bostonlifesciencestimes.com/2022/10/walgreens-boots-alliance-appoints-bryan-c-hanson-to-board-of-directors/ 2022-10-28T14:04:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Bryan-Hanson.jpg https://bostonlifesciencestimes.com/2022/10/latticeflow-secures-12-million-to-eliminate-ai-data-and-model-blind-spots-in-computer-vision/ 2022-10-28T14:06:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/LatticeFlow.jpg https://bostonlifesciencestimes.com/2022/10/bristol-myers-squibb-announces-positive-topline-results-of-phase-3-commands-trial/ 2022-10-31T13:44:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Bristol-Myers-Squibb.jpg https://bostonlifesciencestimes.com/2022/10/lineage-cell-therapeutics-appoints-jill-howe-as-chief-financial-officer/ 2022-10-31T13:46:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Lineage-Cell-Therapeutics.png https://bostonlifesciencestimes.com/2022/10/kbi-biopharma-inc-and-selexis-sa-expand-executive-leadership-team-with-the-appointment-of-abdelaziz-toumi-ph-d-as-chief-business-officer/ 2022-10-31T13:49:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/KBI-Biopharma-Inc..png https://bostonlifesciencestimes.com/2022/10/emerson-to-sell-majority-stake-in-climate-technologies-to-blackstone-in-transaction-valuing-the-business-at-14-0-billion/ 2022-10-31T13:55:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Emerson.webp https://bostonlifesciencestimes.com/2022/10/omnivision-and-adaptivendo-partner-to-provide-a-unified-platform-for-hybrid-and-single-use-flexible-endoscopes/ 2022-10-31T14:06:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Screenshot-2022-10-31-at-10-05-49-TEAM-AdaptivEndo-6-28-22.png https://bostonlifesciencestimes.com/2022/10/impella-rp-flex-with-smartassist-receives-fda-approval-to-treat-right-heart-failure/ 2022-10-31T14:08:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/mpella-RP-Flex-with-SmartAssis-rotated.jpg https://bostonlifesciencestimes.com/2022/10/thermo-fisher-scientific-to-acquire-the-binding-site-group/ 2022-10-31T14:12:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Marc-N.-Casper.jpg https://bostonlifesciencestimes.com/2022/10/mass-general-brigham-implements-dexcare-to-support-care-integration-and-advance-digital-health/ 2022-10-31T14:14:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/DexCare.png https://bostonlifesciencestimes.com/2022/10/zoll-awarded-diagnostic-and-interventional-cardiology-catheter-agreement-with-premier-inc-for-therox-supersaturated-oxygen-therapy/ 2022-10-31T14:16:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/ZOLLs-TherOx%C2%AE-SSO2-System-.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/ZOLLs-TherOx%C2%AE-SSO2-System.jpg https://bostonlifesciencestimes.com/2022/10/accenture-federal-services-awarded-prime-role-on-650m-department-of-veterans-affairs-healthcare-innovation-contract/ 2022-10-31T14:20:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Shawn-Roman.jpg https://bostonlifesciencestimes.com/2022/10/delaware-court-rules-in-favor-of-aim-immunotech-and-declines-to-declare-activist-groups-nominations-valid/ 2022-10-31T14:27:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/AIM-ImmunoTech.png https://bostonlifesciencestimes.com/2022/10/bright-machines-raises-132m-in-new-funding-to-expand-intelligent-automation-in-manufacturing/ 2022-10-31T14:28:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Bright-Machines.png https://bostonlifesciencestimes.com/2022/11/noramco-announces-submission-and-reactivation-of-the-drug-master-file-for-active-pharmaceutical-ingredient-methylnaltrexone-bromide/ 2022-11-01T13:38:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Noramco.jpg https://bostonlifesciencestimes.com/2022/11/the-hartford-names-tracey-ant-head-of-middle-large-commercial-business-units/ 2022-11-01T13:41:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Tracey-Ant-.jpg https://bostonlifesciencestimes.com/2022/11/johnson-johnson-to-acquire-abiomed/ 2022-11-01T13:47:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Michael-R.-Minogue.png https://bostonlifesciencestimes.com/2022/11/acclaimed-life-sciences-leaders-launch-impact-investment-firm-to-accelerate-health-equity/ 2022-11-01T13:50:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Kamil-Ali-Jackson.png https://bostonlifesciencestimes.com/2022/11/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders/ 2022-11-01T13:53:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/OrsoBio-Inc..jpg https://bostonlifesciencestimes.com/2022/11/orum-therapeutics-announces-first-patient-dosed-in-phase-1-clinical-trial-of-orm-5029-in-development-to-treat-her2-expressing-advanced-solid-tumors/ 2022-11-01T14:00:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Orum-Therapeutics.png https://bostonlifesciencestimes.com/2022/11/curvafix-receives-fda-clearance-for-smaller-diameter-intramedullary-implant-for-pelvic-fracture-fixation/ 2022-11-01T14:03:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/CurvaFix%C2%AE-IM-Implant.jpg https://bostonlifesciencestimes.com/2022/11/oui-inc-the-japanese-startup-of-a-smartphone-based-ophthalmic-diagnostic-medical-device-wins-first-prize-at-aea2022-innovation-awards/ 2022-11-01T14:06:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/AEA2022.jpg https://bostonlifesciencestimes.com/2022/11/arcserve-appoints-new-chief-technology-officer/ 2022-11-01T14:08:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Christian-van-den-Branden.jpg https://bostonlifesciencestimes.com/2022/11/applied-uv-announces-new-debt-financings-of-7-5-million-in-aggregate-to-support-growth/ 2022-11-01T14:13:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Applied-UV.jpg https://bostonlifesciencestimes.com/2022/11/naomi-osaka-hyperice-and-modern-health-unite-to-improve-mental-wellness/ 2022-11-01T14:17:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Naomi-Osaka.jpg https://bostonlifesciencestimes.com/2022/11/concerto-biosciences-raises-23-million-in-series-a-to-advance-product-development-expand-pipeline/ 2022-11-02T14:25:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Cheri-Ackerman-e1667399094995.webp https://bostonlifesciencestimes.com/2022/11/stevanato-group-and-gerresheimer-ag-present-ez-fill-smart-a-new-and-innovative-ready-to-use-vial-platform/ 2022-11-02T14:28:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/AG-present-EZ-fill-Smart.jpg https://bostonlifesciencestimes.com/2022/11/applied-industrial-technologies-acquires-automation-inc/ 2022-11-02T14:34:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Applied-Industrial-Technologies-.png https://bostonlifesciencestimes.com/2022/11/instem-unveils-new-additions-to-its-leading-computational-toxicology-software-suite/ 2022-11-02T14:36:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Instem.jpg https://bostonlifesciencestimes.com/2022/11/orsobio-acquires-phase-2-ready-selective-acc2-inhibitor-from-shionogi-co-ltd-for-the-treatment-of-type-2-diabetes/ 2022-11-02T14:39:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/OrsoBio-Inc..jpg https://bostonlifesciencestimes.com/2022/11/kenco-group-launches-life-sciences-division/ 2022-11-02T14:41:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Kenco-Group.jpg https://bostonlifesciencestimes.com/2022/11/u-s-food-and-drug-administration-approves-vemlidy-tenofovir-alafenamide-for-treatment-of-chronic-hepatitis-b-virus-infection-in-pediatric-patients/ 2022-11-02T14:49:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Vemlidy.jpg https://bostonlifesciencestimes.com/2022/11/blaze-bioscience-announces-enrollment-is-complete-on-its-pivotal-phase-2-3-trial-of-tozuleristide-and-the-canvastm-imaging-system-in-pediatric-central-nervous-system-tumors/ 2022-11-02T14:52:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Sarah-Leary-M.D.-neuro-oncologist-at-SCH.jpg https://bostonlifesciencestimes.com/2022/11/neurotech-pharmaceuticals-inc-announces-positive-phase-3-topline-results-for-nt-501-implant-in-macular-telangiectasia-type-2/ 2022-11-02T14:58:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Richard-Small.webp https://bostonlifesciencestimes.com/2022/11/michael-aldridge-seasoned-biotech-executive-appointed-ceo-of-focal-medical/ 2022-11-02T15:00:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Michael-Aldridge.jpg https://bostonlifesciencestimes.com/2022/11/strive-health-and-the-largest-nephrology-group-in-orange-county-california-launch-innovative-partnership-to-improve-kidney-care/ 2022-11-02T15:03:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Kidney-disease.jpg https://bostonlifesciencestimes.com/2022/11/carta-healthcare-secures-20-million-series-b-funding/ 2022-11-02T15:07:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Screenshot-2022-11-02-at-11-07-07-Our-Team-Carta-Healthcare.png https://bostonlifesciencestimes.com/2022/11/walgreens-announces-agreement-in-principle-for-multi-state-opioid-settlement-framework/ 2022-11-02T15:11:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Walgreens.jpg https://bostonlifesciencestimes.com/2022/11/floridas-palm-vascular-centers-is-the-first-healthcare-organization-to-install-xenfi-the-recently-announced-wireless-medical-ecosystem-from-xenter/ 2022-11-02T15:13:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Robert-E.-Beasley-MD-FSIR-FSCAI-.jpg https://bostonlifesciencestimes.com/2022/11/stratasys-makes-strategic-investment-in-axial3d/ 2022-11-02T15:16:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Patient-specific-3D-printed-anatomic-model-of-a-large-tumor.jpg https://bostonlifesciencestimes.com/2022/11/beautyhealth-appoints-david-aquino-as-executive-vice-president-global-operations/ 2022-11-02T15:18:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/David-Aquino-1.jpg https://bostonlifesciencestimes.com/2022/11/kezar-life-sciences-presents-positive-complete-results-from-the-mission-phase-2-trial-evaluating-zetomipzomib-in-lupus-nephritis/ 2022-11-03T15:08:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Kezar-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/11/arima-genomics-announces-new-partnership-with-basepair-to-accelerate-bioinformatics-analysis-of-3d-genomics-data/ 2022-11-03T15:11:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Arima-Genomics.png https://bostonlifesciencestimes.com/2022/11/medable-unifies-and-simplifies-consent-management-for-global-decentralized-and-hybrid-trials/ 2022-11-03T15:14:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Medable.jpg https://bostonlifesciencestimes.com/2022/11/gurnet-point-capital-appoints-stacey-seltzer-as-partner/ 2022-11-03T15:18:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Stacey-Seltzer.jpg https://bostonlifesciencestimes.com/2022/11/carbon-negative-aro-homes-announces-launch-with-21-million-series-a-fundraise/ 2022-11-03T15:20:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Aro-Homes.jpg https://bostonlifesciencestimes.com/2022/11/sia-partners-accelerates-in-the-life-sciences-sector-with-the-acquisition-of-latham-biopharm-group/ 2022-11-03T15:22:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Sia-Partners.jpg https://bostonlifesciencestimes.com/2022/11/elucid-appoints-dr-michael-lesh-to-board-of-directors/ 2022-11-03T15:30:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Dr.-Michael-Lesh.jpg https://bostonlifesciencestimes.com/2022/11/stephen-fisher-md-chief-medical-officer-and-special-advisor-at-chesapeake-employers-insurance-company-joins-harvard-medtechs-medical-advisory-board/ 2022-11-03T15:33:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Harvard-MedTech.jpg https://bostonlifesciencestimes.com/2022/11/exactech-to-showcase-new-innovations-at-aahks-2022-annual-meeting-booth-1101/ 2022-11-03T15:35:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Exactech.jpg https://bostonlifesciencestimes.com/2022/11/eco-healthtech-apparel-brand-swiss-precision-launches-startengine-crowdfunding-campaign/ 2022-11-03T15:41:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Swiss-Precision.jpg https://bostonlifesciencestimes.com/2022/11/vermont-initiative-gives-clinicians-new-tools-for-infectious-disease-diagnosis-and-response/ 2022-11-03T15:47:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Health-Commissioner-Mark-Levine-MD.jpg https://bostonlifesciencestimes.com/2022/11/datscan-ioflupane-i-123-injection-indication-expanded-to-include-use-in-patients-with-suspected-dementia-with-lewy-bodies-dlb/ 2022-11-03T15:54:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Mark-Hibberd.jpg https://bostonlifesciencestimes.com/2022/11/next-dlp-announces-cybersecurity-industry-veteran-constance-stack-as-new-ceo/ 2022-11-03T17:03:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Constance-Stack.jpg https://bostonlifesciencestimes.com/2022/11/halper-sadeh-llc-is-investigating-whether-the-sale-of-oyster-point-pharma-inc-is-fair-to-shareholders/ 2022-11-07T14:36:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Halper-Sadeh-LLC.jpg https://bostonlifesciencestimes.com/2022/11/torben-straight-nissen-joins-repertoire-immune-medicines-as-chief-executive-officer/ 2022-11-07T14:38:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Repertoire%C2%AE-Immune-Medicine.png https://bostonlifesciencestimes.com/2022/11/enpro-completes-divestiture-of-ggb/ 2022-11-07T14:41:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Enpro.png https://bostonlifesciencestimes.com/2022/11/silence-therapeutics-presents-new-analysis-from-sln360-phase-1-single-dose-study-in-high-lipoproteina/ 2022-11-07T14:42:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Silence-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/11/rising-costs-replace-pandemic-concerns-as-top-reason-americans-defer-healthcare/ 2022-11-07T14:44:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Qualtrics.png https://bostonlifesciencestimes.com/2022/11/rejuvenate-bio-launches-new-office-in-san-diego/ 2022-11-07T14:46:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Rejuvenate-Bio.jpg https://bostonlifesciencestimes.com/2022/11/levitasbio-completes-series-c-financing/ 2022-11-07T14:49:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Joe-Walthers.jpg https://bostonlifesciencestimes.com/2022/11/aviclear-now-broadly-available-to-us-physicians-and-practitioners-upon-national-launch/ 2022-11-07T14:51:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/AviClear.jpg https://bostonlifesciencestimes.com/2022/11/villagemd-acquires-summit-health-citymd-creating-one-of-the-largest-independent-provider-groups-in-the-u-s/ 2022-11-07T14:53:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/VillageMD.png https://bostonlifesciencestimes.com/2022/11/family-heart-foundation-study-shows-significant-health-disparities-in-treatment-of-familial-hypercholesterolemia/ 2022-11-07T14:56:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Mary-P.-McGowan-M.D..webp https://bostonlifesciencestimes.com/2022/11/bigfoot-biomedical-announces-insulin-compatibility-expansion-to-support-insulin-affordability-and-flexibility-for-people-with-diabetes/ 2022-11-07T14:59:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Bigfoot-Biomedical.png https://bostonlifesciencestimes.com/2022/11/nucleai-expands-scientific-advisory-board-with-oncology-industry-luminary-dr-julian-adams/ 2022-11-08T14:59:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Dr.-Julian-Adams.jpg https://bostonlifesciencestimes.com/2022/11/qnovia-to-pursue-uk-approval-for-lead-asset-qn-01-in-nicotine-replacement-therapy/ 2022-11-08T15:03:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Brian-Quigley.jpg https://bostonlifesciencestimes.com/2022/11/bruker-announces-acquisition-of-inscopix-for-neuroscience-research/ 2022-11-08T15:05:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Kunal-Ghosh-Ph.D.jpg https://bostonlifesciencestimes.com/2022/11/infinitum-electric-secures-30m-in-additional-growth-capital-to-expand-and-fully-automate-production-facility-in-mexico-and-rebrands-as-infinitum/ 2022-11-08T15:07:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Infinitum-Aircore-EC-motor.jpg https://bostonlifesciencestimes.com/2022/11/korro-bio-expands-leadership-team-with-key-appointments/ 2022-11-08T15:16:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Venkat-Krishnamurthy-Ph.D..png https://bostonlifesciencestimes.com/2022/11/umass-lowell-analog-devices-and-the-analog-devices-foundation-collaborate-to-advance-student-learning-in-science-and-engineering-with-new-rf-microwave-learning-lab/ 2022-11-08T15:18:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/UMass-Lowell.jpg https://bostonlifesciencestimes.com/2022/11/yonalink-raises-6m-in-funding-to-scale-global-growth-and-fuel-expansion-of-platform-designed-to-stream-clinical-trial-data/ 2022-11-08T15:23:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Iddo-Peleg.webp https://bostonlifesciencestimes.com/2022/11/juvena-therapeutics-secures-41-million-to-accelerate-the-discovery-and-development-of-biologics-for-chronic-and-age-related-diseases/ 2022-11-08T15:26:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Dr.-Hanadie-Yousef.jpg https://bostonlifesciencestimes.com/2022/11/ems-company-digicom-electronics-to-address-remedies-for-supply-chain-issues-at-anaheim-electronics-manufacturing-show/ 2022-11-08T15:28:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Digicom-Electronics.jpg https://bostonlifesciencestimes.com/2022/11/omnivision-announces-first-miniature-2-megapixel-cmos-image-sensor-in-square-format-for-disposable-and-reusable-endoscopes/ 2022-11-08T15:31:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Size-OH02B.jpg https://bostonlifesciencestimes.com/2022/11/13-new-validated-materials-and-open-material-options-now-available-from-stratasys/ 2022-11-08T15:32:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Flame-retardant.jpg https://bostonlifesciencestimes.com/2022/11/heather-bender-joins-healthedge-as-chief-people-officer/ 2022-11-08T15:36:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Heather-Bender.jpg https://bostonlifesciencestimes.com/2022/11/vaxxas-announces-initiation-of-phase-i-clinical-study-of-first-needle-free-covid-19-vaccine-hexapro-delivered-using-high-density-microarray-patch-hd-map/ 2022-11-08T15:46:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/David-L.-Hoey.jpg https://bostonlifesciencestimes.com/2022/11/scholar-rock-appoints-jing-l-marantz-m-d-ph-d-m-b-a-as-chief-medical-officer/ 2022-11-10T14:54:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Jing-Marantz-M.D.-Ph.D.-M.B.A..jpg https://bostonlifesciencestimes.com/2022/11/white-oak-healthcare-finance-supports-multi-site-acquisitions-by-united-dental-corporation/ 2022-11-10T14:56:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-10-https-whiteoaksf-com.png https://bostonlifesciencestimes.com/2022/11/beigene-announces-brazil-approvals-for-brukinsa-as-a-treatment-for-rare-blood-cancers/ 2022-11-10T14:57:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BRUKINSA.jpg https://bostonlifesciencestimes.com/2022/11/kirsten-suto-seckler-named-to-prweek-health-influencer-30-list/ 2022-11-10T14:59:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Kirsten-Suto-Seckler.jpg https://bostonlifesciencestimes.com/2022/11/ovation-appoints-marty-miller-as-chief-revenue-officer-and-hana-dembe-as-head-of-product-marketing/ 2022-11-10T15:02:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/ovation.jpg https://bostonlifesciencestimes.com/2022/11/aimmune-therapeutics-to-present-positive-results-from-phase-3-poseidon-study-of-palforzia/ 2022-11-10T15:05:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/PALFORZIA.jpg https://bostonlifesciencestimes.com/2022/11/flora-growth-announces-shareholders-owning-over-73-of-shares-of-franchise-global-health-support-acquisition-by-flora/ 2022-11-10T15:07:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Luis-Merchan.jpg https://bostonlifesciencestimes.com/2022/11/us-tech-startup-subjectwell-secures-35-million-in-investment-focuses-growth-in-south-african-operations/ 2022-11-10T15:09:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Ivor-Clarke.jpg https://bostonlifesciencestimes.com/2022/11/citiustech-acquires-wilco-source-expands-specialized-salesforce-capabilities-for-healthcare-life-sciences/ 2022-11-10T15:12:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Bhaskar-Sambasivan.webp https://bostonlifesciencestimes.com/2022/11/parthenon-therapeutics-and-imaginab-announce-license-and-supply-agreement-to-advance-new-class-of-anti-cancer-therapies-clinical-development-program/ 2022-11-10T15:15:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Laurent-Audoly-Ph.D..webp https://bostonlifesciencestimes.com/2022/11/delphinus-medical-ships-softvue-breast-imaging-system-to-east-alabama-medical-center/ 2022-11-10T15:18:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/SoftVue%E2%84%A2-3D-Whole-Breast-Ultrasound-Tomography-System.webp https://bostonlifesciencestimes.com/2022/11/new-study-finds-85-of-aneurysms-identified-by-viz-aneurysm-had-not-been-referred-for-neurovascular-review/ 2022-11-10T15:26:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Viz-ANEURYSM.jpg https://bostonlifesciencestimes.com/2022/11/applied-medical-commemorates-20-years-of-wound-protection-with-its-market-leading-alexis-protector-retractors/ 2022-11-10T15:29:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Alexis-Protectors.jpg https://bostonlifesciencestimes.com/2022/11/us-patent-issued-for-exactechs-predict-first-machine-learning-based-software-that-informs-surgeons-with-patient-specific-outcome-predictions-after-shoulder-replacement-surgery/ 2022-11-10T15:31:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Exactechs-Predict.jpg https://bostonlifesciencestimes.com/2022/11/coefficient-raises-18m-series-a-to-bring-the-power-of-data-and-automation-to-spreadsheet-users-announces-new-product-plans/ 2022-11-10T15:40:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Navneet-Loiwal-and-Tommy-Tsai.jpg https://bostonlifesciencestimes.com/2022/11/genine-wilson-joins-ingenovis-health-as-president-of-travel-nurse-and-allied-division/ 2022-11-10T15:41:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Genine-Wilson.jpg https://bostonlifesciencestimes.com/2022/11/perfect-corp-debuts-dermatologist-verified-ai-skincare-pro-software-ipad-solution-dedicated-to-skincare-professionals-and-med-spas/ 2022-11-10T15:44:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Perfect-Corp.jpg https://bostonlifesciencestimes.com/2022/11/quantica-introduces-a-desktop-system-for-multi-material-3d-application-development/ 2022-11-10T15:49:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/NovoJet%E2%84%A2-C-7.jpg https://bostonlifesciencestimes.com/2022/11/mvm-closes-oversubscribed-fund-at-500-million-hard-cap/ 2022-11-14T14:49:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/MVM-Partners.jpg https://bostonlifesciencestimes.com/2022/11/bruker-announces-agreement-to-acquire-neurescence-inc-bolstering-neuroscience-research-portfolio/ 2022-11-14T14:53:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Yasaman-Soudagar.png https://bostonlifesciencestimes.com/2022/11/world-first-inhaled-covid-19-vaccine-developed-in-partnership-between-aerogen-and-cansinobio-first-public-booster-immunization-in-china/ 2022-11-14T14:58:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Inhaled-vaccine.jpg https://bostonlifesciencestimes.com/2022/11/alice-zhang-ceo-co-founder-of-verge-genomics-recognized-today-by-both-fortune-and-fierce-biotech-as-a-pioneer-in-ai-driven-drug-discovery/ 2022-11-14T15:00:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Alice-Zhang.jpg https://bostonlifesciencestimes.com/2022/11/appili-therapeutics-ati-1701-biodefense-vaccine-secures-us14-million-of-funding-from-the-u-s-department-of-defense-in-partnership-with-the-u-s-air-force-academy/ 2022-11-14T15:06:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Appili-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/11/sambanova-delivers-next-generation-datascale-system-to-argonne-national-laboratory/ 2022-11-14T15:09:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/SambaNova.jpg https://bostonlifesciencestimes.com/2022/11/trisalus-life-sciences-to-become-publicly-traded-through-merger-with-medtech-acquisition-corporation/ 2022-11-14T15:14:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/TriSalus-Life-Sciences.jpg https://bostonlifesciencestimes.com/2022/11/desktop-metal-announces-major-contract-with-the-u-s-department-of-veterans-affairs-for-variety-of-3d-printed-freefoam-products/ 2022-11-14T15:16:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/FreeFoam.jpg https://bostonlifesciencestimes.com/2022/11/droplettes-micro-infuser-device-named-to-times-best-inventions-of-2022-list/ 2022-11-14T15:21:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Droplette.jpg https://bostonlifesciencestimes.com/2022/11/braincheck-awarded-1-5m-grant-by-us-small-business-innovation-research-sbir-program-to-measure-effectiveness-of-digital-cognitive-care-management-platform/ 2022-11-14T15:26:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/BrainCheck.png https://bostonlifesciencestimes.com/2022/11/perkinelmer-announces-its-eonis-scid-sma-kit-is-first-to-receive-marketing-authorization-by-u-s-fda-for-sma-screening-in-newborns/ 2022-11-14T15:43:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/1200px-PerkinElmer_logo.svg_.png https://bostonlifesciencestimes.com/2022/11/charles-river-laboratories-to-present-at-november-investor-conferences/ 2022-11-14T15:44:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Charles-River-Laboratories.jpg https://bostonlifesciencestimes.com/2022/11/xironetic-receives-fda-clearance-for-augmented-reality-surgical-software/ 2022-11-14T15:47:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Xironetic.png https://bostonlifesciencestimes.com/2022/11/docgo-appoints-veteran-technology-human-resources-executive-vina-leite-ms-to-its-board-of-directors-and-announces-key-leadership-promotions/ 2022-11-14T15:49:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/DocGo.png https://bostonlifesciencestimes.com/2022/11/genentech-provides-update-on-phase-iii-graduate-program-evaluating-gantenerumab-in-early-alzheimers-disease/ 2022-11-14T15:51:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Genentech.jpg https://bostonlifesciencestimes.com/2022/11/donald-templin-joins-voya-financial-as-chief-financial-officer/ 2022-11-14T15:53:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Donald-C.-Templin.jpg https://bostonlifesciencestimes.com/2022/11/lucy-therapeutics-expands-leadership-team-with-appointment-of-julia-gaebler-ph-d-as-chief-business-officer/ 2022-11-15T15:03:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Julia-Gaebler-Ph.D..jpg https://bostonlifesciencestimes.com/2022/11/clif-bar-company-announces-1-million-organic-research-endowment-to-tuskegee-university/ 2022-11-15T15:06:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Clif-Bar-Company.jpg https://bostonlifesciencestimes.com/2022/11/advanced-energy-introduces-first-fully-integrated-intelligent-configurable-capacitor-charger-for-surgical-and-aesthetic-laser-applications/ 2022-11-15T15:08:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Configurable-Capacitor-Charger.jpg https://bostonlifesciencestimes.com/2022/11/slingshot-biosciences-inc-partners-with-palex-medical-to-distribute-synthetic-cells-throughout-spain-and-portugal/ 2022-11-15T15:13:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Screenshot-2022-06-15-at-10-35-27-About-Us-%E2%80%A2-Slingshot-Bio.png https://bostonlifesciencestimes.com/2022/11/institute-for-protein-innovation-welcomes-esteemed-industry-leader-kenneth-fasman-ph-d-as-president-and-chief-executive-officer/ 2022-11-15T15:54:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Kenneth-Fasman-Ph.D..jpg https://bostonlifesciencestimes.com/2022/11/biomind-labs-announces-fda-investigational-new-drug-clearance-for-its-new-chemical-entity-triptax-targeting-treatment-resistant-depression/ 2022-11-15T16:11:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Alejandro-Antalich.png https://bostonlifesciencestimes.com/2022/11/duane-difranco-md-senior-medical-director-for-utilization-management-at-blue-cross-blue-shield-of-michigan-joins-harvard-medtechs-medical-advisory-board/ 2022-11-15T16:13:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/06/Harvard-MedTech.jpg https://bostonlifesciencestimes.com/2022/11/kyocera-develops-new-gan-laser-chip-worlds-smallest-to-be-mass-produced-from-silicon-working-substrate/ 2022-11-15T16:20:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/100-Micron-Long-Laser.jpg https://bostonlifesciencestimes.com/2022/11/insulet-issues-a-nationwide-voluntary-medical-device-correction-for-the-omnipod-5-controller/ 2022-11-15T16:24:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Omnipod%C2%AE-5-Controller.jpg https://bostonlifesciencestimes.com/2022/11/angela-byrne-rejoins-cognito-as-us-director-of-business-strategy/ 2022-11-15T16:26:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Angela-Byrne.jpg https://bostonlifesciencestimes.com/2022/11/college-students-reporting-increased-levels-of-financial-anxiety/ 2022-11-15T16:28:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Corebridge-Financial.jpg https://bostonlifesciencestimes.com/2022/11/brightwood-capital-advisors-provides-incremental-term-loan-to-support-interstate-waste-services-continued-growth/ 2022-11-15T16:31:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Brightwood-Capital-Advisors.jpg https://bostonlifesciencestimes.com/2022/11/penumbra-launches-first-hands-free-full-body-virtual-reality-based-offering-for-rehabilitation-expanding-real-system-platform/ 2022-11-15T16:32:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/REAL-y-Series.jpg https://bostonlifesciencestimes.com/2022/11/population-health-leaders-navvis-and-esse-health-finalize-merger/ 2022-11-15T16:35:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Screenshot-2022-11-15-at-11-34-31-Population-Health-Leaders-Navvis-and-Esse-Health-Finalize-Merger.png https://bostonlifesciencestimes.com/2022/11/abacus-insights-partners-with-blue-cross-blue-shield-of-massachusetts-to-accelerate-health-care-data-transformation/ 2022-11-15T16:37:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Abacus-Insights.webp https://bostonlifesciencestimes.com/2022/11/unlearn-appoints-alex-lang-ph-d-as-vice-president-technology/ 2022-11-16T14:51:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Alex-Lang-Ph.D..jpg https://bostonlifesciencestimes.com/2022/11/saama-hires-life-sciences-expert-dr-clinton-white-as-chief-delivery-officer/ 2022-11-16T14:53:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Dr.-Clinton-White.jpg https://bostonlifesciencestimes.com/2022/11/new-heartbeam-patent-for-12-lead-electrocardiogram-ecg-smartwatch-based-monitor-intended-for-detection-of-heart-attacks-and-complex-cardiac-arrhythmias/ 2022-11-16T14:55:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/HeartBeam.webp https://bostonlifesciencestimes.com/2022/11/sequre-dx-emerges-from-stealth-mode-to-fulfill-the-promise-of-on-target-gene-editing-therapies-for-biopharma-partners-physicians-and-patients/ 2022-11-16T14:58:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/SeQure-Dx.jpg https://bostonlifesciencestimes.com/2022/11/cintas-opens-brand-new-cleanroom-location-in-syracuse-region/ 2022-11-16T15:01:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Cleanroom.jpg https://bostonlifesciencestimes.com/2022/11/battery-ventures-hires-ex-palo-alto-networks-bridgecrew-executive-barak-schoster-goihman-to-expand-israel-presence/ 2022-11-16T15:05:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Barak-Schoster.jpg https://bostonlifesciencestimes.com/2022/11/austin-ericson-former-assistant-general-counsel-at-50-billion-aum-h-i-g-capital-joins-star-mountain-capital-as-legal-counsel-chief-compliance-officer/ 2022-11-16T15:13:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Austin-Ericson.jpg https://bostonlifesciencestimes.com/2022/11/cosette-pharmaceuticals-appoints-kevin-hickey-vice-president-brand-sales-and-marketing-to-accelerate-transformation/ 2022-11-17T14:27:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Kevin-Hickey.jpg https://bostonlifesciencestimes.com/2022/11/beigene-receives-european-commission-approval-for-brukinsa-zanubrutinib-for-the-treatment-of-adults-with-chronic-lymphocytic-leukemia-cll/ 2022-11-17T14:29:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/BRUKINSA.jpg https://bostonlifesciencestimes.com/2022/11/laronde-appoints-pablo-j-cagnoni-as-chief-executive-officer/ 2022-11-17T14:37:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Pablo-J.-Cagnoni.webp https://bostonlifesciencestimes.com/2022/11/afyren-signs-new-contract-to-provide-biobased-organic-acid-to-u-s-manufacturer-of-industrial-lubricants/ 2022-11-17T14:39:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/AFYREN.png https://bostonlifesciencestimes.com/2022/11/biodesix-announces-senior-secured-financing-agreement-with-perceptive-advisors-for-up-to-50-million/ 2022-11-17T14:41:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Biodesix.jpg https://bostonlifesciencestimes.com/2022/11/emmanuelle-toussaint-executive-director-of-bioquebec-is-named-one-of-canadas-most-inspiring-climate-leaders/ 2022-11-17T14:43:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Emmanuelle-Toussaint.jpg https://bostonlifesciencestimes.com/2022/11/thermo-fisher-scientific-introduces-all-in-one-aav-production-system-for-scalable-gene-therapy-workflows-and-commercial-applications/ 2022-11-17T14:45:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2022/11/solaris-biotech-and-wildtype-announce-agreement-for-large-scale-bioreactors-for-cultivated-seafood-production/ 2022-11-17T14:47:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Solaris-Industrial-Scale-Bioreactor-Systems.jpg https://bostonlifesciencestimes.com/2022/11/livanova-receives-510k-clearance-for-ecmo-from-fda-for-lifesparc-the-next-generation-advanced-circulatory-support-system/ 2022-11-17T14:57:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/LifeSPARC.png https://bostonlifesciencestimes.com/2022/11/skin-like-electronics-could-monitor-your-health-continuously/ 2022-11-17T14:59:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Wearable-electronics.jpg https://bostonlifesciencestimes.com/2022/11/vicarious-surgical-partners-with-renowned-surgeon-to-successfully-perform-two-cadaveric-ventral-hernia-procedures/ 2022-11-17T15:01:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Adam-Sachs.png https://bostonlifesciencestimes.com/2022/11/medstar-health-taps-kyndryl-to-transform-its-it-organization/ 2022-11-17T15:04:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/MedStar-Health.jpg https://bostonlifesciencestimes.com/2022/11/ge-healthcare-announces-80-million-investment-to-expand-contrast-media-production-capacity/ 2022-11-17T15:05:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/GE-Healthcare-Manufacturing-Facility-Lindesnes-Norway.jpg https://bostonlifesciencestimes.com/2022/11/delbert-laboratories-announce-the-acquisition-from-noventia-pharma-srl-of-the-european-marketing-authorisation-of-ceplene-0-5mg-0-5ml/ 2022-11-18T14:53:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/DELBERT-Laboratorie.jpg https://bostonlifesciencestimes.com/2022/11/orthofix-and-seaspine-announce-john-bostjancic-to-serve-as-cfo-for-combined-company-post-closing/ 2022-11-18T14:56:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Orthofix.webp https://bostonlifesciencestimes.com/2022/11/mayor-wu-kicks-off-vicinity-energys-electrification-plans/ 2022-11-18T14:58:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Mayor-Wu.jpg https://bostonlifesciencestimes.com/2022/11/bioohio-relaunches-as-ohio-life-sciences-ols-a-new-brand-and-reorganization-reflecting-the-dynamic-life-sciences-ecosystem-in-the-state-of-ohio/ 2022-11-18T14:59:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Steve-Huffman.jpg https://bostonlifesciencestimes.com/2022/11/carmell-therapeutics-gains-alignment-with-fda-on-a-path-forward-to-evaluate-the-use-of-its-lead-product-a-bone-healing-accelerant-in-foot-and-ankle-fusion-surgery/ 2022-11-18T15:01:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Carmell-Therapeutics.png https://bostonlifesciencestimes.com/2022/11/lsi-announces-first-ever-medtech-ecosystem-partner-in-china/ 2022-11-18T15:04:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Screenshot-2022-11-18-at-10-03-29-LSI-Announces-First-Ever-Medtech-Ecosystem-Partner-in-China.png https://bostonlifesciencestimes.com/2022/11/croivalve-reports-successful-first-in-human-implants-of-its-duo-tricuspid-coaptation-valve-system/ 2022-11-18T15:05:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/CroiValve.jpg https://bostonlifesciencestimes.com/2022/11/allurion-announces-appointment-of-moderna-co-founder-and-mit-institute-professor-robert-s-langer-as-chair-of-its-scientific-advisory-board/ 2022-11-18T15:07:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Professor-Robert-S.-Langer.jpg https://bostonlifesciencestimes.com/2022/11/delphinus-medical-technologies-to-demonstrate-softvue-whole-breast-ultrasound-system-at-rsna-annual-meeting/ 2022-11-18T15:09:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/SoftVue%E2%84%A2-3D-Whole-Breast-Ultrasound-Tomography-System.webp https://bostonlifesciencestimes.com/2022/11/opna-bio-launches-with-38-million-series-a-financing-to-advance-novel-oncology-discovery-program-and-diversified-pipeline-of-clinical-and-preclinical-programs/ 2022-11-21T14:40:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Gideon-Bollag-PhD.jpg https://bostonlifesciencestimes.com/2022/11/positive-updated-interim-results-from-nox-a12-gloria-phase-1-2-in-brain-cancer-presented-at-the-society-for-neuro-oncology-2022-annual-meeting/ 2022-11-21T14:43:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/TME-Pharma-N.V..jpg https://bostonlifesciencestimes.com/2022/11/fogpharma-announces-178-million-series-d-financing-to-advance-pipeline-of-first-in-class-helicon-polypeptide-therapeutics-targeting-major-cancer-drivers/ 2022-11-21T14:45:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/FogPharma.jpg https://bostonlifesciencestimes.com/2022/11/teva-announces-appointment-of-richard-francis-as-president-and-ceo/ 2022-11-21T14:46:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Richard-Francis.jpg https://bostonlifesciencestimes.com/2022/11/merck-to-acquire-imago-biosciences-inc/ 2022-11-21T14:48:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/merk.png https://bostonlifesciencestimes.com/2022/11/healiva-acquires-critical-cell-therapy-manufacturing-assets-from-b-braun/ 2022-11-21T14:50:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Healiva.png https://bostonlifesciencestimes.com/2022/11/peer-reviewed-study-finds-that-masimo-set-pulse-oximetry-has-no-clinically-significant-difference-in-accuracy-or-bias-between-black-and-white-people/ 2022-11-21T14:55:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Masimo-SET%C2%AE-Pulse-Oximetry-with-RD-SET%C2%AE-Sensor.jpg https://bostonlifesciencestimes.com/2022/11/swing-therapeutics-announces-positive-results-from-studies-of-stanza-a-digital-therapeutic-for-fibromyalgia-treatment/ 2022-11-21T14:58:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Swing-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/11/ameresco-announces-the-acquisition-of-wind-farm-in-west-county-cork-ireland/ 2022-11-21T15:00:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Ameresco.jpg https://bostonlifesciencestimes.com/2022/11/align-business-advisory-services-adds-dr-jeffrey-baumann-to-advisory-board/ 2022-11-21T15:03:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Dr.-Jeffrey-Baumann.jpg https://bostonlifesciencestimes.com/2022/11/biomed-realty-appoints-ankit-patel-as-executive-vice-president-and-chief-financial-officer/ 2022-11-21T15:04:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Ankit-Patel.jpg https://bostonlifesciencestimes.com/2022/11/baron-budd-obtains-537-5-million-class-settlement-for-2442-public-entities-in-monsanto-water-contamination-lawsuit/ 2022-11-21T15:06:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Monsanto.jpg https://bostonlifesciencestimes.com/2022/11/dr-cheryl-pegus-former-walmart-evp-of-health-wellness-joins-morgan-health/ 2022-11-21T15:09:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Dr.-Cheryl-Pegus.jpg https://bostonlifesciencestimes.com/2022/11/lantern-pharma-announces-positive-data-highlighting-the-anti-tumor-potency-of-drug-candidate-lp-184-for-glioblastoma-at-the-society-for-neuro-oncology-annual-meeting/ 2022-11-22T15:08:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Lantern-Pharma.jpg https://bostonlifesciencestimes.com/2022/11/generate-biomedicines-grows-leadership-team-with-head-of-vaccines-and-infectious-disease-research-and-senior-vice-president-of-technical-operations/ 2022-11-22T15:13:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Generate-Biomedicines.jpg https://bostonlifesciencestimes.com/2022/11/turbine-raises-e20-million-in-series-a-financing-to-advance-programs-partnerships-towards-the-clinic-with-worlds-first-cancer-cell-simulation-platform/ 2022-11-22T15:16:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Turbine.png https://bostonlifesciencestimes.com/2022/11/waters-introduces-new-pfas-quantitation-workflow-enabled-by-enhancements-to-waters_connect-informatics-platform/ 2022-11-22T15:18:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Waters-ACQUITY-Premier-UPLC-System.jpg https://bostonlifesciencestimes.com/2022/11/clinical-evidence-shows-reduced-costs-and-improved-outcomes-in-heart-transplantation/ 2022-11-22T15:51:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Paragonix-SherpaPak%C2%AE-Cardiac-Transport-System.jpg https://bostonlifesciencestimes.com/2022/11/collective-health-announces-chris-newman-as-chief-financial-officer/ 2022-11-22T15:54:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Collective-Health.jpg https://bostonlifesciencestimes.com/2022/11/rsv-cases-rise-again-with-90-of-us-er-physicians-treating-a-case-in-past-two-weeks-as-severity-average-caseloads-also-increase-says-wave-2-of-incrowd-rsv-tracking-report/ 2022-11-22T15:59:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/InCrowd.jpg https://bostonlifesciencestimes.com/2022/11/payzen-raises-220-million-growth-round-for-personalized-healthcare-affordability/ 2022-11-22T16:04:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/PayZen.webp https://bostonlifesciencestimes.com/2022/11/laudio-expands-leadership-operations-platform-at-unc-health-and-renews-with-boston-medical-center-launches-with-deaconess-health-system-and-kaleida-health/ 2022-11-22T16:06:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Russ-Richmond-MD.png https://bostonlifesciencestimes.com/2022/11/cross-country-healthcare-announces-new-appointment-to-board-of-directors/ 2022-11-22T16:11:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Venkat-Bhamidipati.jpg https://bostonlifesciencestimes.com/2022/11/circular-economy-totalenergies-and-air-liquide-innovate-to-produce-renewable-low-carbon-hydrogen-at-the-grandpuits-zero-crude-platform/ 2022-11-22T16:20:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Circular-Economy.jpg https://bostonlifesciencestimes.com/2022/11/bit-bio-expands-its-portfolio-with-three-new-human-cell-products-for-research-and-drug-discovery-in-neurodegenerative-and-neurological-diseases/ 2022-11-23T15:06:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/bit.bio_.jpg https://bostonlifesciencestimes.com/2022/11/waters-corporation-appoints-dan-brennan-and-mark-vergnano-to-board-of-directors/ 2022-11-23T15:08:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Waters-Corporation.jpg https://bostonlifesciencestimes.com/2022/11/airtank-announces-carecart-a-first-of-its-kind-ecommerce-platform-built-exclusively-for-the-healthcare-and-medical-technology-sectors/ 2022-11-23T15:15:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/AirTank-Inc..jpg https://bostonlifesciencestimes.com/2022/11/berry-global-announces-appointment-of-three-new-directors-and-forms-capital-allocation-committee/ 2022-11-23T15:25:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Meredith-Harper.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Chaney-Sheffield.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Peter-Thomas.jpg https://bostonlifesciencestimes.com/2022/11/strand-therapeutics-announces-series-a1-bringing-total-round-to-us97-million/ 2022-11-28T18:11:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Strand-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/11/medimaps-group-appoints-meinhard-f-schmidt-as-board-chairman-adds-anne-le-grand-and-five-additional-board-members/ 2022-11-28T18:13:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Medimaps.jpg https://bostonlifesciencestimes.com/2022/11/neurologica-announces-fda-510k-clearance-of-bodytom-64/ 2022-11-28T18:16:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/NeuroLogica-Corp..jpg https://bostonlifesciencestimes.com/2022/11/mispro-to-open-contract-vivarium-in-bostons-seaport/ 2022-11-29T14:33:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Philippe-Lamarre.webp https://bostonlifesciencestimes.com/2022/11/astrazeneca-to-acquire-neogene-therapeutics-accelerating-ambition-in-oncology-cell-therapy/ 2022-11-29T14:35:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Carsten-Linnemann-PhD.png https://bostonlifesciencestimes.com/2022/11/medical-informatics-corp-raises-27-million-in-financing-to-help-hospitals-manage-staff-shortages-and-create-new-standard-of-data-driven-care/ 2022-11-29T14:38:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Emma-Fauss-Ph.D.-scaled-e1669732691986.jpg https://bostonlifesciencestimes.com/2022/11/bighat-biosciences-announces-research-collaboration-with-merck/ 2022-11-29T14:41:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Mark-DePristo.jpg https://bostonlifesciencestimes.com/2022/11/adicet-bio-appoints-nancy-boman-m-d-ph-d-as-senior-vice-president-and-chief-regulatory-officer/ 2022-11-29T14:43:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Nancy-Boman-M.D.-Ph.D..jpg https://bostonlifesciencestimes.com/2022/11/t-heart-appoints-sarah-sorrel-as-independent-board-member/ 2022-11-29T14:44:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Sarah-Sorrel.jpg https://bostonlifesciencestimes.com/2022/11/healthcare-under-cyberattack-unprotected-medical-iot-devices-threaten-patient-care/ 2022-11-29T14:50:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Capterra.png https://bostonlifesciencestimes.com/2022/11/novocures-optune-approved-in-canada-for-the-treatment-of-newly-diagnosed-and-recurrent-glioblastoma/ 2022-11-29T14:53:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Optune.png https://bostonlifesciencestimes.com/2022/11/illinois-hiv-care-connect-presents-personal-stories-of-healthy-aging-with-hiv/ 2022-11-29T15:00:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Illinois-HIV-Care-Connect.png https://bostonlifesciencestimes.com/2022/11/ksl-pulse-scientific-named-national-distributor-in-canada-for-first-of-its-kind-covid-19-flu-at-home-molecular-test/ 2022-11-29T15:02:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Covid-19-Flu-at-home-molecular-test.jpg https://bostonlifesciencestimes.com/2022/11/dr-ravi-karra-joins-advanced-clinical-to-accelerate-global-growth-and-deliver-innovative-oncology-trials/ 2022-11-30T15:54:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Dr.-Ravi-Karra.jpg https://bostonlifesciencestimes.com/2022/11/nimble-therapeutics-names-pete-gough-as-chief-scientific-officer/ 2022-11-30T15:57:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Pete-Gough-e1669823830238.jpg https://bostonlifesciencestimes.com/2022/11/charles-river-associates-cra-acquires-biostrategies-group-inc/ 2022-11-30T15:58:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-12-at-10-21-21-Paul-Maleh-Our-People-Charles-River-Associates.png https://bostonlifesciencestimes.com/2022/11/si-ware-partners-with-eurofins-agro-to-explore-applications-for-feeds-and-forages-in-laboratory-and-field-environments/ 2022-11-30T16:00:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Si-Ware-and-Eurofins-Agro.jpg https://bostonlifesciencestimes.com/2022/11/experic-closes-14-million-series-b-financing/ 2022-11-30T16:02:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Experic.jpg https://bostonlifesciencestimes.com/2022/11/aurion-biotech-expands-its-leadership-team/ 2022-11-30T16:09:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Sterling-Chung.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Sherita-Hall.jpg https://bostonlifesciencestimes.com/2022/11/lazurite-and-hospital-for-special-surgery-announce-a-collaboration-agreement-focused-on-lazurites-arthrofree-wireless-surgical-camera-system/ 2022-11-30T16:11:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Lazurites-ArthroFree%E2%84%A2-System.jpg https://bostonlifesciencestimes.com/2022/11/utmb-and-hdt-bio-awarded-prototype-project-funding-worth-up-to-87-4m-from-the-u-s-government-to-develop-sarna-vaccine-technology/ 2022-11-30T16:15:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/UTMB.jpg https://bostonlifesciencestimes.com/2022/12/otsuka-and-sunovion-initiate-clinical-development-of-ulotaront-for-the-adjunctive-treatment-of-major-depressive-disorder/ 2022-12-01T15:00:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Otsuka.jpg https://bostonlifesciencestimes.com/2022/12/botanical-solution-inc-bsi-croda-pharma-partnership-agreement-to-accelerate-production-for-gmp-qs-21/ 2022-12-01T15:00:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Croda-Pharma.jpg https://bostonlifesciencestimes.com/2022/12/wuxi-sta-and-multiply-labs-announce-partnership-and-successfully-deploy-robotic-manufacturing-system-for-personalized-drugs/ 2022-12-01T15:02:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/The-Robotic-Cluster-in-Wuxi-City-China.jpg https://bostonlifesciencestimes.com/2022/12/obio-appoints-new-chair-and-members-to-plan-for-the-future-of-the-healthcare-innovation-sector/ 2022-12-01T15:05:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Frank-Florio.jpg https://bostonlifesciencestimes.com/2022/12/august-bioservices-closes-65m-series-b/ 2022-12-01T15:07:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Jenn-Adams-CEO-of-August-Bio.png https://bostonlifesciencestimes.com/2022/12/alnylam-ranks-1-on-boston-globes-top-places-to-work-list-for-2022/ 2022-12-01T15:08:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Alnylam-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/12/liminatus-pharma-llc-and-iris-acquisition-corp-to-combine-to-incorporate-and-accelerate-much-needed-cancer-treatments/ 2022-12-01T15:14:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Chris-Kim-JD-LL.M.-SJD-e1669907657236.png https://bostonlifesciencestimes.com/2022/12/belgian-company-minze-health-raises-e3-9m-to-further-scale-its-digital-health-solutions-for-the-treatment-of-urinary-tract-problems/ 2022-12-01T15:15:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Minze-Health.jpg https://bostonlifesciencestimes.com/2022/12/johnson-johnson-names-ceo-joaquin-duato-as-chairman-of-the-board/ 2022-12-01T15:17:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Joaquin-Duato.png https://bostonlifesciencestimes.com/2022/12/organ-recovery-systems-lifeport-liver-transporter-preserves-first-livers-for-transplant-as-part-of-the-pilot-continued-access-study/ 2022-12-01T15:19:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/LifePort-Liver-Transporter.jpg https://bostonlifesciencestimes.com/2022/12/baxter-introduces-exactamix-pro-next-generation-automated-nutrition-compounder-at-ashp-meeting/ 2022-12-01T15:21:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/ExactaMix-Pro-Automated-Compounder.jpg https://bostonlifesciencestimes.com/2022/12/surgical-innovation-associates-sia-announces-definitive-agreement-to-be-acquired-by-integra-lifesciences/ 2022-12-01T15:22:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Surgical-Innovation-Associates.jpg https://bostonlifesciencestimes.com/2022/12/akili-announces-adhd-expert-dr-scott-kollins-to-join-as-chief-medical-officer/ 2022-12-01T15:23:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Dr.-Scott-Kollins.jpg https://bostonlifesciencestimes.com/2022/12/wise-receives-fda-clearance-for-its-wise-cortical-strip-bringing-neuromonitoring-to-the-next-level/ 2022-12-01T15:26:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/WISE-Cortical-Strip.jpg https://bostonlifesciencestimes.com/2022/12/vaxxas-appoints-doug-cubbin-as-chief-financial-officer/ 2022-12-01T15:28:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Doug-Cubbin.jpg https://bostonlifesciencestimes.com/2022/12/apollo-intelligence-appoints-rey-lado-as-chief-people-officer/ 2022-12-01T15:32:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Apollo-Intelligence.jpg https://bostonlifesciencestimes.com/2022/12/scientists-develop-12-hour-method-to-predict-diabetes-onset-in-patients-using-artificial-intelligence/ 2022-12-02T15:16:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/03/Klick-Health.jpg https://bostonlifesciencestimes.com/2022/12/lsi-appoints-vice-president-of-business-development-and-vice-president-of-growth/ 2022-12-02T15:18:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Life-Science-Intelligence.jpg https://bostonlifesciencestimes.com/2022/12/cisco-investments-and-third-culture-capital-among-notable-investors-in-voiceitts-latest-funding-round-to-scale-its-accessible-speech-recognition/ 2022-12-02T15:22:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Voiceitt-scaled.jpg https://bostonlifesciencestimes.com/2022/12/turnongreen-selected-as-endorsed-supplier-of-ev-chargers-by-best-western-hotels-resorts/ 2022-12-02T15:24:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/TurnOnGreen.jpg https://bostonlifesciencestimes.com/2022/12/cosette-pharmaceuticals-announces-the-launch-of-griseofulvin-oral-suspension-125-mg-5-ml/ 2022-12-06T14:38:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Apurva-Saraf.jpg https://bostonlifesciencestimes.com/2022/12/generate-biomedicines-expands-leadership-team-with-chief-digital-officer/ 2022-12-06T14:40:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Screenshot-2022-12-06-at-09-40-20-Dimitris-Agrafiotis-NEW-EMPLOYEE-STARTING-DEC-6-2022.jpg-AVIF-Image-600-%C3%97-750-pixels.png https://bostonlifesciencestimes.com/2022/12/karuna-therapeutics-appoints-bill-meury-as-president-and-chief-executive-officer/ 2022-12-06T14:44:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Bill-Meur.jpg https://bostonlifesciencestimes.com/2022/12/activ-surgical-secures-ce-mark-approval-for-activsight-intelligent-light/ 2022-12-06T14:47:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/ActivSight%E2%84%A2-Intelligent-Light.jpg https://bostonlifesciencestimes.com/2022/12/endogastric-solutions-inc-announces-ceo-transition-and-18m-financing-to-expand-commercialization/ 2022-12-06T14:49:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/EndoGastric-Solutions-Inc..jpg https://bostonlifesciencestimes.com/2022/12/arcion-achieves-soc-type-1-type-2-certification-and-hipaa-compliance/ 2022-12-06T14:51:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Arcion.jpg https://bostonlifesciencestimes.com/2022/12/new-report-from-bluesight%e2%93%a1-sheds-light-on-u-s-consumer-trust-in-healthcare-and-pharmaceutical-management/ 2022-12-06T14:54:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Bluesight.jpg https://bostonlifesciencestimes.com/2022/12/entact-bio-launches-with-81-million-series-a-to-develop-precision-medicines-for-targeted-protein-enhancement/ 2022-12-06T14:59:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Entact-Bio.jpg https://bostonlifesciencestimes.com/2022/12/avalon-bioventures-raises-first-fund-dedicated-to-early-stage-biotech-investments/ 2022-12-06T15:02:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Avalon-BioVentures.jpg https://bostonlifesciencestimes.com/2022/12/first-patients-in-the-world-treated-with-impella-rp-flex-with-smartassist/ 2022-12-06T15:08:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Impella-RP-Flex-with-SmartAssist-Illustration.jpg https://bostonlifesciencestimes.com/2022/12/energous-receives-regulatory-approval-in-south-korea-for-wattup-powerbridge-transmitters/ 2022-12-06T15:09:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/1W-WattUp-PowerBridge-Transmitter.jpg https://bostonlifesciencestimes.com/2022/12/us-survey-signals-big-shifts-in-primary-care-to-pharmacy-clinic-settings-as-consumers-seek-lower-medication-and-healthcare-costs/ 2022-12-07T15:40:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Peter-Bonis-MD.jpg https://bostonlifesciencestimes.com/2022/12/aurion-biotech-appoints-jonathan-sparks-jd-phd-as-chief-legal-officer/ 2022-12-07T15:44:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Jonathan-Sparks-JD-PhD.jpg https://bostonlifesciencestimes.com/2022/12/endologix-receives-fda-approval-of-pma-supplement-for-afx2-system/ 2022-12-07T15:48:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/AFX2-Endovascular-AAA-System.jpg https://bostonlifesciencestimes.com/2022/12/butterfly-announces-ceo-transition/ 2022-12-07T15:54:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Butterfly-Network-Inc..jpg https://bostonlifesciencestimes.com/2022/12/simplex-quantum-inc-raises-round-of-series-a-funding/ 2022-12-07T15:56:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/SIMPLEX-QUANTUM-Inc..png https://bostonlifesciencestimes.com/2022/12/farmers-national-bank-announces-appointment-of-chief-operating-officer/ 2022-12-07T16:03:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Michael-Matuszak.jpg https://bostonlifesciencestimes.com/2022/12/uvdi-announces-promotion-of-kristine-steely-to-vice-president-global-sales/ 2022-12-07T16:06:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Kristine-Steely-UVDI-Vice-President.jpg https://bostonlifesciencestimes.com/2022/12/u-s-fda-accepts-for-priority-review-the-biologics-license-application-for-pfizers-respiratory-syncytial-virus-vaccine-candidate-for-the-prevention-of-rsv-disease-in-older-adults/ 2022-12-07T16:15:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/01/Pfizer-Building-logo.jpg https://bostonlifesciencestimes.com/2022/12/ksq-appoints-mahesh-karande-to-its-board-of-directors/ 2022-12-08T15:05:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Mahesh-Karande.png https://bostonlifesciencestimes.com/2022/12/mtti-obtains-fda-allowance-of-investigational-new-drug-ind-for-hurthle-cell-thyroid-cancer/ 2022-12-08T15:11:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Molecular-Targeting-Technologies-Inc.jpg https://bostonlifesciencestimes.com/2022/12/azalea-health-appoints-chief-technology-officer/ 2022-12-08T15:16:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Azalea-Health.jpg https://bostonlifesciencestimes.com/2022/12/cognex-acquires-german-lighting-technology-provider-sac/ 2022-12-08T15:19:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Joerg-Kuechen.jpg https://bostonlifesciencestimes.com/2022/12/kindercare-names-dr-marquita-davis-as-new-chief-academic-officer/ 2022-12-08T15:22:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Dr.-Marquita-Davis.jpg https://bostonlifesciencestimes.com/2022/12/be-biopharma-appoints-john-mayfield-ph-d-as-chief-business-officer/ 2022-12-08T15:25:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/John-Mayfield-Ph.D..jpg https://bostonlifesciencestimes.com/2022/12/green-rock-energy-partners-acquires-pennsylvania-renewable-natural-gas-production-facility/ 2022-12-08T15:27:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Green-Rock-Energy.jpg https://bostonlifesciencestimes.com/2022/12/dana-farber-cancer-institute-selects-vibrent-healths-next-generation-digital-health-research-platform-to-enable-early-detection-for-the-prevention-of-multiple-myeloma/ 2022-12-08T15:30:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Vibrent-Health.jpg https://bostonlifesciencestimes.com/2022/12/massbios-2022-transportation-survey-finds-30-increase-in-commuters-driving-alone-39-decrease-in-people-taking-public-transportation-after-covid-19/ 2022-12-08T15:32:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Kendalle-Burlin-OConnell.jpg https://bostonlifesciencestimes.com/2022/12/functional-precision-oncology-leader-kiyatec-announces-series-c-round-with-us18-million-closing-to-accelerate-adoption-of-transformational-cancer-platform/ 2022-12-12T15:58:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Kiyatec.jpg https://bostonlifesciencestimes.com/2022/12/revbio-launches-an-experiment-for-its-regenerative-biomaterial-on-the-international-space-station/ 2022-12-12T16:05:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/The-RevBio-Team.jpg https://bostonlifesciencestimes.com/2022/12/nanotronics-appoints-dr-jonathan-lee-as-chief-scientific-officer/ 2022-12-12T16:13:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Dr.-Jonathan-Lee.jpg https://bostonlifesciencestimes.com/2022/12/unosquare-acquires-airship-in-birmingham-alabama/ 2022-12-12T16:22:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Unosquare.png https://bostonlifesciencestimes.com/2022/12/savia-health-raises-8-5-million-seed-round-to-optimize-patient-care-pathways/ 2022-12-12T16:25:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/SaVia-Health.jpg https://bostonlifesciencestimes.com/2022/12/organon-appoints-kirke-weaver-as-general-counsel-and-corporate-secretary/ 2022-12-12T16:27:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Kirke-Weaver.jpg https://bostonlifesciencestimes.com/2022/12/masimo-announces-limited-market-release-of-sepsis-index/ 2022-12-12T16:30:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Masimo-Patient-SafetyNet%E2%84%A2-with-Sepsis-Index-Si%E2%84%A2.jpg https://bostonlifesciencestimes.com/2022/12/gamida-cell-announces-closing-of-25-million-financing-with-highbridge/ 2022-12-12T16:38:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Abbey-Jenkins.jpg https://bostonlifesciencestimes.com/2022/12/merck-begins-tender-offer-to-acquire-imago-biosciences-inc/ 2022-12-12T16:40:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Merck-e1637590913813.png https://bostonlifesciencestimes.com/2022/12/basecamp-research-raises-20m-series-a-to-design-protein-products-reflecting-the-worlds-biodiversity/ 2022-12-13T15:10:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Basecamp-Researc.jpg https://bostonlifesciencestimes.com/2022/12/lantern-pharma-announces-development-of-drug-candidate-lp-184-for-triple-negative-breast-cancer-tnbc/ 2022-12-13T15:11:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/11/Lantern-Pharma.jpg https://bostonlifesciencestimes.com/2022/12/veranex-acquires-fusion-biotec-to-continue-accelerating-medtech-diagnostic-solutions/ 2022-12-13T15:13:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Veranex.jpg https://bostonlifesciencestimes.com/2022/12/chimeron-bio-welcomes-kevin-heyeck-as-new-ceo/ 2022-12-13T15:15:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Kevin-Heyeck.png https://bostonlifesciencestimes.com/2022/12/tellus-therapeutics-announces-35-million-series-a-financing/ 2022-12-13T15:17:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Tellus-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/12/immunotek-plasma-expands-in-louisiana/ 2022-12-13T15:19:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/ImmunoTek-Plasma.jpg https://bostonlifesciencestimes.com/2022/12/annogen-announces-research-project-with-pfizer-to-test-non-coding-genetic-sequences/ 2022-12-13T15:22:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Annogen.jpg https://bostonlifesciencestimes.com/2022/12/regis-college-launches-healthcare-certificate-training-programs-to-address-critical-workforce-shortages-in-new-england/ 2022-12-13T15:28:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Regis-College.png https://bostonlifesciencestimes.com/2022/12/accenture-invests-in-behavr-to-help-expand-access-to-mental-and-behavioral-healthcare-using-virtual-reality/ 2022-12-13T15:31:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Accenture.jpg https://bostonlifesciencestimes.com/2022/12/masimo-takes-major-step-in-connecting-the-hospital-to-the-home/ 2022-12-13T15:34:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Masimo.jpg https://bostonlifesciencestimes.com/2022/12/tandem-diabetes-care-to-acquire-insulin-patch-pump-developer-amf-medical/ 2022-12-13T15:35:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/The-Sigi%E2%84%A2-Patch-Pump.jpg https://bostonlifesciencestimes.com/2022/12/takeda-to-acquire-late-stage-potential-best-in-class-oral-allosteric-tyk2-inhibitor-ndi-034858-from-nimbus-therapeutics/ 2022-12-13T15:38:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/Takeda.jpg https://bostonlifesciencestimes.com/2022/12/dr-cameron-k-martin-named-president-of-rocky-mountain-university-of-health-professions/ 2022-12-13T15:39:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Dr.-Cameron-K.-Martin.jpg https://bostonlifesciencestimes.com/2022/12/virpax-pharmaceuticals-reports-on-fda-pre-ind-response-for-nobrxiol/ 2022-12-14T15:09:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Virpax%C2%AE-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/12/trinity-life-sciences-announces-the-appointment-of-paul-r-lucchese-as-general-counsel/ 2022-12-14T15:13:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Paul-R.-Lucchese.jpg https://bostonlifesciencestimes.com/2022/12/fujifilms-life-sciences-corporate-venture-capital-fund-invests-in-phenovista-biosciences/ 2022-12-14T15:18:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Fujifilm.jpg https://bostonlifesciencestimes.com/2022/12/ai-proteins-expands-executive-team-with-hire-of-industry-veteran-wendy-dwyer-as-chief-business-officer/ 2022-12-14T15:23:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/AI-Proteins.png https://bostonlifesciencestimes.com/2022/12/activ-surgical-appoints-manisha-shah-bugaj-as-chief-executive-officer/ 2022-12-14T15:34:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Manisha-Shah-Bugaj.jpg https://bostonlifesciencestimes.com/2022/12/eurosets-announces-first-patient-treated-with-colibri-the-lightest-extracorporeal-life-support-system/ 2022-12-14T15:37:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Colibri.jpg https://bostonlifesciencestimes.com/2022/12/coastal-medical-transportation-systems-names-michael-pieretti-as-chief-quality-officer/ 2022-12-14T15:43:58+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Michael-Pieretti.jpg https://bostonlifesciencestimes.com/2022/12/engageware-appoints-software-veteran-nina-vellayan-as-chief-executive-officer/ 2022-12-14T15:46:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Nina-Vellayan.webp https://bostonlifesciencestimes.com/2022/12/thea-pharma-announces-fda-approval-of-iyuzeh-for-the-reduction-of-elevated-intraocular-pressure-iop-in-patients-with-open-angle-glaucoma-or-ocular-hypertension/ 2022-12-15T15:50:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Thea-Pharma.jpg https://bostonlifesciencestimes.com/2022/12/thermo-fisher-scientifics-advanced-analytical-instruments-receive-rd-100-awards/ 2022-12-15T15:56:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Thermo-Scientific-Gallery-Enzyme-Master-Enzyme-Analyzer.jpg https://bostonlifesciencestimes.com/2022/12/enlaza-therapeutics-launches-with-61-million-financing-to-advance-the-first-covalent-biologic-therapeutic-platform/ 2022-12-15T15:58:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Enlaza-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/12/parthenon-therapeutics-appoints-joseph-paul-eder-md-as-chief-medical-officer/ 2022-12-15T16:02:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Parthenon-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/12/ingenovis-health-names-robin-geiger-as-senior-vice-president-of-clinician-advocacy/ 2022-12-15T16:05:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Robin-Geiger.jpg https://bostonlifesciencestimes.com/2022/12/students-enter-the-metaverse-as-wolters-kluwer-biodigital-launch-extended-reality-anatomy/ 2022-12-15T16:08:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Wolters-Kluwer.jpg https://bostonlifesciencestimes.com/2022/12/cabinet-health-raises-17-million-to-further-its-mission-to-build-the-worlds-first-sustainable-healthcare-company-and-tackle-the-pharmaceutical-plastic-crisis/ 2022-12-15T16:13:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Cabinet-Health.jpg https://bostonlifesciencestimes.com/2022/12/edison-partners-invests-15-million-in-schedule-k-1-automation-disruptor-k1x-inc/ 2022-12-15T16:17:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Edison-Partners.png https://bostonlifesciencestimes.com/2022/12/accenture-federal-services-awarded-a-position-on-national-cancer-institutes-it-services-blanket-purchase-agreement/ 2022-12-15T16:23:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Jill-Olmstead.jpg https://bostonlifesciencestimes.com/2022/12/massachusetts-general-hospital-reports-results-of-interim-analysis-from-refine-als-biomarker-trial-by-mitsubishi-tanabe-pharma-usa-utilizing-oxford-biodynamics-episwitch-platform-for-p/ 2022-12-16T14:46:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Massachusetts-General-Hospital.png https://bostonlifesciencestimes.com/2022/12/henry-schein-makes-investment-to-form-strategic-partnership-with-biotech-dental-group/ 2022-12-16T14:53:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Henry-Schein-Inc..jpg https://bostonlifesciencestimes.com/2022/12/click-therapeutics-receives-fda-breakthrough-device-designation-for-prescription-digital-therapeutic-to-treat-episodic-migraine/ 2022-12-16T14:57:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Click-Therapeutics.jpg https://bostonlifesciencestimes.com/2022/12/disinfection-technology-company-applied-uv-announces-strategic-manufacturing-and-supply-chain-collaboration-with-canon/ 2022-12-16T15:01:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Airocide-Air-Purifier.jpg https://bostonlifesciencestimes.com/2022/12/vizabli-inc-completes-2-5m-seed-round-financing/ 2022-12-16T15:03:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Vizabli-Inc..jpg https://bostonlifesciencestimes.com/2022/12/harrow-secures-capital-to-close-recently-announced-acquisition/ 2022-12-16T15:06:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Harrow-Health.jpg https://bostonlifesciencestimes.com/2022/12/maxar-technologies-to-be-acquired-by-advent-international-for-6-4-billion/ 2022-12-16T15:07:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Maxar-Technologies.png https://bostonlifesciencestimes.com/2022/12/staar-surgical-ceo-caren-mason-to-retire-tom-frinzi-appointed-new-ceo/ 2022-12-19T16:53:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Tom-Frinzi.jpg https://bostonlifesciencestimes.com/2022/12/n-lorem-foundation-initiates-clinical-trials-for-three-nano-rare-patients/ 2022-12-19T16:56:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Sally-Luke-and-Susannah.jpg https://bostonlifesciencestimes.com/2022/12/tailormed-strengthens-nations-largest-network-of-patients-providers-pharmacies-and-life-science-companies-with-support-from-ballad-ventures-inception-health-and-university-hospitals-vent/ 2022-12-19T17:05:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/TailorMed.jpg https://bostonlifesciencestimes.com/2022/12/kite-to-acquire-tmunity-therapeutics-to-pursue-next-generation-car-t-cell-therapy-advancements-in-cancer/ 2022-12-20T16:05:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Kite-a-Gilead-Compan.png https://bostonlifesciencestimes.com/2022/12/seagen-astellas-and-merck-announce-fda-acceptance-of-sblas-for-padcev-with-keytruda-for-the-first-line-treatment-of-certain-patients-with-locally-advanced-or-metastatic-urothelial-cancer/ 2022-12-20T16:09:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/Seagen-Inc.png https://bostonlifesciencestimes.com/2022/12/ganymede-bio-the-cloud-provider-purpose-built-for-the-life-sciences-and-manufacturing-industries-raises-12-75-million-in-series-a-funding/ 2022-12-20T16:12:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Ganymede-Bio.jpg https://bostonlifesciencestimes.com/2022/12/quantum-si-announces-commercial-availability-of-platinumtm-the-worlds-first-next-generation-single-molecule-protein-sequencing-platform/ 2022-12-20T16:32:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Grace-Johnston-PhD.jpg https://bostonlifesciencestimes.com/2022/12/parallel-bio-secures-4-3-million-seed-round-to-accelerate-drug-discovery-through-human-immune-system-in-a-dish/ 2022-12-20T16:35:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Screenshot-2022-12-20-at-11-34-27-Team-%E2%80%94-Parallel-Bio.png https://bostonlifesciencestimes.com/2022/12/hims-hers-welcomes-back-dr-pat-carroll-as-chief-medical-officer/ 2022-12-20T16:41:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Dr.-Pat-Carroll.jpg https://bostonlifesciencestimes.com/2022/12/karl-storz-receives-innovative-technology-designation-from-vizient-for-tipcam1-rubina-with-artip-solo-robotic-assistance/ 2022-12-20T17:29:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/TIPCAM%C2%AE1-Rubina%C2%AE.jpg https://bostonlifesciencestimes.com/2022/12/adc-therapeutics-and-sobi-announce-european-commission-approval-of-zynlonta-loncastuximab-tesirine-for-the-treatment-of-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/ 2022-12-21T15:14:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ADC-Therapeutics-SA.png https://bostonlifesciencestimes.com/2022/12/enveda-biosciences-closes-68-million-combined-series-b-equity-and-debt-financing/ 2022-12-21T15:15:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Enveda-Biosciences.jpg https://bostonlifesciencestimes.com/2022/12/alnylam-submits-cta-application-for-aln-khk-an-investigational-rnai-therapeutic-for-the-treatment-of-type-2-diabetes/ 2022-12-21T15:17:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Alnylam-Ranks.jpg https://bostonlifesciencestimes.com/2022/12/fda-approves-impella-ecp-pivotal-heart-pump-and-first-patients-enrolled-in-pivotal-clinical-trial/ 2022-12-21T15:20:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Impella-ECP-Pivotal-Heart-Pump.jpg https://bostonlifesciencestimes.com/2022/12/ultrasound-sensor-specialist-novosound-inks-deal-with-nasdaq-listed-pavmed-inc-to-advance-intravascular-imaging-technology/ 2022-12-21T15:35:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Dave-Hughes-scaled-e1671636889955.jpg https://bostonlifesciencestimes.com/2022/12/rocket-pharmaceuticals-provides-update-on-anticipated-registration-path-for-rp-a501-in-danon-disease-following-end-of-phase-1-fda-meeting/ 2022-12-22T14:44:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rocket-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2022/12/bruce-a-hauk-named-chief-operating-officer-of-sjw-group/ 2022-12-28T16:08:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Bruce-A.-Hauk.jpg https://bostonlifesciencestimes.com/2022/12/namodenoson-increases-survival-for-the-most-severe-patients-with-advanced-liver-cancer/ 2022-12-28T16:14:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/12/Can-Fite.jpg https://bostonlifesciencestimes.com/2022/12/gilead-to-acquire-all-remaining-rights-to-potential-first-in-class-immunotherapy-gs-1811-from-jounce-therapeutics/ 2022-12-28T16:15:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2022/12/johnson-johnson-completes-acquisition-of-abiomed/ 2022-12-28T16:25:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/09/Johnson-Johnson.jpg https://bostonlifesciencestimes.com/2022/12/u-s-fda-accepts-for-review-the-biologics-license-application-for-pfizers-investigational-pentavalent-meningococcal-vaccine-candidate-menabcwy-in-adolescents/ 2022-12-28T16:43:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/04/Pfizer.jpg https://bostonlifesciencestimes.com/2023/01/biocytogen-and-hansoh-pharma-announce-an-antibody-license-agreement/ 2023-01-03T15:02:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Biocytogen.jpg https://bostonlifesciencestimes.com/2023/01/bluebird-bio-appoints-joseph-vittiglio-jd-as-chief-business-and-legal-officer/ 2023-01-03T15:05:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/bluebird-bio.png https://bostonlifesciencestimes.com/2023/01/thermo-fisher-scientific-completes-acquisition-of-the-binding-site-group/ 2023-01-03T15:07:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2023/01/vandemark-chemical-announces-jim-elliott-joining-as-chief-executive-officer/ 2023-01-03T15:11:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/VanDeMark-Chemical.png https://bostonlifesciencestimes.com/2023/01/wellvii-and-care-daily-partner-for-health-at-home/ 2023-01-03T15:19:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/myWellvii-Platform.jpg https://bostonlifesciencestimes.com/2023/01/recor-medical-names-lara-barghout-president-and-chief-executive-officer/ 2023-01-03T15:22:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/ReCor-Medical-Inc..jpg https://bostonlifesciencestimes.com/2023/01/acadia-healthcare-names-laura-groschen-companys-new-chief-information-officer/ 2023-01-03T15:32:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Laura-Groschen.jpg https://bostonlifesciencestimes.com/2023/01/new-prospective-study-evaluates-the-accuracy-of-masimo-sphb-noninvasive-and-continuous-hemoglobin-monitoring-during-elective-cesarean-section/ 2023-01-03T15:37:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Masimo-Root%C2%AE-with-SpHb%C2%AE-and-PVi%C2%AE.jpg https://bostonlifesciencestimes.com/2023/01/massbio-launches-second-year-of-massbiodrive-startup-accelerator-with-spring-2023-application-new-partnerships-and-resources/ 2023-01-03T18:32:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/08/Kendalle-Burlin-OConnell.jpg https://bostonlifesciencestimes.com/2023/01/catalyst-advisors-lp-appoints-new-partner-to-support-global-expansion-commitment-to-dei-focused-leadership/ 2023-01-04T15:43:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Dr.-Young.jpg https://bostonlifesciencestimes.com/2023/01/biognosys-and-bruker-form-partnership-for-advanced-proteomics-cro-services-for-global-biopharma-and-biomarker-customers/ 2023-01-04T15:45:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Biognosys.jpg https://bostonlifesciencestimes.com/2023/01/adc-therapeutics-appoints-mohamed-zaki-as-chief-medical-officer/ 2023-01-04T15:46:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Mohamed-Zaki-MD-PhD.jpg https://bostonlifesciencestimes.com/2023/01/experity-announces-appointment-of-brian-berning-as-chief-financial-officer/ 2023-01-04T15:48:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Brian-Berning.jpg https://bostonlifesciencestimes.com/2023/01/digitalis-ventures-appoints-misti-ushio-as-a-managing-partner/ 2023-01-04T15:54:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Dr.-Misti-Ushio.jpg https://bostonlifesciencestimes.com/2023/01/pharmaessentia-establishes-a-new-research-and-development-facility-in-the-boston-area/ 2023-01-04T15:58:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/PharmaEssentia.jpg https://bostonlifesciencestimes.com/2023/01/belharra-therapeutics-debuts-with-130-million-in-funding/ 2023-01-04T16:00:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Belharra-Therapeutics.jpg https://bostonlifesciencestimes.com/2023/01/nuvig-therapeutics-appoints-julie-smith-chief-executive-officer/ 2023-01-04T16:05:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Julie-Smith.png https://bostonlifesciencestimes.com/2023/01/sesen-bio-reiterates-confidence-in-pending-merger-with-carisma-therapeutics/ 2023-01-04T16:07:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Sesen-Bio.jpg https://bostonlifesciencestimes.com/2023/01/neurologica-announces-a-research-partnership-with-the-university-of-dundee-using-state-of-the-art-photon-counting-detector-technology/ 2023-01-04T16:09:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Photon-Counting-Detector-Technology.jpg https://bostonlifesciencestimes.com/2023/01/endostim-concludes-pre-submission-meeting-with-the-fda-and-prepares-submission-for-premarket-approval-of-the-endostim-system-for-the-treatment-of-drug-refractory-gerd/ 2023-01-04T16:16:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/EndoStim.jpg https://bostonlifesciencestimes.com/2023/01/ganymed-robotics-raises-additional-e15-m-through-series-b-extension-bringing-total-amount-to-e36-m/ 2023-01-04T16:21:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Ganymed-Robotics.png https://bostonlifesciencestimes.com/2023/01/braskem-acquires-taulman3d-expanding-its-portfolio-of-materials-for-additive-manufacturing-applications/ 2023-01-04T16:44:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/taulman3D.jpg https://bostonlifesciencestimes.com/2023/01/fda-grants-lantern-pharma-orphan-drug-designation-for-drug-candidate-lp-284-in-mantle-cell-lymphoma/ 2023-01-05T15:19:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Panna-Sharma.jpeg https://bostonlifesciencestimes.com/2023/01/onc-ai-raises-25-million-series-a-financing-co-led-by-massmutual-and-action-potential-venture-capital/ 2023-01-05T15:22:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Akshay-Nanduri.jpg https://bostonlifesciencestimes.com/2023/01/ge-healthcare-names-health-tech-pioneer-taha-kass-hout-first-chief-technology-officer/ 2023-01-05T15:26:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/GE-HealthCare.png https://bostonlifesciencestimes.com/2023/01/advanced-energy-launches-medical-and-industrial-power-conversion-platforms-with-leading-power-density/ 2023-01-05T15:28:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Advanced-Energy-Launches-Medical-and-Industrial-Power-Conversion-Platforms-with-Leading-Power-Density.jpg https://bostonlifesciencestimes.com/2023/01/cardiac-dimensions-raises-35-million-in-series-d-financing/ 2023-01-05T15:34:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/The-Carillon-Mitral-Contour-System.jpg https://bostonlifesciencestimes.com/2023/01/perspectum-completes-36-million-first-close-of-series-c-funding-led-by-oppenheimer-holdings/ 2023-01-05T15:37:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/patients-biliary-tree-and-pancreatic-duct.jpg https://bostonlifesciencestimes.com/2023/01/sofinnova-partners-welcomes-mano-iyer-as-venture-partner/ 2023-01-05T16:02:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Mano-Iyer.jpg https://bostonlifesciencestimes.com/2023/01/elligo-health-research-names-dawn-sauro-as-new-chief-operating-officer/ 2023-01-05T16:14:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Dawn-Sauro.jpg https://bostonlifesciencestimes.com/2023/01/pristine-surgical-receives-fda-510k-clearance-for-summit-the-worlds-first-4k-single-use-surgical-arthroscope/ 2023-01-05T16:29:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Summit%E2%84%A2.jpg https://bostonlifesciencestimes.com/2023/01/avs-raises-20-million-in-series-b-round-to-advance-pulsatile-intravascular-lithotripsy-pivl-solutions/ 2023-01-05T16:31:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/AVS-an-early-stage-medical-device-company.jpg https://bostonlifesciencestimes.com/2023/01/kris-srinivasan-joins-restorixhealth-as-vice-president-strategy-and-business-development/ 2023-01-05T16:37:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Kris-Srinivasan.jpg https://bostonlifesciencestimes.com/2023/01/thomas-pike-to-join-labcorp-as-president-and-chief-executive-officer-of-its-drug-development-clinical-development-business-unit/ 2023-01-05T16:41:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Thomas-Pike.jpg https://bostonlifesciencestimes.com/2023/01/positive-results-from-single-ascending-dose-phase-1-study-of-ale-f02-targeting-claudin-1/ 2023-01-09T15:28:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Roberto-Iacone.jpg https://bostonlifesciencestimes.com/2023/01/qiagen-completes-acquisition-of-verogen-strengthening-leadership-in-human-id-forensics-with-ngs-technologies/ 2023-01-09T15:30:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/11/QIAGEN.png https://bostonlifesciencestimes.com/2023/01/glycomine-announces-first-patient-dosed-in-phase-2-clinical-study-of-glm101-a-potential-treatment-for-pmm2-cdg/ 2023-01-09T15:33:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Glycomine-Inc..jpg https://bostonlifesciencestimes.com/2023/01/agilent-investing-725-million-to-expand-state-of-the-art-manufacturing-capacity-for-production-of-nucleic-acid-based-therapeutics/ 2023-01-09T15:35:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Agilent.jpg https://bostonlifesciencestimes.com/2023/01/safe-green-holdings-corp-taps-global-life-sciences-diagnostics-executive-elizabeth-cormier-may-to-join-company-board-of-directors/ 2023-01-09T15:37:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Elizabeth-Cormier-May.jpg https://bostonlifesciencestimes.com/2023/01/rimkus-announces-chief-executive-officer-transition-plans/ 2023-01-09T15:38:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/onathan-Higgins.jpg https://bostonlifesciencestimes.com/2023/01/myrtelle-announces-positive-interim-data-in-phase-1-2-clinical-trial-of-its-proprietary-investigational-gene-therapy-raav-olig001-aspa-in-canavan-disease/ 2023-01-09T15:41:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Myrtelle.png https://bostonlifesciencestimes.com/2023/01/dexcom-appoints-teri-lawver-as-chief-commercial-officer/ 2023-01-09T15:44:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Dexcom-scaled-e1673279069762.jpg https://bostonlifesciencestimes.com/2023/01/hifibio-therapeutics-receives-fda-clearance-of-ind-application-for-hfb200603/ 2023-01-09T15:47:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Liang-Schweizer-Ph.D..jpg https://bostonlifesciencestimes.com/2023/01/dla-piper-advises-arlington-capital-partners-and-everest-clinical-research-in-its-acquisition-of-brightech-international/ 2023-01-09T15:49:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/DLA-Piper.png https://bostonlifesciencestimes.com/2023/01/new-studies-demonstrate-benefits-of-using-preoperative-planning-and-navigation-in-shoulder-surgery/ 2023-01-09T15:51:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Exactech.jpg https://bostonlifesciencestimes.com/2023/01/qosina-announces-partnership-with-ilc-dover-and-expanded-portfolio-of-liquid-bag-chambers/ 2023-01-09T15:53:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/ILC-Dover-has-partnered-with-Qosina.jpg https://bostonlifesciencestimes.com/2023/01/opticyte-earns-fda-breakthrough-device-designation-for-the-first-cell-o2-patient-monitor-for-organ-failure/ 2023-01-09T15:54:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Opticyte.jpg https://bostonlifesciencestimes.com/2023/01/villagemd-announces-new-president-of-value-based-care-dr-stuart-levine/ 2023-01-09T15:57:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/VillageMD.png https://bostonlifesciencestimes.com/2023/01/rite-aid-corporation-names-elizabeth-busy-burr-interim-chief-executive-officer/ 2023-01-09T16:09:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Rite-Aid.png https://bostonlifesciencestimes.com/2023/01/new-study-evaluates-the-performance-of-masimo-sphb-noninvasive-spot-check-hemoglobin-in-the-emergency-department/ 2023-01-09T16:14:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Masimo-Rad-67%C2%AE-with-SpHb%C2%AE.jpg https://bostonlifesciencestimes.com/2023/01/ipsen-to-acquire-albireo-accelerating-growth-in-rare-disease-with-treatments-for-several-pediatric-liver-diseases/ 2023-01-09T16:17:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Ipsen.png https://bostonlifesciencestimes.com/2023/01/maugel-destefano-architects-and-the-richmond-group-complete-ksq-therapeutics-rd-facility/ 2023-01-10T14:25:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/KSQ-Therapeutics_Laboratory.jpg https://bostonlifesciencestimes.com/2023/01/global-talent-leader-wilsonhcg-acquires-personify-to-further-expand-its-healthcare-and-life-sciences-talent-solutions/ 2023-01-10T14:31:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/WilsonHCG.jpg https://bostonlifesciencestimes.com/2023/01/rocket-pharmaceuticals-expands-cardiac-gene-therapy-portfolio-with-addition-of-rp-a601-for-pkp2-acm-and-announces-positive-updated-phase-1-data-for-rp-a501-in-danon-disease/ 2023-01-10T14:34:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rocket-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2023/01/micronoma-receives-fda-breakthrough-device-designation-for-oncobiotalung-a-novel-liquid-biopsy-assay-for-lung-carcinoma-detection/ 2023-01-10T14:37:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Micronoma.jpg https://bostonlifesciencestimes.com/2023/01/nextpoint-therapeutics-announces-80-million-series-b-financing-co-led-by-leaps-by-bayer-and-sanofi-ventures-to-advance-novel-immuno-oncology-programs/ 2023-01-10T14:39:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/NextPoint-Therapeutics.png https://bostonlifesciencestimes.com/2023/01/neurotech-pharmaceuticals-inc-expands-executive-team-with-the-appointment-of-scott-hunter-as-chief-commercial-officer/ 2023-01-10T14:41:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Scott-Hunter.jpg https://bostonlifesciencestimes.com/2023/01/new-clinical-study-shows-neuroptics-neurological-pupil-index-an-important-value-for-assessing-brain-injury-is-unaffected-by-clinical-intoxication/ 2023-01-10T14:44:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/NeurOptics.jpg https://bostonlifesciencestimes.com/2023/01/aspen-surgical-announces-ceo-succession/ 2023-01-10T14:47:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Steve-Blazejewski.jpg https://bostonlifesciencestimes.com/2023/01/fresenius-kabis-ivenix-infusion-system-goes-live-at-san-luis-valley-health/ 2023-01-10T14:52:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/The-Ivenix-Infusion-System-from-Fresenius-Kabi.jpg https://bostonlifesciencestimes.com/2023/01/results-of-the-first-post-commercial-utilization-review-of-jelmyto-provide-new-evidence-that-reinforces-its-efficacy-and-safety-in-patients-with-low-grade-upper-tract-urothelial-cancer/ 2023-01-11T15:18:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Screenshot-2022-02-03-at-10-23-59-Leadership-Team-UroGen-Pharma.png https://bostonlifesciencestimes.com/2023/01/coeus-holdings-names-dean-hakanson-md-chief-medical-officer/ 2023-01-11T15:20:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/COEUS-Holdings.jpg https://bostonlifesciencestimes.com/2023/01/cari-health-raises-2-3m-in-seed-round-to-advance-remote-medication-monitoring/ 2023-01-11T15:27:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Patrik-Schmidle.png https://bostonlifesciencestimes.com/2023/01/energy4life-device-aims-to-detect-correct-and-protect-emotional-human-energy/ 2023-01-11T15:29:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Energy4Life.jpg https://bostonlifesciencestimes.com/2023/01/sheetak-announces-product-line-expansion-with-centum-c3-multi-stage-cooler-based-on-novel-patented-thermoelectric-device-structures/ 2023-01-11T15:31:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/CENTUM%C2%AE-C3-Chips.jpg https://bostonlifesciencestimes.com/2023/01/censinet-secures-9m-in-new-funding-to-accelerate-third-party-risk-management-in-healthcare/ 2023-01-11T15:33:11+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Censinet.webp https://bostonlifesciencestimes.com/2023/01/modmed-appoints-chief-people-officer-jody-beaverson/ 2023-01-11T15:35:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Jody-Beaverson.jpg https://bostonlifesciencestimes.com/2023/01/woebot-health-names-trina-histon-vice-president-of-clinical-product-strategy/ 2023-01-11T15:37:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Trina-Histon.jpg https://bostonlifesciencestimes.com/2023/01/cardiosolution-announces-new-regional-chief-medical-officers/ 2023-01-11T15:40:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Alan-Berger-M.D..jpg https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Jasdeep-Dalawari-M.D..jpg https://bostonlifesciencestimes.com/2023/01/northstar-medical-radioisotopes-sets-new-industry-precedent-in-advancing-non-uranium-based-commercial-production-of-molybdenum-99-mo-99/ 2023-01-11T15:41:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/IBA-RhodotronR-TT300-HE-High-Energy-Electron-Accelerator.jpg https://bostonlifesciencestimes.com/2023/01/the-ima-group-acquires-clinical-trials-of-america/ 2023-01-11T15:43:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/The-IMA-Group.jpg https://bostonlifesciencestimes.com/2023/01/corium-pharma-solutions-appoints-mark-sirgo-as-chief-executive-officer/ 2023-01-17T14:34:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Corium-Pharma-Solutions-Inc..jpg https://bostonlifesciencestimes.com/2023/01/lantern-pharma-receives-pre-ind-feedback-from-the-fda-clearing-a-path-for-drug-candidate-lp-184s-phase-1-clinical-trial-in-q2-2023/ 2023-01-17T14:35:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Lantern-Pharma.jpg https://bostonlifesciencestimes.com/2023/01/catalent-appoints-ricardo-zayas-as-north-american-biologics-operations-leader/ 2023-01-17T14:36:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Ricardo-Zayas.jpg https://bostonlifesciencestimes.com/2023/01/908-devices-unveils-new-glucose-and-lactate-on-line-device-for-bioprocess-monitoring-and-control/ 2023-01-17T14:38:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/05/Screenshot_2021-05-04-About-Us-908-Devices.png https://bostonlifesciencestimes.com/2023/01/helios-technologies-signs-definitive-agreement-to-acquire-schultes-precision-manufacturing/ 2023-01-17T14:41:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Helios-Technologies.jpg https://bostonlifesciencestimes.com/2023/01/one80-intermediaries-appoints-rick-grimes-as-national-wholesale-practice-leader/ 2023-01-17T14:42:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Rick-Grimes.jpg https://bostonlifesciencestimes.com/2023/01/amylyx-pharmaceuticals-announces-exclusive-amx0035-distribution-agreement-with-israel-based-neopharm/ 2023-01-17T14:45:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/07/Amylyx-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2023/01/aegis-sciences-corporation-acquires-healthtrackrxs-toxicology-business-unit/ 2023-01-17T14:51:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Aegis-Sciences-Corporation.jpg https://bostonlifesciencestimes.com/2023/01/urovant-sciences-announces-collaboration-with-holly-robinson-peete-to-help-raise-awareness-for-overactive-bladder-and-treatment-options/ 2023-01-19T14:33:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Holly-Robinson-Peete.jpg https://bostonlifesciencestimes.com/2023/01/sun-pharma-to-acquire-concert-pharmaceuticals-advancing-the-potential-treatment-of-alopecia-areata/ 2023-01-19T14:35:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Sun-Pharmaceutical.jpg https://bostonlifesciencestimes.com/2023/01/normunity-appoints-olga-granaturova-as-chief-operating-officer-and-chief-business-officer/ 2023-01-19T14:37:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Olga-Granaturova.jpg https://bostonlifesciencestimes.com/2023/01/brukinsa-zanubrutinib-receives-marketing-authorization-for-chronic-lymphocytic-leukemia-cll-and-marginal-zone-lymphoma-mzl-in-great-britain-by-mhra/ 2023-01-19T14:46:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Screenshot-2023-01-19-at-09-45-32-MehrdadMobasher_HS-800x800.png-PNG-Image-800-%C3%97-800-pixels-e1674139588719.png https://bostonlifesciencestimes.com/2023/01/setpoint-medical-announces-80m-preferred-stock-financing-to-advance-companys-novel-treatment-for-autoimmune-diseases/ 2023-01-19T14:49:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/SetPoint-Medical.jpg https://bostonlifesciencestimes.com/2023/01/surmodics-provides-regulatory-update-related-to-its-fda-premarket-approval-application-for-the-surveil-drug-coated-balloon/ 2023-01-19T14:50:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/srmdx_logo_diamond_cmyk-590cropped.jpg https://bostonlifesciencestimes.com/2023/01/feinstein-institutes-researchers-turn-on-the-vagus-nerve-control-the-inflammatory-reflex/ 2023-01-19T14:52:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Sangeeta-Chavan-PhD.jpg https://bostonlifesciencestimes.com/2023/01/revbio-receives-approval-to-start-a-dental-clinical-trial-in-italy-for-its-regenerative-biomaterial/ 2023-01-19T14:54:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/RevBio.jpg https://bostonlifesciencestimes.com/2023/01/montecito-medical-acquires-six-building-portfolio-in-kansas-city-area/ 2023-01-19T15:03:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Montecito-Medical.jpg https://bostonlifesciencestimes.com/2023/01/venti-technologies-strengthens-leadership-team-with-two-appointments-to-accelerate-growth/ 2023-01-19T15:05:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Venti-Technologies.jpg https://bostonlifesciencestimes.com/2023/01/astrazeneca-begins-tender-offer-to-acquire-cincor-pharma-inc/ 2023-01-23T15:04:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AstraZeneca-Building.jpg https://bostonlifesciencestimes.com/2023/01/tandem-diabetes-care-completes-acquisition-of-insulin-patch-pump-developer-amf-medical/ 2023-01-23T15:05:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Tandem-Diabetes.jpg https://bostonlifesciencestimes.com/2023/01/iqhq-appoints-janice-sears-and-anshul-mangal-as-independent-members-to-its-board-of-directors/ 2023-01-23T15:07:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/IQHQ.png https://bostonlifesciencestimes.com/2023/01/agilent-to-collaborate-with-quest-diagnostics-to-extend-access-to-the-agilent-resolution-ctdx-first-liquid-biopsy-test/ 2023-01-23T15:10:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Agilent-Technologies-Inc.jpg https://bostonlifesciencestimes.com/2023/01/thermo-fisher-scientific-launches-ce-ivd-marked-assay-to-detect-treatment-resistant-strains-of-hiv-1/ 2023-01-23T15:12:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Thermo-Fisher-1.jpg https://bostonlifesciencestimes.com/2023/01/xylem-to-acquire-evoqua-in-7-5-billion-all-stock-transaction/ 2023-01-23T15:14:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Xylem-Inc..png https://bostonlifesciencestimes.com/2023/01/adarx-pharmaceuticals-raises-46-million-as-lead-product-enters-the-clinic/ 2023-01-23T15:15:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/ADARx-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2023/01/the-athinoula-a-martinos-center-for-biomedical-imaging-at-massachusetts-general-hospital-selects-cubresas-brainpet-insert-system-to-support-brain-research-studies/ 2023-01-23T15:18:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Cubresa.png https://bostonlifesciencestimes.com/2023/01/kerecis-announces-new-fish-skin-burn-products/ 2023-01-23T15:20:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Kerecis.jpg https://bostonlifesciencestimes.com/2023/01/researchers-harness-the-power-of-masimo-roots-advanced-multimodal-monitoring-capabilities-to-study-the-impact-of-different-ventilatory-strategies-on-brain-oxygenation-during-thoracoscop/ 2023-01-23T15:49:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Masimo-Root%C2%AE.jpg https://bostonlifesciencestimes.com/2023/01/stevanato-group-collaborates-with-transcoject-to-provide-pre-fillable-syringe-polymer-options-for-pharma/ 2023-01-24T14:51:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Pre-Fillable-Syringe-Polymer-Options.jpg https://bostonlifesciencestimes.com/2023/01/thermo-fisher-scientific-partners-with-astrazeneca-to-develop-solid-tissue-and-blood-based-companion-diagnostic-test-for-tagrisso/ 2023-01-24T14:55:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/03/Thermo-Fisher.jpg https://bostonlifesciencestimes.com/2023/01/nippon-life-to-commit-further-1-billion-in-resolution-life-following-strategic-partnership-with-blackstone/ 2023-01-24T14:58:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Nippon-Life.jpg https://bostonlifesciencestimes.com/2023/01/entegris-chief-financial-officer-greg-graves-plans-to-retire/ 2023-01-24T15:01:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Greg-Graves.jpg https://bostonlifesciencestimes.com/2023/01/atum-announces-leap-in-transposase-licensing-agreement-with-codiak-biosciences-to-support-manufacturing-of-exosome-based-therapeutics/ 2023-01-24T15:06:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/ATUM.jpg https://bostonlifesciencestimes.com/2023/01/cytosmart-technologies-joins-the-axion-biosystems-brand/ 2023-01-24T15:19:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Axion-BioSystems.jpg https://bostonlifesciencestimes.com/2023/01/mahmee-hires-dr-amanda-williams-leader-in-maternal-health-equity-as-medical-director/ 2023-01-24T15:24:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Dr.-Amanda-Williams.jpg https://bostonlifesciencestimes.com/2023/01/heartbeam-appoints-robert-eno-as-president/ 2023-01-24T15:26:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Robert-Eno.jpg https://bostonlifesciencestimes.com/2023/01/restore-hyper-wellness-appoints-emma-nasif-as-chief-compliance-officer/ 2023-01-24T15:28:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Emma-Nasif.jpg https://bostonlifesciencestimes.com/2023/01/commercehealthcare-releases-2023-healthcare-finance-trends-report/ 2023-01-24T15:30:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Sue-Martin.jpg https://bostonlifesciencestimes.com/2023/01/trinity-health-and-strive-health-launch-kidney-care-collaboration-through-loyola-physician-partners/ 2023-01-24T15:33:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Trinity-Health.jpg https://bostonlifesciencestimes.com/2023/01/bayer-appoints-ben-kampelman-as-vice-president-of-communications-for-crop-science-north-america/ 2023-01-24T15:35:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Ben-Kampelman.jpg https://bostonlifesciencestimes.com/2023/01/forge-biologics-deepens-genetic-medicine-cdmo-capabilities-with-leadership-team-expansion-across-cgmp-manufacturing-analytical-development-and-client-development/ 2023-01-25T15:17:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Forge-Biologics.jpg https://bostonlifesciencestimes.com/2023/01/crown-bioscience-to-acquire-indivumeds-service-business-and-supporting-biobank/ 2023-01-25T15:22:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Crown-Bioscience-1.jpg https://bostonlifesciencestimes.com/2023/01/myosana-therapeutics-raises-5-million-in-seed-funding/ 2023-01-25T15:23:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Myosana-Therapeutics.jpg https://bostonlifesciencestimes.com/2023/01/miach-orthopaedics-secures-40-million-financing/ 2023-01-25T15:27:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Patrick-McBrayer-e1674660425588.jpg https://bostonlifesciencestimes.com/2023/01/tidepool-announces-fda-clearance-of-tidepool-loop/ 2023-01-25T15:28:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Tidepool.jpg https://bostonlifesciencestimes.com/2023/01/childrens-hospital-los-angeles-to-launch-5-3-million-nih-study-for-first-clinical-trial-for-down-syndrome-regression-disorder/ 2023-01-25T15:32:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Dr.-Jonathan-Santoro.jpg https://bostonlifesciencestimes.com/2023/01/new-ocean-health-solutions-promotes-marnie-hall-to-chief-marketing-and-strategy-officer/ 2023-01-25T15:34:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Marnie-Hall.jpg https://bostonlifesciencestimes.com/2023/01/montecito-medical-acquires-veterinary-property-in-charleston-sc/ 2023-01-25T15:37:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Charleston-Veterinary-Referral-Center-Charleston-SC.jpg https://bostonlifesciencestimes.com/2023/01/scientist-com-launches-softserv-a-suite-of-software-development-and-auditing-services-for-life-science-research-companies/ 2023-01-26T15:23:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/scientist.jpg https://bostonlifesciencestimes.com/2023/01/innocoll-holdings-ltd-appoints-kimball-hall-as-chief-executive-officer/ 2023-01-26T15:25:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Kimball-Hall.jpg https://bostonlifesciencestimes.com/2023/01/alleviant-medical-closes-75m-in-financing-receives-fda-ide-approval-for-pivotal-clinical-trial/ 2023-01-26T15:29:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Alleviant.png https://bostonlifesciencestimes.com/2023/01/cardiac-dimensions-appoints-angie-swenson-as-vice-president-clinical-operations/ 2023-01-26T15:31:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Cardiac-Dimensions-scaled.jpeg https://bostonlifesciencestimes.com/2023/01/know-labs-inc-names-ron-erickson-chief-executive-officer-former-ceo-phil-bosua-becomes-a-technology-consultant-to-the-company/ 2023-01-26T15:34:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Know-Labs-Inc..jpeg https://bostonlifesciencestimes.com/2023/01/bristol-myers-squibb-receives-positive-chmp-opinion-for-reblozyl-luspatercept-for-adult-patients-with-anemia-associated-non-transfusion-dependent-ntd-beta-thalassemia/ 2023-01-27T14:47:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/12/Bristol-Myers-Squibb.jpg https://bostonlifesciencestimes.com/2023/01/legend-biotech-announces-phase-3-cartitude-4-study-of-carvykti-ciltacabtagene-autoleucel-has-met-its-primary-endpoint-in-the-treatment-of-patients-with-relapsed-and-refractory-multiple-myeloma/ 2023-01-27T14:51:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Legend-Biotech.jpg https://bostonlifesciencestimes.com/2023/01/permira-to-acquire-acuity-knowledge-partners-from-equistone/ 2023-01-27T14:55:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Acuity-Knowledge.jpg https://bostonlifesciencestimes.com/2023/01/aptar-pharma-launches-first-metal-free-nasal-spray-pump-meeting-growing-need-for-highly-recyclable-packaging/ 2023-01-30T15:30:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/APF-Futurity-by-Aptar-Pharma.jpg https://bostonlifesciencestimes.com/2023/01/spesolimab-meets-primary-and-key-secondary-endpoint-for-prevention-of-generalized-pustular-psoriasis-flares/ 2023-01-30T15:33:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/gpp.jpg https://bostonlifesciencestimes.com/2023/01/alto-neuroscience-announces-60-million-in-additional-financing/ 2023-01-30T15:36:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Alto-Neuroscience.jpg https://bostonlifesciencestimes.com/2023/01/hinge-health-announces-deborah-conrad-as-companys-first-chief-marketing-officer/ 2023-01-30T15:43:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Deborah-Conrad.jpg https://bostonlifesciencestimes.com/2023/01/valent-biosciences-announces-the-acquisition-of-fbsciences/ 2023-01-30T15:50:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Valent-BioSciences.png https://bostonlifesciencestimes.com/2023/01/helios-technologies-closes-acquisition-of-schultes-precision-manufacturing/ 2023-01-30T15:54:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Helios-Technologies.jpg https://bostonlifesciencestimes.com/2023/01/vibrant-emotional-health-names-dr-tia-dole-as-new-chief-988-suicide-crisis-lifeline-officer/ 2023-01-30T15:57:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Dr.-Tia-Dole.jpg https://bostonlifesciencestimes.com/2023/01/masimo-announces-the-limited-market-release-of-visual-clinical-activity-monitoring-vcam/ 2023-01-30T15:59:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Masimo-VCAM.jpg https://bostonlifesciencestimes.com/2023/01/stemline-therapeutics-a-subsidiary-of-menarini-group-receives-u-s-fda-approval-for-orserdu-elacestrant-as-the-first-and-only-treatment-specifically-indicated-for-patients-with-esr1-mutat/ 2023-01-30T16:01:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/ORSERDU.jpg https://bostonlifesciencestimes.com/2023/01/virpax-pharmaceuticals-engages-new-england-investors-to-direct-licensing-strategy-for-envelta-in-china/ 2023-01-31T16:17:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/Virpax%C2%AE-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2023/01/bioskryb-welcomes-accomplished-genomics-executive-suresh-pisharody-as-new-ceo/ 2023-01-31T16:19:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Suresh-Pisharody.jpg https://bostonlifesciencestimes.com/2023/01/wilson-sonsini-adds-former-sec-official-tamara-brightwell-to-public-company-practice/ 2023-01-31T16:21:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Tamara-Brightwell.jpg https://bostonlifesciencestimes.com/2023/01/colossal-biosciences-secures-150m-series-b-and-announces-plan-to-de-extinct-the-iconic-dodo/ 2023-01-31T16:23:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Dr.-Beth-Shapiro-Ph.D..jpg https://bostonlifesciencestimes.com/2023/01/arima-genomics-announces-agreement-with-protean-biodiagnostics-to-make-arima-gene-fusion-test-widely-available-to-clinicians/ 2023-01-31T16:24:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Arima-Genomics.jpg https://bostonlifesciencestimes.com/2023/01/artiva-biotherapeutics-receives-fda-fast-track-designation-for-ab-101/ 2023-01-31T16:29:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Thorsten-Graef-e1675182518553.jpg https://bostonlifesciencestimes.com/2023/01/casma-therapeutics-announces-ceo-transition/ 2023-01-31T16:33:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Screenshot-2023-01-31-at-11-32-20-Our-team-Casma.png https://bostonlifesciencestimes.com/2023/01/cagent-vascular-announces-superior-lumen-gain-greater-volumetric-blood-flow-using-serration-angioplasty-a-sub-analysis-of-the-prelude-btk-study/ 2023-01-31T16:39:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Carol-A.-Burns-e1675183151281.webp https://bostonlifesciencestimes.com/2023/01/charles-river-associates-cra-expands-its-forensic-services-practice/ 2023-01-31T16:42:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/07/Screenshot-2022-07-12-at-10-21-21-Paul-Maleh-Our-People-Charles-River-Associates.png https://bostonlifesciencestimes.com/2023/01/vision-research-supplies-embedded-phantom-high-speed-camera-for-use-with-fda-cleared-sepsis-test/ 2023-01-31T16:45:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/The-Phantom-VEO-710-high-speed-camera.jpg https://bostonlifesciencestimes.com/2023/01/largest-ob-gyn-in-the-southeast-with-200-providers-selects-eclinicalworks-cloud-ehr-and-healow-solutions/ 2023-01-31T16:49:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Atlanta-Womens-Health-Group.jpg https://bostonlifesciencestimes.com/2023/01/levels-secures-7m-series-a-extension-funding-to-solve-metabolic-health-crisis/ 2023-01-31T16:57:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/01/Levels.jpg https://bostonlifesciencestimes.com/2023/02/ellipses-pharma-announces-fda-approval-of-ind-application-for-ep0042-for-patients-with-acute-myeloid-leukaemia/ 2023-02-01T14:31:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr-Rajan-Jethwa.png https://bostonlifesciencestimes.com/2023/02/gilead-awards-7-6-million-in-grants-to-advance-health-equity-in-breast-cancer/ 2023-02-01T14:33:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/06/Gilead-Sciences.png https://bostonlifesciencestimes.com/2023/02/trimas-announces-the-acquisition-of-aarts-packaging/ 2023-02-01T14:37:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/TriMas.png https://bostonlifesciencestimes.com/2023/02/frazier-life-sciences-adds-highly-experienced-t-cell-immunologist-to-team/ 2023-02-01T14:39:25+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Frazier-Life-Sciences.jpg https://bostonlifesciencestimes.com/2023/02/scenic-biotech-enters-cooperative-research-development-agreement-with-the-national-institutes-of-health-for-genetic-modifier-based-treatment-approach-for-niemann-pick-type-c-disease/ 2023-02-01T14:46:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Sebastian-Nijman.jpg https://bostonlifesciencestimes.com/2023/02/aviadobio-announces-appointment-of-jeff-goater-as-chair-of-the-board-of-directors/ 2023-02-01T14:56:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/AviadoBio.png https://bostonlifesciencestimes.com/2023/02/ronovo-surgical-emerges-with-50m-to-accelerate-paradigm-shift-towards-intelligent-robotic-laparoscopy/ 2023-02-01T14:59:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/The-Phantom-VEO-710-high-speed-camera.jpg https://bostonlifesciencestimes.com/2023/02/aluna-raises-15-3m-in-series-b-funding-to-empower-asthma-copd-and-cystic-fibrosis-patients-and-their-doctors/ 2023-02-01T15:02:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Aluna.webp https://bostonlifesciencestimes.com/2023/02/innovative-products-create-value-for-shoulder-arthroplasty-patients/ 2023-02-01T15:04:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Innovative-Products-Create-Value-for-Shoulder-Arthroplasty-Patients.jpg https://bostonlifesciencestimes.com/2023/02/xenex-makes-de-novo-petition-to-fda-for-lightstrike-uv-room-disinfection-technology/ 2023-02-01T15:12:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/LightStrike-ultraviolet.jpg https://bostonlifesciencestimes.com/2023/02/diversified-maintenance-announces-acquisition-of-perennial-medical-cleaning-solutions/ 2023-02-01T15:14:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Diversified-Maintenance.png https://bostonlifesciencestimes.com/2023/02/adc-therapeutics-announces-pricing-of-underwritten-offering-by-a-selling-shareholder/ 2023-02-02T14:26:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/ADC-Therapeutics-SA.png https://bostonlifesciencestimes.com/2023/02/biomed-realty-announces-2022-esg-achievements-portfolio-receives-gresb-and-leed-recognitions/ 2023-02-02T14:28:04+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/BioMed-Realty.jpg https://bostonlifesciencestimes.com/2023/02/advanced-energy-introduces-ultra-miniature-programmable-high-voltage-precision-dc-dc-converters/ 2023-02-02T14:30:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Ultra-Miniature-Programmable-High-Voltage-Precision-DC-DC-Converters.jpg https://bostonlifesciencestimes.com/2023/02/thermo-fisher-scientific-to-power-all-current-u-s-sites-with-100-percent-renewable-electricity/ 2023-02-02T14:31:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Marc-N.-Casper.jpg https://bostonlifesciencestimes.com/2023/02/pharmacyte-biotech-to-implement-second-10-million-share-repurchase-plan/ 2023-02-02T14:37:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/01/PharmaCyte-Biotech.jpg https://bostonlifesciencestimes.com/2023/02/reflexion-receives-fda-clearance-for-scintix-biology-guided-radiotherapy-cutting-edge-treatment-applicable-for-early-and-late-stage-cancers/ 2023-02-02T14:38:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/RefleXion.jpg https://bostonlifesciencestimes.com/2023/02/livanova-launches-sentiva-duo/ 2023-02-02T14:42:54+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/LivaNovas-SenTiva-DUO.jpg https://bostonlifesciencestimes.com/2023/02/kyocera-develops-new-contactless-intelligent-millimeter-wave-sensing-system/ 2023-02-02T14:44:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Contactless-Intelligent-Millimeter-Wave-Sensing-System.jpg https://bostonlifesciencestimes.com/2023/02/tezspire-approved-for-self-administration-in-the-us-with-a-new-pre-filled-pen/ 2023-02-02T14:48:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/02/AstraZeneca-Building.jpg https://bostonlifesciencestimes.com/2023/02/transcarent-announces-zoe-harte-as-chief-people-officer/ 2023-02-02T14:49:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Zoe-Harte.jpg https://bostonlifesciencestimes.com/2023/02/bruker-announces-successful-customer-installations-of-first-two-compact-1-0-ghz-nmr-systems-to-advance-structural-biology/ 2023-02-03T15:06:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr.-Ichio-Shimada.jpg https://bostonlifesciencestimes.com/2023/02/neurent-medical-announces-limited-market-release-of-neuromark-system-to-treat-chronic-rhinitis/ 2023-02-03T15:09:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Neurent-Medical.jpg https://bostonlifesciencestimes.com/2023/02/ambrx-biopharma-strengthens-clinical-leadership-with-appointment-of-sandra-aung-ph-d-as-head-of-clinical-development/ 2023-02-03T15:14:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Ambrx-Biopharma-scaled.jpg https://bostonlifesciencestimes.com/2023/02/vista-staffing-solutions-names-andrea-nelson-as-new-president/ 2023-02-03T15:17:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Andrea-Nelson.jpg https://bostonlifesciencestimes.com/2023/02/abp-acquisition-to-acquire-alerislife-for-1-31-per-share/ 2023-02-03T15:19:41+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/AlerisLife-Inc.-e1675437557320.png https://bostonlifesciencestimes.com/2023/02/silence-therapeutics-appoints-j-p-gabriel-as-chief-technical-operations-officer/ 2023-02-06T14:19:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/J.P.-Gabriel.jpg https://bostonlifesciencestimes.com/2023/02/cyteir-therapeutics-promotes-david-gaiero-to-chief-financial-officer/ 2023-02-06T14:22:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/David-Gaiero.jpg https://bostonlifesciencestimes.com/2023/02/zs-to-acquire-intelligent-study-design-company-trials-ai/ 2023-02-06T14:25:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/ZS.png https://bostonlifesciencestimes.com/2023/02/slingshot-biosciences-announces-11-million-in-series-a3-financing/ 2023-02-06T14:27:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Slingshot-Biosciences.jpg https://bostonlifesciencestimes.com/2023/02/the-access-to-advanced-health-institute-announces-9-9m-award-to-develop-a-nasal-spray-influenza-rna-vaccine-through-phase-1-clinical-trials/ 2023-02-06T14:31:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/AAHIs-GMP-Manufacturing-Suite.jpg https://bostonlifesciencestimes.com/2023/02/align-technology-announces-250-million-accelerated-stock-repurchase-agreement/ 2023-02-06T14:34:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Align-Technology.png https://bostonlifesciencestimes.com/2023/02/sensydia-achieves-study-target-for-heart-sound-ai/ 2023-02-06T14:36:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Sensydias-Cardiac-Performance-System.jpg https://bostonlifesciencestimes.com/2023/02/transmed7-llc-announces-first-clinical-cases-of-concorde-soft-tissue-biopsy-devices-for-commercial-launch/ 2023-02-06T14:38:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr.-Michael-Berry-MD-FACS.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Concorde-US-biopsy-device.jpg https://bostonlifesciencestimes.com/2023/02/sage-therapeutics-and-biogen-announce-fda-accepts-filing-of-new-drug-application-and-grants-priority-review-of-zuranolone-in-the-treatment-of-major-depressive-disorder-and-postpartum-depression/ 2023-02-06T14:51:10+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Sage-Therapeutics.jpg https://bostonlifesciencestimes.com/2023/02/powerplant-partners-elevates-kathryn-cicoletti-to-coo-and-jigar-majmundar-to-vp/ 2023-02-06T14:52:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Kathryn-Cicoletti.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Jigar-Majmundar.jpg https://bostonlifesciencestimes.com/2023/02/rocket-pharmaceuticals-receives-fda-regenerative-medicine-advanced-therapy-rmat-designation-for-rp-a501-gene-therapy-for-danon-disease/ 2023-02-07T13:56:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/09/Rocket-Pharmaceuticals.jpg https://bostonlifesciencestimes.com/2023/02/evonetix-closes-24-million-usd-20-million-financing/ 2023-02-07T13:58:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Colin-McCracken.jpg https://bostonlifesciencestimes.com/2023/02/folio-photonics-expands-engineering-leadership-team-with-the-appointment-of-greg-kittilson-as-vice-president-of-engineering/ 2023-02-07T14:00:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Greg-Kittilson.jpg https://bostonlifesciencestimes.com/2023/02/mb-sciences-releases-neighborhood-trials-app-to-improve-diversity-in-clinical-trials/ 2023-02-07T14:03:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/MB-Sciences.jpg https://bostonlifesciencestimes.com/2023/02/bellevue-university-professor-appointed-to-cacrep-board-of-directors/ 2023-02-07T14:04:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr.-Carlos-Del-Rio.jpg https://bostonlifesciencestimes.com/2023/02/levitasbio-launches-leviselect-suite-of-cell-depletion-enrichment-kits/ 2023-02-07T14:06:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/LevitasBio.jpg https://bostonlifesciencestimes.com/2023/02/emids-names-sean-narayanan-as-chief-executive-officer-with-founder-saurabh-sinha-to-become-chairman/ 2023-02-07T14:07:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Sean-Narayanan.jpg https://bostonlifesciencestimes.com/2023/02/mattiq-launches-with-revolutionary-approach-to-developing-sustainable-materials/ 2023-02-07T14:08:53+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Mattiq-Co-founder.jpg https://bostonlifesciencestimes.com/2023/02/stratasys-introduces-first-monolithic-multi-color-3d-printed-dentures-solution/ 2023-02-07T14:22:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/3D-printed-dentures.jpg https://bostonlifesciencestimes.com/2023/02/corentec-appoints-michael-son-as-executive-vice-president/ 2023-02-07T14:25:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Michael-Son.jpg https://bostonlifesciencestimes.com/2023/02/freudenberg-medical-expands-medical-tubing-production-to-massachusetts/ 2023-02-07T14:26:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Custom-platinum-cured-silicone-tubing-for-medical-devices.jpg https://bostonlifesciencestimes.com/2023/02/hims-launches-hard-mints-a-highly-personalized-treatment-for-erectile-dysfunction/ 2023-02-07T14:30:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Hims.jpg https://bostonlifesciencestimes.com/2023/02/amulet-capital-partners-acquires-eruptr/ 2023-02-07T14:32:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Amulet-Capital.jpg https://bostonlifesciencestimes.com/2023/02/strateos-appoints-alexander-k-arrow-as-chief-financial-officer-and-expands-team/ 2023-02-08T14:16:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Alexander-K.-Arrow.jpg https://bostonlifesciencestimes.com/2023/02/boston-headquartered-mercury-a-leader-in-healthcare-and-life-science-shipping-spearheads-relief-effort-fundraising-to-help-the-people-of-turkey/ 2023-02-08T14:18:15+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Mercury-a-Leader-in-Healthcare.jpg https://bostonlifesciencestimes.com/2023/02/novaliq-plans-to-file-a-marketing-authorization-application-for-cyclasol-in-the-e-u-for-the-treatment-of-dry-eye-disease-in-july-2023/ 2023-02-08T14:22:08+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Novaliq.png https://bostonlifesciencestimes.com/2023/02/carbios-appoints-four-new-board-members-to-strengthen-international-expertise-in-brand-development-business-growth-and-scientific-research/ 2023-02-08T14:23:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Carbios.jpg https://bostonlifesciencestimes.com/2023/02/lazurite-announces-upcoming-events-in-support-of-its-arthrofree-wireless-camera-system/ 2023-02-08T14:26:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/ArthroFree.jpg https://bostonlifesciencestimes.com/2023/02/avania-acquires-maxis-advancing-medtech-leadership-in-pre-clinical-regulatory-strategy-and-clinical-expertise/ 2023-02-08T14:28:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Avania.webp https://bostonlifesciencestimes.com/2023/02/paragonix-announces-first-pediatric-use-of-lungguard-system-in-groundbreaking-time-shift-lung-transplantation-case/ 2023-02-08T14:30:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Lisa-Anderson-Ph.D..jpg https://bostonlifesciencestimes.com/2023/02/livanova-initiates-limited-commercial-release-in-europe-of-the-essenz-perfusion-system-for-cardiopulmonary-bypass-procedures/ 2023-02-08T14:32:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Essenz.jpg https://bostonlifesciencestimes.com/2023/02/letsgetchecked-promotes-flo-newcum-to-senior-vice-president-of-strategic-account-management-to-help-the-company-continue-delivering-excellence-across-its-growing-client-portfolio/ 2023-02-08T14:36:33+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Flo-Newcum.jpg https://bostonlifesciencestimes.com/2023/02/brendan-swift-to-join-atf-medical-as-vice-president-payer-partnerships-marketing/ 2023-02-08T14:37:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Brendan-Swift.jpg https://bostonlifesciencestimes.com/2023/02/cosette-pharmaceuticals-announces-the-approval-and-launch-of-metronidazole-gel-usp-1/ 2023-02-09T14:18:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Apurva-Saraf.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Metronidazole-Gel.jpg https://bostonlifesciencestimes.com/2023/02/prokarium-announces-30-million-financing-to-deliver-lead-program-into-clinic-and-build-novel-therapeutic-platform/ 2023-02-09T14:20:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Prokarium.jpg https://bostonlifesciencestimes.com/2023/02/verily-appoints-utpal-koppikar-as-chief-financial-officer/ 2023-02-09T14:22:26+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2020/12/Verily.png https://bostonlifesciencestimes.com/2023/02/kites-tecartus-car-t-cell-therapy-demonstrates-overall-survival-benefit-in-three-year-follow-up-of-pivotal-zuma-3-trial-in-relapsed-refractory-b-cell-acute-lymphoblastic-leukemia/ 2023-02-09T14:23:12+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Kite-a-Gilead-Compan.png https://bostonlifesciencestimes.com/2023/02/eclinical-solutions-appoints-new-executive-to-global-leadership-team-to-scale-footprint-in-asia-life-sciences-market/ 2023-02-09T14:26:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Chandra-Koduru.jpg https://bostonlifesciencestimes.com/2023/02/labcorp-unveils-new-name-for-future-independent-clinical-development-business-fortrea/ 2023-02-09T14:27:17+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Fortrea.jpg https://bostonlifesciencestimes.com/2023/02/halle-berry-long-standing-pendulum-customer-joins-company-as-chief-communications-officer-and-becomes-equity-owner-and-investor/ 2023-02-09T14:29:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Halle-Berry.jpg https://bostonlifesciencestimes.com/2023/02/reshape-bio-raises-8-million-to-automate-experimental-tasks-and-build-new-infrastructure-for-food-agriculture-and-microbial-research/ 2023-02-09T14:31:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Reshape-Bio.jpg https://bostonlifesciencestimes.com/2023/02/allurion-a-global-leader-in-weight-loss-technology-to-become-publicly-listed-through-business-combination-with-compute-health-acquisition-corp/ 2023-02-09T14:34:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Allurion-Technologies.jpg https://bostonlifesciencestimes.com/2023/02/rqm-acquires-giotto-compliance/ 2023-02-09T14:41:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/RQM-e1675953699233.jpg https://bostonlifesciencestimes.com/2023/02/teva-reaches-agreement-with-florida-to-settle-the-states-price-fixing-claims/ 2023-02-09T14:43:30+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Teva-Pharmaceuticals.png https://bostonlifesciencestimes.com/2023/02/star-mountain-capital-names-george-mattson-as-president/ 2023-02-09T14:48:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/George-Mattson.jpg https://bostonlifesciencestimes.com/2023/02/leo-pharma-announces-positive-phase-3-topline-results-from-delta-2-trial-with-delgocitinib-cream-in-adults-with-moderate-to-severe-chronic-hand-eczema/ 2023-02-10T15:15:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/10/LEO-Pharma.jpg https://bostonlifesciencestimes.com/2023/02/spinal-elements-appoints-ron-lloyd-as-president-and-chief-executive-officer/ 2023-02-10T15:22:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Ron-Lloyd.jpg https://bostonlifesciencestimes.com/2023/02/virpax-announces-positive-preclinical-toxicology-results-in-support-of-molecular-envelope-technology-met/ 2023-02-13T14:18:05+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2021/08/Anthony-P.-Mack.jpg https://bostonlifesciencestimes.com/2023/02/catalent-appoints-joseph-a-ferraro-as-senior-vice-president-general-counsel-chief-compliance-officer-and-secretary/ 2023-02-13T14:20:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Joseph-A.-Ferraro.jpg https://bostonlifesciencestimes.com/2023/02/sophia-genetics-expands-partnership-with-astrazeneca-to-include-multimodal-approaches-for-cancer-drug-development/ 2023-02-13T14:22:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/SOPHiA-GENETICS.jpg https://bostonlifesciencestimes.com/2023/02/bioaffinity-technologies-appoints-julie-anne-overton-director-of-corporate-communications/ 2023-02-13T14:25:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/bioAffinity-Technologies-Inc..jpg https://bostonlifesciencestimes.com/2023/02/cardiawave-granted-3-new-patents-extending-its-intellectual-property-protection-for-its-technology-in-the-united-states/ 2023-02-13T14:28:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Cardiawaves-medical-device-Valvosoft%C2%AE.jpg https://bostonlifesciencestimes.com/2023/02/anavasi-diagnostics-receives-fda-emergency-use-authorization-for-the-ascenciodx-covid-19-test-and-the-ascenciodx-molecular-detector/ 2023-02-13T14:30:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/The-AscencioDx%C2%AE-Molecular-Detector.jpg https://bostonlifesciencestimes.com/2023/02/henry-schein-announces-400-million-share-repurchase-plan/ 2023-02-13T14:31:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/05/Henry-Schein-1.jpg https://bostonlifesciencestimes.com/2023/02/insulet-acquires-insulin-pump-patents-from-bigfoot-biomedical-as-both-companies-prioritize-improved-insulin-delivery-technologies/ 2023-02-13T14:33:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Eric-Benjamin.jpg https://bostonlifesciencestimes.com/2023/02/sunrise-receives-fda-clearance-for-its-at-home-sleep-apnea-test/ 2023-02-13T14:41:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Sunrise.webp https://bostonlifesciencestimes.com/2023/02/curi-bio-names-nicholas-a-geisse-ph-d-as-new-chief-executive-officer/ 2023-02-14T14:15:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Nicholas-A.-Geisse-Ph.D..jpg https://bostonlifesciencestimes.com/2023/02/numat-technologies-announces-appointment-of-dr-jeffrey-m-dysard-as-executive-vice-president-and-chief-technology-officer/ 2023-02-14T14:16:32+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr.-Jeffrey-M.-Dysard.jpg https://bostonlifesciencestimes.com/2023/02/new-study-illuminates-strategies-for-bioluminescence-imaging-of-the-brain/ 2023-02-14T14:18:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Promega.jpg https://bostonlifesciencestimes.com/2023/02/tasso-high-volume-liquid-blood-collection-device-earns-ce-mark-certification/ 2023-02-14T14:22:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/The-TassoOne%E2%84%A2-Plus.jpg https://bostonlifesciencestimes.com/2023/02/insulet-acquires-assets-of-automated-glucose-control-llc-agc/ 2023-02-14T14:23:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Eric-Benjamin.jpg https://bostonlifesciencestimes.com/2023/02/mdi-health-raises-20-million-series-a-to-tackle-medication-related-problems/ 2023-02-14T14:27:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/MDI-Health.jpg https://bostonlifesciencestimes.com/2023/02/amazon-ai-researcher-zachary-lipton-joins-abridge-as-chief-scientific-officer/ 2023-02-14T14:29:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Zachary-Lipton.jpeg https://bostonlifesciencestimes.com/2023/02/ferring-pharmaceuticals-announces-availability-of-rebyota-the-first-and-only-fda-approved-microbiome-based-treatment-for-the-prevention-of-recurrence-of-c-diff-infection-in-adults/ 2023-02-14T14:32:35+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/REBYOTA.jpg https://bostonlifesciencestimes.com/2023/02/safe-green-holdings-corp-announces-agreement-to-provide-four-medical-modules-to-the-peoples-health-care/ 2023-02-14T14:33:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Eric-Tate.jpg https://bostonlifesciencestimes.com/2023/02/ivy-fertility-acquires-fertility-associates-of-memphis/ 2023-02-14T14:35:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Ivy-Fertility.jpg https://bostonlifesciencestimes.com/2023/02/mahana-therapeutics-appoints-justin-zamirowski-jr-as-chief-commercial-officer/ 2023-02-15T14:16:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Justin-Zamirowski-Jr..jpg https://bostonlifesciencestimes.com/2023/02/tae-life-sciences-announces-first-cancer-patient-treatments-using-accelerator-based-biologically-targeted-radiation-therapy/ 2023-02-15T14:19:51+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/TAE-Life-Sciences.png https://bostonlifesciencestimes.com/2023/02/waters-corporation-to-acquire-wyatt-technology-light-scattering-instrument-and-software-leader/ 2023-02-15T14:21:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Waters-Corporation.jpg https://bostonlifesciencestimes.com/2023/02/the-access-to-advanced-health-institute-announces-3m-award-to-develop-an-intranasal-pan-viral-countermeasure-against-respiratory-viruses/ 2023-02-15T14:23:16+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Intranasal-Pan-Viral-Countermeasure.jpg https://bostonlifesciencestimes.com/2023/02/novasure-v5-global-endometrial-ablation-device-approved-for-use-in-canada-and-europe/ 2023-02-15T14:32:56+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/NovaSure%C2%AE-V5-Global-Endometrial-Ablation-Device.jpg https://bostonlifesciencestimes.com/2023/02/pairwise-grows-commercial-leadership-team-as-consumer-product-launch-nears/ 2023-02-15T14:38:52+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/John-Schouten.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Neil-Merritt.jpg https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Megan-Thomas.jpg https://bostonlifesciencestimes.com/2023/02/emulate-announces-inaugural-global-mps-day-and-virtual-symposium-to-raise-awareness-of-animal-model-alternatives-in-scientific-research/ 2023-02-16T14:21:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Global-MPS-Day.jpg https://bostonlifesciencestimes.com/2023/02/survey-finds-57-of-u-s-physicians-have-changed-their-perception-of-a-medication-as-a-result-of-info-on-social-media/ 2023-02-16T14:22:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Sermo.jpg https://bostonlifesciencestimes.com/2023/02/haya-therapeutics-adds-world-leading-cardiologist-and-dark-genome-pioneer-to-advisory-boards/ 2023-02-16T14:23:46+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr.-Ahmad-Masri.jpg https://bostonlifesciencestimes.com/2023/02/aera-therapeutics-launches-with-193-million-in-financing-to-enable-and-advance-the-next-generation-of-transformative-genetic-medicines/ 2023-02-16T14:25:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Aera-Therapeutics.jpg https://bostonlifesciencestimes.com/2023/02/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer/ 2023-02-16T14:27:37+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Filippo-Canducci.jpg https://bostonlifesciencestimes.com/2023/02/robigo-secures-7m-seed-round-to-protect-crops-from-untreatable-diseases/ 2023-02-16T14:28:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Robigo.png https://bostonlifesciencestimes.com/2023/02/curvafix-launches-smaller-diameter-curvafix-im-implant/ 2023-02-16T14:30:36+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/CurvaFix%C2%AE-IM-Implant.jpg https://bostonlifesciencestimes.com/2023/02/perfuze-announces-fda-clearance-and-first-u-s-clinical-use-of-millipede-088-access-catheter/ 2023-02-16T14:32:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Millipede-088-Access-Catheter.jpg https://bostonlifesciencestimes.com/2023/02/cyril-gradis-joins-dynacor-board-of-directors/ 2023-02-16T14:34:19+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Cyril-Gradis.jpg https://bostonlifesciencestimes.com/2023/02/avilar-therapeutics-increases-financing-to-75-million-to-advance-pipeline-of-novel-extracellular-protein-degraders/ 2023-02-16T14:36:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Daniel-Grau.jpg https://bostonlifesciencestimes.com/2023/02/colorado-governor-polis-helps-agilent-break-ground-on-725-million-expansion-of-manufacturing-operations-in-frederick/ 2023-02-17T14:42:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Brian-Carothers.jpg https://bostonlifesciencestimes.com/2023/02/lazurite-names-physicians-to-medical-advisory-board/ 2023-02-17T14:46:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Laith-Jazrawi-M.D..jpg https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Mark-Schickendantz-M.D..jpg https://bostonlifesciencestimes.com/2023/02/medidata-bolsters-senior-leadership-team-to-further-accelerate-the-digital-transformation-of-life-sciences-with-unmatched-end-to-end-solutions/ 2023-02-21T16:35:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Dassault-Systemes.jpg https://bostonlifesciencestimes.com/2023/02/divis-laboratories-selects-juniper-networks-for-automated-network-infrastructure-across-massive-pharma-manufacturing-facilities/ 2023-02-21T16:37:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Juniper-Networks.jpg https://bostonlifesciencestimes.com/2023/02/delphinus-medical-technologies-appoints-veteran-medical-technology-executive-scott-a-white-to-chief-commercial-officer-role/ 2023-02-21T16:38:18+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Scott-White.jpg https://bostonlifesciencestimes.com/2023/02/desktop-health-announces-global-availability-of-einstein-pro-xl-an-affordable-production-grade-3d-printer-for-dental-labs-and-other-medical-professionals/ 2023-02-21T16:39:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Einstein-Pro-XL.jpg https://bostonlifesciencestimes.com/2023/02/fentanyl-is-widening-grip-on-the-nation-as-western-presence-and-detection-with-other-drugs-increase-to-record-highs-millennium-health-signals-report-shows/ 2023-02-21T16:41:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Millennium-Health.jpg https://bostonlifesciencestimes.com/2023/02/mirion-technologies-announces-150-million-investment-from-t-rowe-price-priced-at-the-market/ 2023-02-21T16:43:02+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Mirion-Technologies-scaled.jpg https://bostonlifesciencestimes.com/2023/02/u-s-fda-accepts-biologics-license-application-for-pfizers-respiratory-syncytial-virus-maternal-vaccine-candidate-for-priority-review/ 2023-02-21T16:45:43+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/02/Pfizer-Inc.jpg https://bostonlifesciencestimes.com/2023/02/engooden-health-taps-healthcare-executive-tom-frosheiser-as-ceo/ 2023-02-21T16:48:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Engooden-Health.jpg https://bostonlifesciencestimes.com/2023/02/kite-completes-acquisition-of-tmunity/ 2023-02-22T15:25:38+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2022/10/Kite-a-Gilead-Compan.png https://bostonlifesciencestimes.com/2023/02/ansa-bio-appoints-dr-matthew-mcmanus-as-chair-of-the-board/ 2023-02-22T15:28:48+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr.-Matthew-McManus.jpg https://bostonlifesciencestimes.com/2023/02/cleara-biotech-appoints-nicholas-j-sarlis-md-phd-as-chief-medical-officer-and-head-of-clinical-development/ 2023-02-22T15:30:01+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Nicholas-J.-Sarlis-MD-PhD.jpg https://bostonlifesciencestimes.com/2023/02/gordon-rees-chicago-office-continues-expansion-with-esteemed-healthcare-team/ 2023-02-22T15:34:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Diane-E.-Webster.jpg https://bostonlifesciencestimes.com/2023/02/nanovibronix-to-launch-rental-program-for-painshield-and-uroshield/ 2023-02-22T15:36:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/PainShield.jpg https://bostonlifesciencestimes.com/2023/02/spectrum-solutions-receives-fda-510k-class-ii-medical-device-clearance-for-sdna-saliva-collection-device/ 2023-02-22T15:37:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Spectrum-Solutions-has-received-FDA-510k-Class-II-Medical-Device-Clearance-for-SDNA-Saliva-Collection-Device..jpg https://bostonlifesciencestimes.com/2023/02/cartography-biosciences-appoints-chester-wong-as-vp-head-of-business-development/ 2023-02-23T15:59:28+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Chester-Wong.jpg https://bostonlifesciencestimes.com/2023/02/with-6-5m-in-new-funding-earthly-introduces-fast-repeatable-easy-to-use-saas-ci-cd-platform/ 2023-02-23T16:04:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Earthly.jpg https://bostonlifesciencestimes.com/2023/02/portable-butterfly-iq-ultrasound-system-for-university-hospital-bonn-and-faculty-of-medicine-students/ 2023-02-23T16:13:45+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Prof.-Wolfgang-Holzgreve.jpg https://bostonlifesciencestimes.com/2023/02/review-highlights-growing-evidence-that-pharmajets-precision-delivery-devices-improve-nucleic-acid-vaccine-performance/ 2023-02-23T16:15:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/PharmaJet.jpg https://bostonlifesciencestimes.com/2023/02/health-care-ceos-u-s-surgeon-general-to-convene-at-northwell-healths-4th-annual-gun-violence-prevention-forum/ 2023-02-23T16:18:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Michael-Dowling.jpg https://bostonlifesciencestimes.com/2023/02/elliott-bay-announces-joint-venture-to-acquire-healthcare-properties-across-the-us/ 2023-02-23T16:21:03+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Elliott-Bay-Capital-Trust.jpg https://bostonlifesciencestimes.com/2023/02/gridium-strengthens-balance-sheet-with-14m-in-funding-to-accelerate-growth/ 2023-02-23T16:25:14+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Gridium.jpg https://bostonlifesciencestimes.com/2023/02/childrens-hospital-los-angeles-leads-nation-in-liver-transplants/ 2023-02-23T16:29:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Childrens-Hospital-Los-Angeles-Liver-Transplant-Team.jpg https://bostonlifesciencestimes.com/2023/02/mouthwatch-introduces-dentistry-one/ 2023-02-23T16:33:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dentistry.jpg https://bostonlifesciencestimes.com/2023/02/natera-appoints-ruth-e-williams-brinkley-to-its-board-of-directors/ 2023-02-23T16:34:40+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Ruth-E.-Williams-Brinkley.jpg https://bostonlifesciencestimes.com/2023/02/perkinelmer-launches-envison-nexus-multimode-plate-reader-to-drive-improved-research-and-discovery-workflows/ 2023-02-24T15:22:59+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/EnVision%C2%AE-Nexus%E2%84%A2-Multimode-Plate-Reader.jpg https://bostonlifesciencestimes.com/2023/02/compana-pet-brands-launches-technical-center-of-excellence-led-by-new-chief-veterinary-officer-dr-micah-kohles/ 2023-02-27T15:27:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr.-Micah-Kohles.jpg https://bostonlifesciencestimes.com/2023/02/oni-appoints-paul-scagnetti-as-ceo-to-implement-next-chapter-of-growth/ 2023-02-27T15:28:50+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Paul-Scagnetti.jpg https://bostonlifesciencestimes.com/2023/02/saranas-appoints-mike-mackinnon-as-ceo/ 2023-02-27T15:33:07+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Mike-MacKinnon.jpg https://bostonlifesciencestimes.com/2023/02/cortney-stapleton-named-chief-executive-officer-of-the-bliss-group/ 2023-02-27T15:36:42+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Cortney-Stapleton.jpg https://bostonlifesciencestimes.com/2023/02/palm-medical-centers-adds-business-development-officer-to-accelerate-network-growth/ 2023-02-27T15:38:20+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Brandon-Zeman.jpg https://bostonlifesciencestimes.com/2023/02/atlatl-closed-fundraising-launched-the-pioneering-project-aseed-along-with-hillhouse-co-founding-an-innovative-ecosystem-in-life-sciences/ 2023-02-28T14:27:39+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Aseed-project.jpg https://bostonlifesciencestimes.com/2023/02/spectrum-chemical-expands-biocertified-products-portfolio-to-meet-growing-demand-for-biologics/ 2023-02-28T14:29:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Jim-Luchsinger.jpg https://bostonlifesciencestimes.com/2023/02/korro-bio-appoints-dr-steve-colletti-as-chief-scientific-officer/ 2023-02-28T14:32:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Dr.-Steve-Colletti.png https://bostonlifesciencestimes.com/2023/02/synergy-laboratories-taps-sophia-genetics-technology-for-new-cancer-profiling-solution/ 2023-02-28T14:37:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Joseph-Cohil.webp https://bostonlifesciencestimes.com/2023/02/microba-launches-next-generation-healthcare-testing/ 2023-02-28T15:08:13+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Microba.jpg https://bostonlifesciencestimes.com/2023/02/beautyhealth-to-acquire-skinstylus-fda-cleared-microneedling-device/ 2023-02-28T15:14:29+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/SkinStylus%C2%AE.jpg https://bostonlifesciencestimes.com/2023/02/stratasys-signs-agreement-with-ricoh-usa-inc-for-print-on-demand-medical-models/ 2023-02-28T15:24:22+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/02/Anatomic-3D-printed-models.jpg https://bostonlifesciencestimes.com/2023/03/strand-therapeutics-appoints-jay-stella-as-chief-business-officer/ 2023-03-01T14:00:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Jay-Stella.jpg https://bostonlifesciencestimes.com/2023/03/trinity-life-sciences-launches-contract-analytics-offering-allowing-life-sciences-companies-to-confidently-navigate-u-s-contracting-and-gross-to-net-decision-making/ 2023-03-01T14:04:21+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/trinity-life-sciences.jpg https://bostonlifesciencestimes.com/2023/03/alten-acquires-qa-consultants-bringing-independent-software-quality-engineering-capabilities-to-its-services-portfolio/ 2023-03-01T14:05:44+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/QA-Consultants.jpg https://bostonlifesciencestimes.com/2023/03/thymmune-secures-7m-in-seed-financing-to-develop-thymus-cell-therapy-platform-for-immune-system-renewal/ 2023-03-01T14:08:06+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Thymmune.png https://bostonlifesciencestimes.com/2023/03/cytoimmune-therapeutics-appoints-yulii-bogatyrenko-as-chief-business-officer-and-expands-the-board-of-directors-with-the-appointment-of-graeme-bell/ 2023-03-01T14:12:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/CytoImmune-Therapeutics.jpg https://bostonlifesciencestimes.com/2023/03/tandemai-raises-35-million-in-series-a-financing-to-expand-integrated-computational-and-wet-lab-solutions-to-accelerate-drug-discovery/ 2023-03-01T14:15:27+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/TandemAI.png https://bostonlifesciencestimes.com/2023/03/wave-neuroscience-to-lead-panel-on-brainwave-data-and-the-future-of-mental-health-at-sxsw-2023/ 2023-03-01T14:18:55+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Wave-Neuroscience.jpg https://bostonlifesciencestimes.com/2023/03/reflexion-announces-installation-of-x1-platform-at-smilow-cancer-hospital-at-yale-new-haven/ 2023-03-01T14:20:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/RefleXion%C2%AE-X1-platform-at-Smilow-Cancer-Hospitalv.jpg https://bostonlifesciencestimes.com/2023/03/nexus-pharmaceuticals-inc-receives-fda-approval-for-emerphed-ephedrine-sulfate-injection-pre-filled-syringe/ 2023-03-01T14:24:31+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/EMERPHED.jpg https://bostonlifesciencestimes.com/2023/03/lisa-davidson-joins-bliss-bio-health-as-executive-vice-president/ 2023-03-01T14:27:09+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Lisa-Davidson.jpg https://bostonlifesciencestimes.com/2023/03/theoremone-taps-joe-devon-for-head-of-accessibility-with-a-mandate-to-build-ai-for-accessibility-services/ 2023-03-01T14:29:34+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Joe-Devon.jpg https://bostonlifesciencestimes.com/2023/03/ge-healthcare-announces-completion-of-phase-i-subject-recruitment-in-early-clinical-development-program-for-a-first-of-its-kind-macrocyclic-manganese-based-mri-contrast-agent/ 2023-03-01T14:31:00+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/GE-HealthCare.jpg https://bostonlifesciencestimes.com/2023/03/hannon-armstrong-appoints-former-exim-chairman-kimberly-a-reed-and-ceo-jeffrey-a-lipson-to-board-of-directors/ 2023-03-01T14:33:57+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Kimberly-A.-Reed.jpg https://bostonlifesciencestimes.com/2023/03/oligo-factory-opens-new-state-of-the-art-oligo-manufacturing-facility/ 2023-03-02T15:35:47+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Oligo-Factory.jpg https://bostonlifesciencestimes.com/2023/03/vector-laboratories-acquires-click-chemistry-tools-and-fluoroprobes-to-expand-manufacturing-capabilities/ 2023-03-02T15:38:24+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Vector-Laboratories-scaled.jpg https://bostonlifesciencestimes.com/2023/03/aptar-appoints-julie-xing-to-its-board-of-directors/ 2023-03-02T15:59:49+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/Julie-Xing.jpg https://bostonlifesciencestimes.com/2023/03/terapore-technologies-raises-10m-to-bring-precision-nanofiltration-solutions-to-new-markets/ 2023-03-02T16:04:23+00:00 https://bostonlifesciencestimes.com/wp-content/uploads/2023/03/TeraPore-Technologies.jpg